RVIV Reviv3 Procare Company (QB)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

FORM 10-K

 

x	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE FISCAL YEAR ENDED MAY 31, 2024

 

OR

 

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM TO

 

Commission file number: 001-41958

 

 

AXIL BRANDS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware		47-4125218
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

   

901 S Fremont Avenue, Unit 158, Alhambra, CA		91803 (Zip Code)
(Address of Principal Executive Offices)

 

(888) 638-8883 

(Registrant’s telephone number including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		AXIL		The NYSE American

 

Securities registered pursuant to section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. 

YES ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act: 

YES ☐ No ☒ 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ¨ 

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ¨ 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). YES ☐ NO ☒

 

As of November 30, 2023 the last business day of the registrant’s most recently completed second fiscal quarter, the aggregate market value of the voting and non-voting common equity held by non-affiliates was $29,428,114.95. For purposes of this computation, all officers, directors and 10% beneficial owners of the registrant are deemed to be affiliates. Such determination should not be deemed to be an admission that such officers, directors or 10% beneficial owners are, in fact, affiliates of the registrant.

 

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.

 

		Shares Outstanding
Title of Class		August 6, 2024
Common Stock		6,393,939

 

Documents incorporated by reference: None

 

 

Table of Contents 

 

Cautionary Note Regarding Forward-Looking Information
PART I	1
ITEM 1. BUSINESS.	1
ITEM 1A. RISK FACTORS.	5
ITEM 1B. UNRESOLVED STAFF COMMENTS.	5
ITEM 1C. CYBERSECURITY.	6
ITEM 2. PROPERTIES.	7
ITEM 3. LEGAL PROCEEDINGS.	7
ITEM 4. MINE SAFETY DISCLOSURES.	7
PART II	8
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.	8
ITEM 6. [RESERVED]	8
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.	9
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.	14
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.	14
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.	14
ITEM 9A. CONTROLS AND PROCEDURES.	14
ITEM 9B. OTHER INFORMATION.	16
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.	16
PART III	17
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.	17
ITEM 11. EXECUTIVE COMPENSATION.	21
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.	23
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.	25
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.	26
PART IV	27
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.	27
ITEM 16. FORM 10-K SUMMARY	30
SIGNATURES	30

 

Cautionary Note Regarding Forward-Looking Information 

 

This Annual Report on Form 10-K, in particular Part II Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains certain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements represent our expectations, beliefs, intentions or strategies concerning future events, including, but not limited to, any statements regarding our assumptions about financial performance; the continuation of historical trends; the sufficiency of our cash balances for future liquidity and capital resource needs; the expected impact of changes in accounting policies on our results of operations, financial condition or cash flows; anticipated problems and our plans for future operations, including expected growth; and the economy in general or the future of the beauty and hair care industry and the hearing protection and ear bud business, all of which are subject to various risks and uncertainties.

 

There are a number of factors that could cause our actual results to differ from those indicated in the forward-looking statements, many of which are outside of our control. They include: the impact of unstable market and general economic conditions on our business, financial condition and stock price, including inflationary cost pressures, interest rate changes, decreased discretionary consumer spending, supply chain disruptions and constraints, labor shortages, ongoing economic disruption, the possibility of an economic recession and other macroeconomic factors, geopolitical events and uncertainty, including the effects of the Ukraine-Russia conflict and the Israel-Hamas conflict and other downturns in the business cycle or the economy; our financial performance and liquidity, including our ability to successfully generate sufficient revenue to support our operations; our expectations regarding our financing arrangements and our ability to obtain additional capital if and as needed, including potential difficulties of obtaining financing due to market conditions resulting from geopolitical conditions and other economic factors; risks related to our operations and international markets, such as fluctuations in currency exchange rates, different regulatory environments, trade barriers and sanctions, exchange controls, and social and political instability; changes in the regulatory environment in which we operate, including environmental, health and safety regulations, including those related to climate change; our ability to protect and defend our intellectual property; continuity and security of information technology infrastructure and the potential impact of cybersecurity breaches or disruptions to our management information systems; widespread outages, interruptions or other failures of operational, communication, and other systems; competition; our ability to retain our management and employees and the potential impact of ongoing labor shortages; demands on management resources; availability and cost of the raw materials we use to manufacture our products, including the impacts of inflationary cost pressures and ongoing supply chain disruptions and constraints, which have been, and may continue to be, exacerbated by the Russia-Ukraine conflict, Israel-Hamas conflict and other geopolitical conflicts; additional tax expenses or exposures; product liability claims; the potential outcome of any legal or regulatory proceedings, including ongoing litigation, the disposition of which may have an adverse effect upon our business, financial condition, or results of operations; our ability to engage in acquisitions, investments, partnerships, strategic alliances or dispositions when desired; global or regional catastrophic events, including the effects of natural disasters, which may be worsened by the impact of climate change; effectiveness of our marketing strategy, demand for and market acceptance of our products, as well as our ability to successfully anticipate consumer trends; labor relations; the potential impact of environmental, social and governance matters; implementation of environmental remediation matters; our ability to remediate the material weaknesses in our internal control over financial reporting; and risks related to our common stock, including our ability to maintain our stock exchange listing and the risk that the increase in the stock price following the recent reverse stock split will not be maintained or that the reverse stock split will not otherwise have its intended effect.

 

When used in this Annual Report on Form 10-K and other reports, statements, and information we have filed with the Securities and Exchange Commission (“SEC”), in our press releases, presentations to securities analysts or investors, or in oral statements made by or with the approval of an executive officer, the words or phrases “believes,” “can,” “may,” “will,” “expect,” “should,” “could,” “would,” “continue,” “anticipate,” “intend,” “likely,” “estimate,” “project,” “plan,” “design,” “potential,” “focus” or similar expressions and variations thereof are intended to identify such forward-looking statements. However, any statements contained in this Annual Report on Form 10-K that are not statements of historical fact may be deemed to be forward-looking statements. Furthermore, such forward-looking statements speak only as of the date of this Annual Report on Form 10-K. We caution that these statements by their nature involve risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors. These forward-looking statements are not guarantees of our future performance and involve risks, uncertainties, estimates and assumptions that are difficult to predict. We do not assume the obligation to update any forward-looking statement, except as required by applicable law. You should carefully evaluate such statements in light of factors described in this annual report.

 

The terms “we,” “us,” “our,” “AXIL,” and “the Company” refer to AXIL Brands, Inc. and, where applicable, its consolidated subsidiary.

 

This report also contains estimates and other statistical data obtained from publicly available information, including industry publications, relating to market size and growth and other data about our industry. Industry publications generally state that they obtain their information from sources that they believe to be reliable, but they do not guarantee the accuracy and completeness of the information. Similarly, while we believe that the statistical data and industry data are reliable, we have not independently verified the data. We have not sought the consent of the sources to refer to their reports appearing or incorporated by reference in this report. We did not commission any third party for collecting or providing data used in this report.

 

PART I

 

ITEM 1. BUSINESS.

 

General

 

AXIL is engaged in the manufacturing, marketing, sale and distribution of high-tech, innovative hearing and audio enhancement and protection products that provide cutting-edge solutions for people with varied applications across many industries and professional quality hair and skin care products under various trademarks and brands. The Company is not, and has not been at any time, a shell company. On June 16, 2022 we completed the acquisition of substantially all of the assets of Axil & Associated Brands Corp. (“A&A”), a leader in hearing and audio enhancement and protection. Effective February 14, 2024, the Company changed its name from “Reviv3 Procare Company” to “AXIL Brands, Inc.” We operate on a fiscal year ending May 31.

  

Our Segments

 

Following the A&A acquisition, we conduct our business through two operating segments: hearing enhancement and protection, and hair care and skin care. See Note 15 to our Consolidated Financial Statements in this report for financial information for these segments. We concentrate on attracting new customers and retaining existing customers to increase our total revenue. For the fiscal year ended May 31, 2024, the hearing enhancement and protection segment and the hair care and skin care segment accounted for approximately 95.0% and 5.0% of our revenue, respectively.

 

Our Strategy

 

The Company's strategy centers on driving growth by expanding market share within existing channels and developing new ones through both online and traditional platforms. The Company’s primary focus is optimizing its e-commerce strategies, building sales teams to meet the needs of distribution channels, and enhancing value through strategic partnerships.

 

The Company is in the early stages of executing its geographic expansion into new markets. The Company’s innovation strategy continues to prioritize technological improvements in the hearing enhancement and protection sector. The Company is researching and analyzing potential new verticals to identify and prioritize product investments that will support our expansion into new markets while continuing to serve our existing target markets effectively.

 

Hearing Enhancement and Protection Segment

 

Following the June 16, 2022 A&A acquisition and under the AXIL and related brands, we create high-tech, innovative hearing and audio enhancement and protection products to provide cutting-edge solutions for people with varied applications across many industries, including ear plugs, ear muffs and ear buds. Following the acquisition, the Company shifted its primary business focus to the sale of our premium audio enhancement and protection products sold under the AXIL brand. The Company designs, innovates, engineers, manufactures, markets and services specialized systems in hearing enhancement, hearing protection, wireless audio, and communication. We distribute our products through direct-to-consumer eCommerce channels and local, regional, and national retail chains. We serve the sporting goods market, military, federal agents, law enforcement, tactical, fitness, outdoor, industrial, sporting, and stadium events. We focus primarily on the U.S. markets, followed by Canada, Europe, Australia, New Zealand, and Africa.

 

Currently, through our hearing protection and enhancement segment, we produce 22 products with 38 different stock keeping unit (“SKUs”) and have plans to continue expanding the product lines. The product line includes ear buds, ear muffs, ear plugs, and outdoor speakers. Some of the products incorporate Bluetooth technology that we continually develop to enhance the hearing experience while protecting the ears. AXIL engages product design services to align consumer preferences with the brand image, ensuring that all product lines will correlate. The majority of sales occur through direct-to-consumer via www.goaxil.com, third party platforms, dealers and distributors. Our intellectual property portfolio in this segment includes 2 trademarks and 3 active patents globally. For more information about our intellectual property see “Intellectual Property” below.

 

Our products in this segment include GS Extreme® sound enhancement and hearing protection ear buds with Bluetooth functionality, XCOR® True Wireless, digital ear buds with touch control, TRACKR™ Blu advanced sound enhancement, hearing protection, and Bluetooth audio earmuffs and X-PRO passive ear protection.

 

Our hearing protection and enhancement segment continues to grow as it enters into new distribution and licensing agreements. Our target markets include industrial, construction, farm and agriculture, aviation, forestry, and recreational markets (such as fitness, hiking, biking, auto racing, target shooting, hunting, power sports, power tools, motorcycling, stadium and concert events).

 

Hearing Enhancement and Protection Marketing and Sales:

 

The Company is growing the business as it continues to enter into new distribution and licensing agreements. There is focus on public safety and security markets, as well as entertainment venues. Sales are primarily driven by paid advertising, the expansion of our distribution network, and strategic partnerships, with continued growth expected. The Company continues to expand our marketing footprint in organic social, affiliate, and search engine optimization. The Company has increased its focus on opportunities in domestic and international distribution and retail sales and is allocating resources to expand its sales team, based on capital performance and available opportunities.

 

Hearing Enhancement and Protection Competition:

 

The hearing enhancement and protection products are in a distinct market that overlaps between the consumer electronics and the hearing protection device sectors. We believe the global hearing protection devices market is growing due to the greater awareness of hearing loss. According to the Center for Disease Control and Prevention, 53% of noise-exposed workers report not wearing hearing protection. Demand for innovative products for hearing protection is rising as consumers seek devices that are both comfortable and offer superior hearing protection.

 

The hearing protection and enhancement segment competes with ISOtunes, Walker’s, SureFire, Sordin and others. Many of our competitors in this market have more broadly diversified product lines, well established supply and distribution systems, loyal customer bases and significant financial, marketing, research and development, and other resources. We believe our principal competitive advantages include: brand recognition; product technology and innovation; product quality and safety; price; breadth of product lines; network of technology and content partners; access to third party retailers; sales channels, distributors, retailers and OEM partners; and patent protection. 

 

Hair Care and Skin Care Segment

 

Our hair care and skin care business consists of manufacturing, marketing, sale and distribution of professional quality hair and skin care products under various trademarks and brands and has adopted and used trademarked products for distribution throughout the U.S., Canada, Europe and Asia pursuant to the terms of 12 exclusive distribution agreements with various parties throughout our targeted markets. Our manufacturing operations are outsourced and fulfilled through our co-packers and manufacturing partners.

 

Currently, we produce 8 products with 16 SKUs and plan to expand our product lines in the foreseeable future. Our intellectual property portfolio in this segment includes no patents and 1 trademark globally. For more information about our intellectual property see “Intellectual Property” below.

 

Our primary focus in the hair and skin care segment is to expand our distribution and salon sales through new and existing domestic and international distributors. We are maintaining our emphasis on direct-to-consumer marketing through our e-commerce site and various third-party online platforms. Additionally, we are exploring new revenue opportunities, including co-branding and private-label manufacturing.

 

Hair Care and Skin Care Marketing and Sales:

 

The Reviv3 Procare brand stands for skin health and benefits of healthy scalp and hair follicles. Currently, we sell our hair and skincare products under the Reviv3 Procare brand which includes 8 distinct products. Our Reviv3 Procare System is a series of products which are meant to be used together or on a stand-alone basis. The hair care products consist of PREP shampoo, PRIME conditioner, and TREAT maintenance care. We also sell an introductory kit which includes all three Reviv3 Procare products. In addition, we have products dedicated to hair treatment and repair. Currently we have 3 products in our treatment and repair line. BOOST is designed to deliver nutrients and increase circulation to the scalp, MEND Deep Hair Repair Mask is designed for added moisture and PROTECT is a heat protectant product to prevent damage from irons and dryers. We also have a stand-alone Thickening Spray for giving hair more volume and body.

 

Our hair care and skin care unit is focused on expanding our distribution and salon sales through new and existing domestic and international distributors. We are maintaining our emphasis on direct-to-consumer marketing through our e-commerce site and various third-party online platforms. Additionally, we are exploring new revenue opportunities, including co-branding and private-label manufacturing.

 

Hair Care and Skin Care Competition:

 

According to Statista, the Beauty & Personal Care market worldwide is projected to generate a revenue of $646.20 billion in 2024. The market is projected to grow at an annual rate of 3.33% from 2024 to 2028. The largest segment within this market is Personal Care, which is expected to reach a market volume of $282.80 billion in 2024. 

 

The hair care and skin care segment competes with Keranique, Zenagen, Revita and others. Many of our competitors in this market have more broadly diversified product lines, well established supply and distribution systems, loyal customer bases and significant financial, marketing, research and development and other resources. We believe our principal competitive advantages include product quality, online marketing, and drug-free solutions for healthy scalp and hair.

 

Key Customers

 

For the hearing enhancement and protection segment which accounts for approximately 95% of total revenue, no customers accounted for more than 10% of our net sales in the fiscal year ended May 31, 2024. Approximately 91% of our sales were direct-to-consumer via Shopify and Amazon for the fiscal year ended May 31, 2024.

 

As is customary in the industry, none of our customers is under any obligation to continue purchasing products from us in the future.

 

Key Suppliers

 

Similar to other specialty retailers, we purchase a significant portion of our total inventory from a limited number of vendors. During fiscal year 2024, for our hearing enhancement and protection segment, 87% of our total purchases were from one vendor, and for our hair care and skin care segment, 97% of our total purchases were from two vendors, including 77% from one and 20% from another. The loss of any one or more of these key vendors or our failure to establish and maintain relationships with these and other vendors could have a material adverse effect on our results of operations and financial condition. Our relationships with our vendors allowed us to maintain a competitive in-stock position.

 

Customer Service and Support

 

Key elements of our customer service approach are listening to customers, empathizing with their concerns, responding timely to their requests, and following up with them to make sure any issues have been properly addressed. In order to ensure that sufficient quality of service is provided, we use a customer service platform that integrates all of our systems to provide complete and timely data and tracks all support tickets and conversations with customers. Our customer service manager performs regular monthly reviews of performance metrics and reviews processes. 

 

Governmental Regulation

 

We are subject to a variety of laws, rules and regulations in numerous jurisdictions within the U.S., Canada, Europe, Australia, New Zealand, and Africa. These laws, rules and regulations cover several diverse areas including consumer health and safety, and employee health and safety. These U.S. federal, state, and foreign laws and regulations, which in some cases can be enforced by private parties in addition to government entities, are constantly evolving and can be subject to significant change. The compliance costs and operational burdens imposed by these laws and regulations could be significant. As a result of the often rapidly evolving changes, the application, interpretation, and enforcement of these and other laws and regulations are often uncertain and may be interpreted and applied inconsistently from jurisdiction to jurisdiction and inconsistently with our current policies and practices. We are committed to conducting our business in accordance with applicable laws, rules and regulations.

 

Environmental Matters: We believe that we are in compliance with applicable foreign, federal, state, and local laws, rules and regulations relating to the protection of the environment, and that continued compliance will not have any material effect on our capital expenditures, earnings, or competitive position.

 

Intellectual Property

 

We intend to protect our technology by filing patent applications for the technologies that we consider important to our business. We also rely on trademarks, trade secrets, copyrights and unpatented know-how to protect our proprietary rights.

 

We believe our intellectual property has value, and we have taken in the past, and will take in the future, actions we deem appropriate to protect such property from misappropriation. There can be no assurance, however, that such actions will provide meaningful protection from competition. In the absence of intellectual property protection, we may be vulnerable to competitors who attempt to copy or imitate our products or processes.

 

While we believe that our patents and other proprietary rights are important to our business, we also believe that, due to the rapid pace of technological change in the markets we serve, the successful manufacture and sale of our products also depends upon our engineering, manufacturing, marketing and servicing skills.

 

It is our practice to require that all of our employees and third-party product development consultants assign to us all rights to inventions or other discoveries relating to our business that were made while working for us. In addition, all employees and third-party product development consultants agree not to disclose any private or confidential information relating to our technology, trade secrets or intellectual property.

 

At May 31, 2024, we held 3 active U.S. patents and had 3 pending U.S. patent applications covering various aspects of our technology. Our U.S. patents expire at various times beginning in 2035 and extending through 2038. During the fiscal year ended May 31, 2024, no new U.S. patents were issued to us and no U.S. patents expired. We do not anticipate any expiration of any of our patents in the future years will have a material impact on our business.

 

We have 3 federally registered trademarks for which we consider to be of material importance to our business The registrations for these trademarks are in good standing with the U.S. Patent & Trademark Office. Our trademark registrations must be renewed at various times, and we intend to renew our trademarks, as necessary, for the foreseeable future.

 

In addition, we own reviveprocare.com and www.goaxil.com. As with phone numbers, we do not have, and cannot acquire any property rights to an Internet address. The regulation of domain names in the United States and in other countries is also subject to change. Regulatory bodies could establish additional top-level domains, appoint additional domain name registrars or modify the requirements for holding domain names. As a result, we might not be able to maintain our domain names or obtain comparable domain names, which could harm our business.

 

Seasonality

 

We do not believe our business is subject to substantial seasonal fluctuations. We may experience lower sales in difficult economic scenarios, but we do not foresee the seasonality of our products to be a significant factor.

 

Human Capital Management

 

As of May 31, 2024, we had 14 employees all of whom were employed in the United States and none employed outside the United States. None of our employees are covered by collective bargaining agreements or work councils. Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees, advisors and consultants. Overall, we consider our employee relations to be good and believe our culture to be central to the success of the Company.

 

Health and Safety: The health and safety of our employees is of utmost importance to us. We are continuing to enhance our safety program with additional training and internal risk and hazard assessments. We conduct policy and procedure reviews to ensure compliance with health and safety guidelines and regulatory requirements. We provide protective gear (e.g., eye protection, masks, and gloves) as required by applicable standards and as appropriate. Our goal is to achieve a level of work-related injuries as close to zero as possible through continuous investment in our safety program. 

 

Hiring Practices: We seek to recruit and hire the most qualified people for our open positions without regard to protected status (age, color, creed, disability, domestic violence victim status, gender identity, genetic predisposition or carrier status, marital status, national origin, pregnancy, race religion, sex, sexual orientation, status as a protected veteran or as a member of any other protected group or status).

 

Diversity and Inclusion: Recognizing and respecting our employees’ backgrounds and experiences, and our international presence, we strive to maintain a diverse workforce and inclusive work environment everywhere we operate. 

 

Compensation and Benefits: Our compensation and benefits program is designed to attract and reward individuals who demonstrate the ability and desire to enhance our workplace culture, support our values, drive our operational and strategic goals, and create long-term value for our stockholders.

 

Our Office and Corporate History

 

Our principal executive office is located at 901 S. Fremont Avenue, Unit 158, Alhambra, California 91803. Our telephone number is (888) 638-8883. Axil Brands, Inc. was incorporated in the State of Delaware on May 21, 2015 as a reorganization of Reviv3 Procare, LLC, which was organized on July 31, 2013.

 

Available Information

 

We file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, proxy statements and other information with the Securities and Exchange Commission (“SEC”). Our filings with the SEC are available on the SEC’s website at www.sec.gov. We also maintain websites at reviveprocare.com and www.goaxil.com. We make available, free of charge, in the Investor Relations section of our website, documents we file with or furnish to the SEC, including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports. We make this information available as soon as reasonably practicable after we electronically file such materials with, or furnish such information to, the SEC. The information found on our website is not part of this or any other report we file with, or furnish to, the SEC. Any reference to our websites in this Form 10-K is intended to be an inactive textual reference only. Copies of such documents are available in print at no charge to any stockholder who makes a request. Such requests should be made to our corporate secretary at our corporate headquarters, 901 S. Fremont Avenue, Unit 158, Alhambra, California 91803.

 

ITEM 1A. RISK FACTORS.

 

As a smaller reporting company, we are not required to provide the information required by this Item 1A. 

 

ITEM 1B. UNRESOLVED STAFF COMMENTS.

 

Not applicable.

 

ITEM 1C. CYBERSECURITY.

 

Cybersecurity is an important part of our Enterprise Risk Management (“ERM”) program, and the Company seeks to address cybersecurity risks through a comprehensive, cross-functional approach. The Company’s cybersecurity policies, standards, processes, and practices for assessing, identifying and managing material risks from cybersecurity threats and responding to cybersecurity incidents are continuously analyzed and updated. The Company has established controls and procedures, including an Incident Response Plan, that provide for the identification, notification, escalation, communication, and remediation of data security incidents at appropriate levels so that so that decisions regarding the public disclosure and reporting of such incidents can be made by management in a timely manner. As part of its cybersecurity program, the Company utilizes firewalls, anti-malware, intrusion prevention and detection systems, and access controls. The Company periodically assesses and tests its policies, standards, processes and practices that are designed to address cybersecurity threats and incidents, reports results of such assessments to the Company’s Board of Directors (the “Board”), and periodically makes adjustments to the Company’s cybersecurity program based on these exercises. The Company engages third parties to conduct such testing. The Company seeks to identify and oversee cybersecurity risks presented by third parties and their systems from a risk-based perspective by implementing a comprehensive risk assessment framework, conducting regular audits, and establishing stringent security protocols and standards for third-party engagements. This approach ensures that potential vulnerabilities are identified and mitigated, thereby protecting the Company’s assets and maintaining robust security throughout its supply chain. The Company also conducts cybersecurity training for employees (including mandatory training programs for system users).

 

Our executive management team is responsible for assessing and managing risks from cybersecurity threats to the Company. In addition, in light of the pervasive and increasing threat from cyberattacks, the Board and the Audit Committee, with input from management, assesses the Company’s cybersecurity threats and the measures implemented by the Company in an effort to mitigate and prevent cyberattacks. The Audit Committee consults with management regarding ongoing cybersecurity initiatives, and requests management to report to the full Board regularly on their assessment of the Company’s cybersecurity program and risks. Both the Audit Committee and the full Board receive regular quarterly reports from management on cybersecurity risks and timely reports regarding any significant cybersecurity incident, as well as ongoing updates regarding any such incident until it has been addressed.

 

As of the date of this report, the Company is not aware of any risks from cybersecurity threats that have materially affected or are reasonably likely to materially affect the Company, including its business strategy, results of operations, or financial condition.

 

ITEM 2. PROPERTIES.

 

We currently lease approximately 3,296 square feet of office and warehouse space at 901 S Fremont Avenue, Unit 158, Alhambra, CA 91803 as our principal offices. We lease our offices pursuant to a lease dated November 9, 2022. The term of our lease began on December 1, 2022 and expires on November 30, 2024. Our current monthly base rent is $6,342. We believe these facilities are in good condition and satisfy our operational requirements. We intend to seek additional leased space, which we expect will include some warehouse facilities, as our business grows.

 

We also lease office and warehouse space at 120 E. 13065 S. #101, Draper, Utah 84020 of approximately 2,750 square feet, on a month to month lease with current monthly base rent of $4,330, which is used by the hearing protection and enhancement segment. We believe this office and warehouse are in good condition and satisfy our operational requirements.

 

ITEM 3. LEGAL PROCEEDINGS.

 

From time to time, we become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. While the ultimate resolution is unknown, we do not expect that these lawsuits will individually, or in the aggregate, have a material adverse effect to our results of operations, financial condition, or cash flows. However, the outcome of any litigation is inherently uncertain, and there can be no assurance that any expense, liability, or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular period, depending upon the size of the loss or our income for that particular period.

 

Where it is probable that we will incur a loss and the amount of the loss can be reasonably estimated, we record a liability in our financial statements. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters progress over time. These legal accruals may be increased or decreased to reflect any relevant developments on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, we do not record an accrual, consistent with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be predicted with certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on our results of operations, financial position or cash flows, and the amounts accrued for any individual matter are not material. However, legal proceedings are inherently uncertain. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular period, depending upon the size of the loss or our income for that particular period.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

 

Our common stock commenced trading on the NYSE American on February 14, 2024, under the symbol “AXIL.” Prior to that date, our common stock was quoted on the OTCQB tier of the OTC Markets Group Inc. under the symbol “RVIV.”

 

Securities outstanding and holders of record

 

On August 6, 2024, the total common shares issued and outstanding were 6,393,939 and we had 225 stockholders of record of our common stock.

 

Dividend Policy

 

We have never paid any cash dividends on our common stock and we do not expect to pay cash dividends on our common stock in the foreseeable future. Any future determination to pay dividends on our common stock will be at the discretion of our Board and will depend on our financial condition, results of operations, capital requirements, applicable restrictions in our Articles of Incorporation, applicable restrictions in our Bylaws, contractual limitations, and other factors that our Board deems relevant.

 

Recent Sales of Unregistered Securities

 

Under the terms of the Company’s non-employee director compensation arrangements and pursuant to the 2022 Equity Incentive Plan (as amended, the “Plan”), on February 14, 2024, the Company granted each of its three non-employee Board members 5,000 shares of restricted stock for an aggregate of 15,000 shares of the Company’s common stock that will vest on the one-year anniversary of the grant, subject to the respective director’s continued service as a member of the Board.

 

Effective May 28, 2024, a former officer entered into a Separation Agreement and Release (the “Release”), which includes a standard release of claims and confidentiality and non-disparagement provisions. As consideration for signing the Release, the Company entered into a Consulting Agreement, dated May 28, 2024, with the former officer (the “ Consulting Agreement”), pursuant to which the former officer agreed to provide transition services to the Company through October 31, 2024, unless the Consulting Agreement is terminated earlier. Pursuant to the Consulting Agreement, as compensation for services as a consultant, the former officer was granted 30,000 shares of restricted common stock, which vested upon grant.

 

In addition, during the first quarter of fiscal year 2025, 10,000,000 shares of the Company’s Series A Preferred Stock were converted into 500,000 shares of common stock.

 

The issuances of the securities described above were deemed to be exempt from registration pursuant to Section 4(a)(2) of the Securities Act, including Regulation D and Rule 506 promulgated thereunder, as transactions by the Company not involving a public offering.

 

Issuer Repurchases

 

On March 5, 2024, the Company entered into repurchase agreements with certain stockholders of the Company to purchase in the aggregate 207,748,250 shares of Series A Preferred Stock of the Company (equivalent, in aggregate, to 10,387,413 shares of the Company’s common stock on an as converted basis) for aggregate cash consideration of $1,246,490. This repurchase was approved by the Board. The Company funded the repurchase through cash on hand.

 

ITEM 6. [RESERVED]

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

The following discussion should be read in conjunction with our financial statements and the notes thereto included in this Report beginning on page 23. The results shown herein are not necessarily indicative of the results to be expected in any future periods. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements. Please see the section entitled “Cautionary Note Regarding Forward-Looking Information” above for more information regarding the risks associated with forward-looking information.

 

Overview

 

We are engaged in the manufacturing, marketing, sale and distribution of high-tech, innovative hearing and audio enhancement and protection products that provide cutting-edge solutions for people with varied applications across many industries and professional quality hair and skin care products under various trademarks and brands.

 

As part of the Company’s ongoing rebranding efforts, the Company changed its name from Reviv3 Procare Company to AXIL Brands, Inc. effective February 14, 2024. In addition, on February 14, 2024, the Company successfully completed efforts to uplist from the over-the-counter, or OTC, markets to the NYSE American stock exchange.

 

On May 1, 2022, we entered into an Asset Purchase Agreement dated May 1, 2022 and amended on June 15, 2022 and September 8, 2022 with A&A, a Delaware corporation, and a leader in hearing protection and enhancement products, for the acquisition of both the hearing protection business of A&A consisting of ear plugs and ear muffs, and A&A’s ear bud business. These businesses constituted substantially all of the business operations of A&A. The acquisition was completed subsequently on June 16, 2022. On September 8, 2022, the Company and A&A entered into an amendment to the Asset Purchase Agreement which eliminated the provision in the Asset Purchase Agreement requiring the Company to effectuate a reverse stock split of our common stock and preferred stock pursuant to the Asset Purchase Agreement within a certain period of time.

 

Effective as of January 16, 2024, the Company effected a reverse stock split of the Company’s issued shares of common stock at a ratio of 1-for-20. The reverse stock split did not affect the total number of shares of common stock that the Company is authorized to issue, and any fractional shares remaining after the reverse stock split were rounded up to the nearest whole share. The accompanying consolidated financial statements and notes to the financial statements give retroactive effect to the reverse stock split for all periods presented, unless otherwise specified.

 

As a result of the acquisition of A&A’s assets, the Company has two reportable segments: hair care and skin care, and hearing enhancement and protection.

 

Through our hearing enhancement and protection segment, we design, innovate, engineer, manufacture, market and service specialized systems in hearing enhancement, hearing protection, wireless audio, and communication. Through our hair care and skin care segment, we manufacture, market, sell, and distribute professional quality hair and skin care products. 

 

The Company’s overall business strategy is to establish market awareness of our products through our direct-to-consumer campaigns. We believe the increase in awareness will allow the Company to increase distribution and gain customers through our distribution partners’ retail establishments, with the goal of helping us achieve growth in market share and diversify our sales channels.

 

Results of Operations

 

For the fiscal years ended May 31, 2024 and 2023

 

Our results of operations are summarized below.

 

		Fiscal Year Ended May 31, 2024				Fiscal Year Ended May 31, 2023
Net sales		$	27,498,539			$	23,521,027
Cost of sales		$	7,304,602			$	5,810,216
Gross profit		$	20,193,937			$	17,710,811
Total operating expenses		$	18,690,557			$	15,726,600
Income from operations		$	1,503,380			$	1,984,211
Net income after tax		$	2,003,134			$	1,824,575

 

Net sales increased by $3,977,512 or 17% for the fiscal year ended May 31, 2024, as compared to the fiscal year ended May 31, 2023, primarily due to the increase in sales initiatives in our hearing protection and enhancement segment. 

 

Cost of sales includes primarily the cost of products and freight-in costs. For the fiscal year ended May 31, 2024, the overall cost of sales increased by $1,494,386 or 26%, as compared to the comparable period in 2023 due to increases in our branding and marketing initiatives which increased our sales, thereby leading to an increased cost of sales. Cost of sales as a percentage of net revenues for the fiscal year ended May 31, 2024 was 26.6% as compared to 24.7% for the comparable period in 2023.

 

Gross profit, as a percentage of sales, for the fiscal years ended May 31, 2024 and 2023 was 73.4% and 75.3%, respectively. The decrease in gross profit, as a percentage of sales, was primarily attributable to costs associated with expansion into new retail and distribution channels.

 

Operating expenses are costs related to marketing and selling expenses, compensation and related taxes, professional and consulting fees, and general and administrative costs. Operating expenses for the fiscal years ended May 31, 2024 and 2023 were $18,690,557 and $15,726,600, respectively. Operating expenses as a percentage of net revenues for the fiscal year ended May 31, 2024 were 68.0% as compared to 66.9% for the comparable period in 2023. Operating expenses increased by $2,963,957 or 18.8% due to an increase in marketing and selling expenses of $1,773,848 as a result of costs for displaying our products through various advertising platforms. The remaining $1,190,109 increase was attributable to an increase in professional and consulting expenses of $1,168,506, including expenses related to our listing on NYSE American, partially offset by a decrease of $381,908 in compensation and general and administrative expenses.

 

Income from operations for the fiscal years ended May 31, 2024 and 2023 was $1,503,380 and $1,984,211, respectively. The year over year decrease in income from operations of $480,831 was primarily driven by increased operational expenses relating to the listing on NYSE American.

 

Other income for the fiscal years ended May 31, 2024 and 2023 was $279,549 and $71,277, respectively. The year over year increase in other income of $208,272 was primarily driven by an increase in interest income of $175,756 and an increase in gain on debt settlement of $28,682.

 

Net income after tax for the fiscal years ended May 31, 2024 and 2023 was $2,003,134 and $1,824,575, respectively. The increase of $178,559 for the fiscal year ended May 31, 2024 was primarily related to the tax benefits recognized in relation to the utilization of accumulated tax losses. 

 

Liquidity and Capital Resources 

 

We are currently engaged in our product sales and development. Although we earned net income in the fiscal years ended May 31, 2024 and 2023, we have incurred operating losses in the past. We currently expect to continue to earn net income during the current fiscal year ending May 31, 2025. We believe our current cash balances, coupled with anticipated cash flow from operating activities, will be sufficient to meet our working capital requirements for at least one year from the date of issuance of the accompanying consolidated financial statements. We intend to continue to control our cash expenses as a percentage of expected revenue on an annual basis and thus may use our cash balances in the short-term to invest in revenue growth. As a result of the acquisition of A&A’s assets, we have generated and expect we will continue to generate sufficient cash for our operational needs, including any required debt payments, for at least one year from the date of issuance of the accompanying consolidated financial statements. Management is focused on growing the Company’s existing product lines, introducing new products, as well as expanding its customer base, to increase its revenues. The Company cannot give assurance that it can increase its cash balances or limit its cash consumption and thus maintain sufficient cash balances for its planned operations or future acquisitions. Future business demands, including those resulting from the purchase of A&A’s assets in June 2022, may lead to cash utilization at levels greater than recently experienced. The Company cannot provide any assurance that it will be able to raise additional capital or obtain necessary financing on acceptable terms, or at all. Subject to the foregoing, management believes that the Company has sufficient capital and liquidity to fund its operations for at least one year from the date of issuance of the accompanying consolidated financial statements. 

 

Cash Flows For the Fiscal Years ended May 31, 2024 and 2023

 

The following table provides detailed information about our net cash flows: 

 

		For the Fiscal Year  Ended May 31, 2024				For the Fiscal Year  Ended May 31, 2023
Cash Flows
Net cash provided by operating activities		$	2,677			$	2,918,136
Net cash provided by (used in) investing activities			(160,525	)			1,000,764
Net cash provided by (used in) financing activities			(1,432,756	)			540,051
Net increase (decrease)		$	(1,590,604	)		$	4,458,951

 

Operating Activities

 

For the Fiscal Years ended May 31, 2024 and 2023

 

Net cash provided by operating activities for the fiscal year ended May 31, 2024 was $2,677, attributable to a net income of $2,003,134 which was primarily driven by product revenues. This was augmented by non-cash items such as depreciation and amortization expense of $130,610, bad debts of $25,471, inventory obsolescence of $46,895, stock-based compensation of $267,183, and favorable changes in accounts payable and other current liabilities of $142,470. The net cash provided by operating activities was offset by a decrease in operating assets and liabilities of $2,302,317 primarily due to an increase in inventory, prepaid expenses, and accounts receivable and decrease in contract liabilities and a non-cash gain on debt settlement of $79,182.

 

Net cash provided by operating activities for the fiscal year ended May 31, 2023 was $2,918,136, attributable to a net income of $1,824,575 which was primarily driven by the A&A asset acquisition and increased product revenues. This was augmented by non-cash items such as depreciation and amortization expense of $95,179 due to assets and intangibles acquired on acquisition, bad debts of $76,969 as related to the greater number of customers from the AXIL brand sales, inventory changes of $353,985 as higher levels from the new business line, stock-based compensation of $207,342, favorable changes in accounts payable, contract and current liabilities of $1,235,788. The net cash provided by operating activities was offset by a net decrease in operating assets and liabilities of $825,203 primarily due to an increase in prepaid expenses and accounts receivable and decrease in customer deposits and a non-cash gain on debt settlement of $50,500.

 

Investing Activities

 

For the Fiscal Years ended May 31, 2024 and 2023

 

The Company invested $138,445 in the purchase of property and equipment and $22,080 in the purchase of intangibles during the fiscal year ended May 31, 2024. The Company invested $65,650 in the purchase of property and equipment and acquired $1,066,414 of cash as part of the A&A asset acquisition during the fiscal year ended May 31, 2023.

 

Financing Activities

 

For the Fiscal Years ended May 31, 2024 and 2023

 

Net cash used in financing activities for the fiscal year ended May 31, 2024 was $1,432,756 primarily attributable to the cash paid for the repurchase of preferred stock of $1,246,490 and repayment of the equipment loan, note payable and related party loan of $186,266.

 

Net cash provided by financing activities for the fiscal year ended May 31, 2023 was $540,051 primarily attributable to the cash proceeds of $447,850 for the common stock issuance and $132,620 advances from a related party, partially offset by repayments of equipment financing and repayment of note payable that totaled $40,419.

 

As of May 31, 2024, we had the following secured loan outstanding, administered pursuant to the CARES Act: an Economic Injury Disaster Loan (“EIDL”) in the principal amount of $150,000. The Company continues to pay interest on the loan. 

 

During June 2022, we acquired assets of A&A, a leader in hearing protection and enhancement products, including the acquisition of both the hearing protection business of A&A, consisting of ear plugs and ear muffs, and A&A’s ear bud business. We purchased the business pursuant to issuances of common stock and preferred stock.

 

We are dependent on our product sales to fund our operations and may require additional capital in the future, such as pursuant to the sale of additional common stock or of debt securities or entering into credit agreements or other borrowing arrangements with institutions or private individuals, to maintain operations, which may not be available on favorable terms, or at all, and could require us to sell certain assets or discontinue or curtail our operations. If the current equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult, more costly and more dilutive. Our officers and directors have made no written commitments with respect to providing a source of liquidity in the form of cash advances, loans, and/or financial guarantees. We do not have any plans to seek additional financing at this time and anticipate that our existing cash equivalents and cash provided by operations will be sufficient to meet our working capital requirements. However, if the need arises for additional cash, there can be no assurance that we will be able to raise the capital we need for our operations on favorable terms, or at all. We may not be able to obtain additional capital or generate sufficient revenues to fund our operations. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay or abandon our business plans. If we are unsuccessful at raising sufficient funds, for whatever reason, to fund our operations, we may be forced to cease operations. If we fail to raise funds, we expect that we will be required to seek protection from creditors under applicable bankruptcy laws.

 

Off-Balance Sheet Arrangements

 

As of May 31, 2024, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results or operations, liquidity, capital expenditures or capital resources that is material to investors.

 

Critical Accounting Policies

 

Our discussion and analysis of our results of operations, liquidity and capital resources are based on our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities. Significant estimates made by management include, but are not limited to, the allowance for doubtful accounts, inventory valuations and classifications, the useful life of property and equipment, the valuation of lease liabilities and related right of use assets, the value of stock-based compensation, valuation of deferred tax assets, contract liability, allowance on sales returns, business combinations, segment reporting and the fair value of non-cash common stock issuances. We base our estimates on historical and anticipated results and trends and on various other assumptions that we believe are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results that differ from our estimates could have a significant adverse effect on our operating results and financial position. We believe that the following significant accounting policies and assumptions may involve a higher degree of judgment and complexity than others:

 

Accounts receivable and allowance for doubtful accounts

 

The Company has a policy of providing an allowance for doubtful accounts based on its best estimate of the amount of probable credit losses in its existing accounts receivable. The Company periodically reviews its accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may indicate that the realization of an account may be in doubt. Account balances deemed to be uncollectible are charged to bad debt expense and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

 

Revenue recognition

 

The Company follows Accounting Standards Codification (“ASC”) 606, Revenue From Contracts With Customers. This revenue recognition standard (new guidance) has a five step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied.

 

The Company sells a variety of hair and skin care products and electronic hearing and enhancement products. The Company recognizes revenue for the agreed upon sales price when a purchase order is received from the customer and subsequently the product is shipped to the customer, which satisfies the performance obligation. Consideration paid to the customer to promote and sell the Company’s products is typically recorded as a reduction in revenues. 

 

The five steps for revenue recognition are as follows:

 

Identify the contract with a customer. The Company generally considers completion of a sales order (which requires customer acceptance of the Company’s click-through terms and conditions for website sales and authorization of payment through credit card or another form of payment for sales made over the phone) or purchase orders from non-consumer customers as a customer contract provided that collection is considered probable. For payments that are not made upfront by credit card, the Company assesses customer creditworthiness based on credit checks, payment history, and/or other circumstances. For payments involving third party financier payors, the Company validates customer eligibility and reimbursement amounts prior to shipping the product.

 

Identify the performance obligations in the contract. Product performance obligations include shipment of products and related accessories and service performance obligations include extended warranty coverage.

 

However, as the historical redemption rate under our warranty policy has been low, the option is not accounted for as a separate performance obligation. The Company does not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.

 

Determine the transaction price and allocation to performance obligations. The transaction price in the Company’s customer contracts consists of both fixed and variable consideration. Fixed consideration includes amounts to be contractually billed to the customer while variable consideration includes the 30-days and 60-days right of return that applies to the hearing protection and enhancement segment and hair care and skin care segment products, respectively. To estimate product returns, the Company analyzes historical return levels, current economic trends, and changes in customer demand. Based on this information, the Company reserves a percentage of product sale revenue and accounts for the estimated impact as a reduction in the transaction price.

 

Allocate the transaction price to the performance obligations in the contract. For contracts that contain multiple performance obligations, the Company allocates the transaction price to the performance obligations on a relative standalone selling price basis.

 

Recognize revenue when or as the Company satisfies a performance obligation. Revenue for products is recognized at a point in time, which is generally upon shipment. Revenue for services (extended warranty) is recognized over time on a ratable basis over the warranty period. 

 

As of May 31, 2024 and May 31, 2023, contract liabilities amounted to $1,385,841 and $1,433,048, respectively. Contract liabilities associated with product invoiced but not received by customers at the balance sheet date was $0 and $0, respectively; contract liabilities associated with unfulfilled performance obligations for warranty services offered for a period of one to three years was $1,251,710 and $1,320,401, respectively, and contract liabilities associated with unfulfilled performance obligations for customers’ right of return was $130,201 and $112,647, respectively. Our contract liabilities amounts are expected to be recognized over a period of one year to three years. Approximately $771,180 is expected to be recognized in year 1, $420,630 is expected to be recognized in year 2, and $59,900 is expected to be recognized in year 3. Contract liabilities associated with gift cards purchased by customers amounted to $3,930.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

As a smaller reporting company, we are not required to provide the information required by this Item 7A. 

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

 

The financial statements of the Company and the related report of the Company’s independent registered public accounting firm thereon have been filed under Item 15 hereof.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

We maintain “disclosure controls and procedures,” as such term is defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Principal Executive Officer, and Chief Financial Officer (“CFO”) and Principal Financial and Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure. We conducted an evaluation, under the supervision and with the participation of our CEO and CFO, of the effectiveness of the design and operation of our disclosure controls and procedures as of May 31, 2024. Based on this evaluation of disclosure controls and procedures as of May 31, 2024, our CEO and CFO concluded that our disclosure controls and procedures were not effective due to the material weaknesses in our internal control over financial reporting as described below.

 

Management’s Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) or 15d-15(f). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Our management, including our CEO and CFO, assessed the effectiveness of our internal control over financial reporting as of May 31, 2024 using criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework issued in 2013. Based on the assessment, our management has concluded that as of May 31, 2024, our internal control over financial reporting was not effective based on those criteria due the material weaknesses in our internal control over financial reporting as described below.  

 

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to the rules of the SEC that permit us to provide only management’s report in this annual report.

 

Material Weaknesses in Internal Control Over Financial Reporting

 

A material weakness is a significant deficiency, or combination of significant deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, the application of any evaluation of effectiveness to future periods is subject to the risk that controls may become inadequate because of changes in conditions, or that compliance with the policies or procedures may deteriorate.

 

The ineffectiveness of our internal control over financial reporting was due to the following material weaknesses in our internal control over financial reporting: (1) insufficient number of qualified accounting personnel governing the financial close and reporting process, (2) lack of independent directors, and (3) lack of proper segregation of duties.

 

We have established an audit committee to oversee our financial reporting, internal controls, audit oversight, compliance, risk management, and policies, including whistleblowing and ethics. To enhance segregation of duties and reporting processes, we have added additional staff.

 

The Company has initiated measures to improve the effectiveness of the internal control over financial reporting and disclosure controls and procedures. We have established an audit committee to oversee our financial reporting, internal controls, audit oversight, compliance, risk management, and policies, including whistleblowing and ethics. To enhance segregation of duties and reporting processes, we have added additional staff and may hire additional staff in the near future. We have also engaged a third-party to enhance the reporting in our accounting systems, as well as increase the level of review when any non-routine accounting entry is proposed. We continue to develop our internal control structure and identify key procedures for financial reporting as required by Section 404 of the Sarbanes-Oxley Act of 2002 and document our internal control policies and procedures. We have also adopted written policies and procedures and established controls related to corporate governance, including adopting a Code of Business Conduct and Ethics that applies to all of our employees, including our CEO, CFO, and Board.

 

Despite the measures described above, we anticipate continued material dependence on third parties for accounting and consulting services in the foreseeable future.

 

Each identified material weakness in internal control over financial reporting will not be considered remediated until the applicable controls have been in operation for a sufficient period of time for our management to conclude that such material weakness has been remediated. We will continue to assess the effectiveness of our remediation efforts in connection with our evaluations of internal control over financial reporting. No assurance can be made that our remediation efforts will be completed in a timely manner or that the updated controls and procedures associated with such efforts will be deemed adequate after being subjected to testing.

 

The material weaknesses in internal control over financial reporting described above resulted in an elevated risk that a material misstatement of our annual or interim financial statements would not be prevented or detected by other compensating controls. Notwithstanding the identified material weaknesses, we believe the consolidated financial statements included in this Form 10-K fairly present, in all material respects, our financial condition, results of operations, and cash flows for the periods presented in conformity with GAAP.

 

Changes in Internal Controls

 

There has been no change in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) or 15d-15(d) under the Exchange Act that occurred during the fiscal quarter ended May 31, 2024 that has materially affected or is reasonably likely to materially affect our internal control over financial reporting, other than steps that our management has taken to remedy the internal control weaknesses as described in the section entitled “Material Weaknesses in Internal Control Over Financial Reporting” above.

 

ITEM 9B. OTHER INFORMATION.

 

Rule 10b5-1 Trading Plans

 

During the quarter ended May 31, 2024, none of the Company’s directors or executive officers adopted, modified or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K).

 

2024 Annual Meeting of Stockholders

 

The Company’s 2024 Annual Meeting of Stockholders is scheduled to be held on December 18, 2024. Stockholders of record as of October 23, 2024 will be entitled to receive notice of, and vote at, the 2024 Annual Meeting of Stockholders. As the Company did not hold an annual meeting of stockholders during 2023, stockholder proposals intended to be considered for inclusion in the Company’s proxy materials for the 2024 Annual Meeting of Stockholders are required to be submitted to the Company by September 20, 2024, which the Company has determined is a reasonable time before it begins printing and sending its proxy materials.

 

In addition, since the Company did not hold an annual meeting of stockholders during 2023, in accordance with the Company’s Bylaws, stockholder nominations of director candidates and stockholder proposals to be presented at the 2024 Annual Meeting of Stockholders, but not submitted for inclusion in the Company’s proxy materials, are required to be delivered to the Secretary of the Company at the Company’s principal executive offices not earlier than the close of business on September 19, 2024 and not later than the close of business on October 19, 2024. The Bylaws specify the information that is required to accompany any such stockholder notices.

 

In addition to satisfying the foregoing requirements under our Bylaws, including advance notice of director nominations, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must provide notice that sets forth any additional information required by Rule 14a-19 under the Exchange Act no later than October 21, 2024. Such notice may be mailed to our Secretary at our principal executive offices.

 

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.

 

Not applicable.

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

 

Information about our Directors and Executive Officers

 

The Board is divided into three classes: Class I, Class II and Class III. Each director will serve for a term ending on the date of the third annual meeting following the annual meeting at which such director was elected and such director’s successor is elected and qualified, or until such director’s earlier death, resignation, disqualification or removal from office.

 

The names, ages and positions of our present directors are set forth below:

 

NAME		AGE				DIRECTOR CLASS		POSITION
Jeff Toghraie			57			Class III director, with a term expiring at the 2024 annual meeting of stockholders		Chief Executive Officer and Chairman
Jeff Brown			42			Class III director, with a term expiring at the 2024 annual meeting of stockholders		Chief Financial Officer, Chief Operating Officer, and Director
Manu Ohri			68			Class II director, with a term expiring at the 2025 annual meeting of stockholders		Director
Peter Dunne			83			Class II director, with a term expiring at the 2025 annual meeting of stockholders		Director
Nancy Hundt			56			Class I director, with a term expiring at the 2026 annual meeting of stockholders		Director

 

The names, ages and positions of our executive officers are set forth below:

 

NAME		AGE				POSITION
Jeff Toghraie			57			Chief Executive Officer and Chairman
Jeff Brown			42			Chief Financial Officer, Chief Operating Officer, and Director
Donald Starace*			70			President

  

* Mr. Starace retired from the Company effective August 12, 2024. Mr. Starace’s decision to retire was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.

 

Background of executive officers and directors

 

Jeff Toghraie – Chief Executive Officer and Chairman of the Board of Directors

 

Jeff Toghraie has served as our Chief Executive Officer and as a member of and chairman of our Board since June 2015. Mr. Toghraie joined Intrepid Global Advisors in October 2010 and is a managing director and principal of that firm. Mr. Toghraie has been involved with various privately held development stage companies as a director and/or in advisory positions for more than 20 years.

 

Mr. Toghraie brings more than 20 years of experience in our industry. His background working with development stage companies and vast business and operational experience, provide us with the expertise to implement complex and innovative strategies and makes him uniquely suited to serve on our Board.

 

Jeff Brown – Chief Financial Officer, Chief Operating Officer, and Director

 

Jeff Brown has served as our Chief Financial Officer since May 2024 and Chief Operating Officer since March 2017 and as a member of our Board since February 2024. Prior to that, from July 2016 to March 2017, Mr. Brown held consulting positions at Polar Solar Inc., a company responsible for making commercial solar panels available to the residential market, and Mind Fitness Lab, a technology company that developed and distributed mobile applications for mental health professionals. From June 2012 until July 2015, he was the President of RNA Pro, a company that distributed agricultural supplements. He holds a master’s degree in business administration from Pepperdine University and a bachelor’s degree in political science from University of California, Irvine.

 

Mr. Brown brings over 15 years of operational experience in our industry. His experience, deep industry knowledge, and comprehensive understanding of the execution and operational needs of a fast-growing business allow him to provide targeted and forward-thinking insight to our Board. 

 

Donald Starace – President

 

Donald Starace previously served as our President from February 2015 to August 12, 2024. Mr. Starace has over forty years of dedicated service in the beauty industry. Mr. Starace started his career in some of New York’s most prestigious salons, followed by ten years at Nioxin Research Labs and subsequently Proctor & Gamble in Sales and Education. Mr. Starace owned and operated various businesses through his career including roles in starting the Bank of New Jersey. He was one of the initial investors for the bank and was very influential in raising capital. He also facilitated bringing Taiff (Brazil) professional appliances to the hair industry in the U.S. and Canada. Mr. Starace also previously served as a member of the Board of Adjustments for the Borough of Fort Lee, New Jersey.

 

Peter Dunne – Director

 

Peter Dunne has been a member of our Board since February 2024. From March 2010 until December 2023, Mr. Dunne served as president of Peter Dunne Investments, LLC, a corporate advisory firm, where he served as an advisor and consultant to several U.S. and international firms on the viability of entering the Asia markets. Prior to heading his international consulting firm, Mr. Dunne acted as a transactional advisor to many high-profile mergers and acquisitions including the financing and development of the Forum at Caesars Palace in Las Vegas, the acquisition of the Ralph Lauren headquarters in New York City, the acquisition of the Beverly Wilshire Hotel, and the acquisition of the Four Seasons Hotels in New York and Milan. He holds a bachelor’s degree in business administration from St. John’s University.

 

Mr. Dunne brings more than 20 years of experience in strategic planning. Mr. Dunne’s extensive involvement in strategic planning across a variety of domestic and international consumer and retail industries brings a unique and valuable perspective to our Board.

 

Manu Ohri – Director

 

Manu Ohri has been a member of our Board since February 2024. Mr. Ohri provides consulting and advisory services to various companies. Mr. Ohri previously served as chief financial officer of GT Biopharma, Inc. (Nasdaq: GTBP), a clinical stage biopharmaceutical company, from February 2022 to June 2024. Prior to that, from January 2010 to December 2016, Mr. Ohri served as a management consultant for Anarjay Concepts, Inc., where he provided management consulting and business advisory services to privately-held and publicly traded companies. From January 2017 until June 2019, Mr. Ohri served as chief financial officer and as a member of the board of directors of ToughBuilt Industries, Inc., which designs and distributes tools and accessories to the home improvement community and the building industry. Mr. Ohri is a Certified Public Accountant and Chartered Global Management Accountant with over seven years of experience with Deloitte, LLP and PricewaterhouseCoopers, LLP. He holds a master’s degree in business administration from the University of Detroit and a bachelor’s degree in commerce from the University of Delhi. Mr. Ohri previously served as a director of Shengda Network Technology, Inc.

 

Mr. Ohri has over 30 years of experience working with boards of directors and financial institutions and with compliance with U.S. and international financial accounting and reporting standards, investor relations, mergers and acquisitions, strategic planning, and team-building and project management. He brings to our Board a diverse set of skills, experience, and industry knowledge.

 

Nancy Hundt – Director

 

Nancy Hundt has been a member of our Board since May 2015. She has served as chief operating officer of Academy Optical, Inc., a prescription eyewear retailer, since February 2019. Prior to that, from September 2009 to February 2019, Ms. Hundt served as director of operations for Academy Optical, Inc. Additionally, Ms. Hundt has served as a representative of the American Board of Opticianry, an optical industry retail group, since October 1991.

 

Ms. Hundt brings to our Board more than 30 years of strategic planning and advising experience in the retail industry. She has a diverse background as a consultant and retail sales expert, and she has a strong understanding of our business strategy.

 

Family Relationships

 

There are no family relationships among any of our directors or executive officers.

 

Involvement in Certain Legal Proceedings

 

To the best of our knowledge, none of our directors or executive officers were involved in any legal proceedings described in Item 401(f) of Regulation S-K in the past 10 years.

 

Board Committees

 

Our Board currently consists of five directors, one of whom is female. Our Board has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. Each member of each standing committee of our Board qualifies as an independent director in accordance with the applicable rules of the SEC and NYSE American. Each standing committee operates pursuant to a written charter adopted by our Board, each of which is posted on the Investor Relations section of our website at www.goaxil.com. Our Board may establish other committees as it deems necessary or appropriate from time to time.

 

The following table provides current committee membership for each of the committees of the Board as of August 6, 2024:

 

Name		Audit		Compensation		Nominating and Corporate Governance
Jeff Toghraie
Jeff Brown
Peter Dunne		X		X		X*
Nancy Hundt		X		X*		X
Manu Ohri+		X*		X		X

 

* Committee chairperson.

 

+ Audit committee financial expert.

 

Code of Business Conduct and Ethics

 

Our Board has adopted a Code of Business Conduct and Ethics, which applies to all of our directors, employees, and officers (including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions). The full text of our Code of Business Conduct and Ethics is posted on the Investor Relations section of our website at www.goaxil.com. Any substantive amendment of the Code of Business Conduct and Ethics, and any waiver of the Code of Business Conduct and Ethics for executive officers or directors, will be made only after approval by the Board or the Audit Committee or the Nominating and Corporate Governance Committee of the Board, and will be disclosed on our website. In addition, any such amendment or waiver will be disclosed within four days on a Form 8-K filed with the SEC if then required by applicable rules and regulations, including the rules of the NYSE American, which currently require a Form 8-K to be filed disclosing any waiver of the Code of Business Conduct and Ethics for directors and officers.

 

Indemnification

 

Our Amended and Restated Certificate of Incorporation and our Bylaws, subject to certain provisions of Delaware Law, contain provisions which require or allow us to indemnify any person against liabilities and other expenses incurred as the result of defending or administering any pending or anticipated legal issue in connection with service to us if it is determined that person acted in good faith and in a manner which such person reasonably believed was in the best interest of the Company. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons, we have been advised that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.  

 

Delinquent Section 16(a) Reports

 

Section 16(a) of the Exchange Act requires our officers, directors and persons who own more than 10% of our common stock to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock and other equity securities. To our knowledge, based on solely a review of these reports filed with the SEC, we believe that all Section 16 filing requirements applicable to our executive officers, directors and greater than 10% stockholders were complied with during the fiscal year ended May 31, 2024, except for a Form 4 filed by Manu Ohri on February 20, 2024, reporting the February 14, 2024 grant of restricted stock.

 

Stockholder Nominations and Other Business

 

In February 2024, the Company’s Bylaws were amended to, among other things, establish procedures for stockholders to provide the Company with advance notice nominations of directors and proposals for matters they intend to bring up at a stockholder meeting.

 

ITEM 11. EXECUTIVE COMPENSATION.  

 

The following table sets forth the compensation paid by us for the last two fiscal years ended May 31, 2024, and 2023, to our named executive officers (each, an “NEO”), who, for the fiscal year ended May 31, 2024, were Jeff Toghraie, our Chief Executive Officer and Chairman (Principal Executive Officer), Jeff Brown, our Chief Operating Officer and Chief Financial Officer and Monica Diaz Brickell, our former Chief Financial Officer. Ms. Diaz Brickell served as our Chief Financial Officer until April 30, 2024.

 

Summary Compensation Table

 

Name and Principal Position		Year				Salary ($)				Bonus ($)				Stock Awards ($)				Option Awards ($)(1)				Non-Equity Incentive Plan Compensation ($)				Nonqualified Deferred Compensation Earnings ($)				All Other Compensation  ($)				Total ($)
Jeff Toghraie Chief Executive Officer and Chairman			2024				—				—				—				—				—				—				—				—
			2023				—				—				—				—				—				—				—				—
Jeff Brown (3) Chief Operating Officer, Chief Financial Officer, Director			2024				144,000				67,000				—				—				—				—				—				211,000
			2023				98,000				35,000				—				—				—				—				—				133,000
Monica Diaz Brickell(2) Former Chief Financial Officer			2024				151,726				—				—				—				—				—				298,800				450,526
			2023				17,500				—				—				—				—				—				—				17,500

 

(1)	The value of option awards in this table represents the fair value of such awards granted or modified during the fiscal year, as computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718. The assumptions used to determine the valuation of the awards are discussed in Note 10—Stockholders’ Equity to our financial statements included herein.
(2)	Ms. Diaz Brickell became our Chief Financial Officer on April 24, 2023 and left her position on April 30, 2024. Effective May 28, 2024, Ms. Diaz Brickell entered into the Release, which includes a standard release of claims and confidentiality and non-disparagement provisions. As consideration for signing the Release, the Company entered into the Consulting Agreement, dated May 28, 2024, with Ms. Diaz Brickell, pursuant to which Ms. Diaz Brickell agreed to provide transition services to the Company through October 31, 2024, unless the Consulting Agreement is terminated earlier. Pursuant to the Consulting Agreement, as compensation for her services as a consultant, Ms. Diaz Brickell was granted 30,000 shares of restricted common stock, which vested upon grant.
(3)	Mr. Brown became our Chief Financial Officer on May 1, 2024.

 

Our Chief Executive Officer, Jeff Toghraie, and our Chief Financial Officer and Chief Operating Officer, Jeff Brown, did not have formal employment agreements with the Company in place as of May 31, 2024. Mr. Toghraie is entitled to an annual performance bonus, health benefits and equity awards at the discretion of the Board. Mr. Brown receives a base salary of $144,000 per year and is entitled to annual performance bonus, paid vacation, optional health benefits and equity awards at the discretion of the Board.

  

As of May 31, 2024, we did not have any retirement, pension, or profit sharing plans for the benefit of our executive officers and directors.

 

As noted above, the Company entered into a Consulting Agreement with Ms. Diaz Brickell following her departure from the Company, pursuant to which Ms. Diaz Brickell was granted 30,000 shares of restricted common stock, which vested upon grant, as compensation for her post-termination transition services to the Company as a consultant.

 

Other than the Consulting Agreement with Ms. Diaz Brickell, the Company does not maintain any arrangement with any of the NEOs that would entitle an NEO to any compensation in connection with the NEO’s resignation, retirement or other termination or in connection with a change in control of the Company. In addition, under the Plan, upon the occurrence of a change in control (as defined in the Plan), unless otherwise provided in an award agreement: (i) all outstanding stock options will become immediately exercisable in full; (ii) all outstanding performance shares will vest in full as if the applicable performance conditions were achieved in full, subject to certain adjustments, and will be paid out as soon as practicable; and (iii) all restricted stock will immediately vest in full. Subject to the Plan’s terms, the Compensation Committee or the Board has full power and authority to determine whether, to what extent and under what circumstances any outstanding award will be terminated, canceled, forfeited or suspended. Awards to that are subject to any restriction or have not been earned or exercised in full by the recipient will be terminated and canceled if such recipient is terminated for cause.

 

Outstanding Equity Awards at Fiscal Year-End

 

The following table sets forth certain information regarding outstanding equity awards held by the NEOs as of May 31, 2024:

 

Option Awards

Name

Grant Date

Number of securities underlying unexercised options (#) exercisable

Number of securities underlying unexercised options (#) unexercisable

Option exercise price ($)

Option expiration date

Jeff Toghraie

5/10/22

135,625

19,375

(1)

1.80

4/20/2032

Jeff Brown

5/10/22

96,250

13,750

(1)

1.80

4/20/2032

 

(1)

These options vest and become exercisable over time, with 25% of the options vesting on September 1, 2022 and thereafter vesting 1/24th on the 1st of every month.

 

Director Compensation

 

The following table sets forth the compensation paid by us to our non-employee directors for the fiscal year ended May 31, 2024, which consisted of the value of restricted stock awards of 5,000 shares of the Company’s common stock granted to our non-employee directors during that fiscal year. We did not pay any other compensation to our non-employee directors during the fiscal year ended May 31, 2024. Mr. Toghraie and Mr. Brown do not receive any separate compensation for their services as director.

 

Name		Fees Earned or Paid in Cash ($)		Stock Awards ($)(1)		All Other Compensation  ($)		Total ($)
Peter Dunne		—		$65,000		—		$65,000
Nancy Hundt		—		$65,000		—		$65,000
Manu Ohri		—		$65,000		—		$65,000

 

(1)

Reflects the grant date fair value of 5,000 shares of restricted common stock granted to each of our non-employee directors on February 14, 2024, which vest on February 14, 2025, except as otherwise provided in the applicable award notice. The value of stock awards in this table represents the fair value of such awards granted or modified during the fiscal year, as computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718. The assumptions used to determine the valuation of the awards are discussed in Note 10—Stockholders’ Equity to our financial statements included herein. As of May 31, 2024, each of the non-employee directors held a total of 5,000 unvested shares of the Company’s restricted common stock.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

 

The following table sets forth the ownership, as of August 6, 2024, of our common stock by each person known by us to be the beneficial owner of more than five percent (5%) of our outstanding common stock, our directors, our named executive officers, and our directors and current executive officers as a group. Except as indicated by the footnotes below, we believe, based on the information furnished to us, that the persons named in the table below have sole voting and investment power with respect to all shares of common stock shown that they beneficially own, subject to community property laws where applicable. The information does not necessarily indicate beneficial ownership for any other purpose.

 

Shares of our common stock that are subject to options currently exercisable or exercisable within 60 days of August 6, 2024 and to outstanding shares of convertible preferred stock are deemed to be outstanding for computing the percentage ownership of the person holding these options or shares of preferred stock and the percentage ownership of any group in which the holder is a member, but are not deemed outstanding for computing the percentage of any other person.

 

We have based our calculation of the percentage of beneficial ownership on 6,393,939 shares of our common stock outstanding on August 6, 2024.

 

Unless otherwise noted below, the address for each of the stockholders in the table below is c/o Axil Brands, Inc., 901 S. Fremont Avenue, Unit 158, Alhambra, California 91083.

 

Name of Beneficial Owner		Number of Shares Beneficially Owned		Percent
5% Stockholders:
Jeff Toghraie, Chief Executive Officer and Chairman(1)		3,449,538		47.1%
Don Frank Nathaniel Vasquez(2)		1,276,251		20.0%
Shircoo, Inc.(3)		534,510		8.4%
Named Executive Officers and Directors (not otherwise included above):
Jeff Brown, Chief Financial Officer, Chief Operating Officer and Director(4)		125,143		1.9%
Monica Diaz Brickell, Former Chief Financial Officer(5)		30,000		*
Peter Dunne, Director(6)		26,250		*
Nancy Hundt, Director(7)		7,273		*
Manu Ohri, Director(8)		15,001		*
				*
All Current Executive Officers and Directors as a Group (6 persons)(9)		3,668,147		49.4%

 

* Represents beneficial ownership of less than 1% of the outstanding common stock.

 

(1)

Based on a Schedule 13D/A filed with the SEC on April 24, 2024 by Jeff Toghraie, Intrepid Global Advisors, Inc. (“Intrepid”), of which Mr. Toghraie is the managing director, and Don Frank Nathaniel Vasquez and a Form 4 filed by Mr. Toghraie with the SEC on April 24, 2024, Mr. Toghraie may be deemed to beneficially own, in the aggregate, 3,449,538 shares of common stock, consisting of 1,246,700 shares of common stock held directly by Intrepid, over which Mr. Toghraie and Intrepid have shared voting and dispositive power; 1,275,000 shares of common stock held directly by Don Frank Nathaniel Vasquez, over which Mr. Toghraie and Intrepid have shared voting power with Mr. Vasquez, pursuant to a Voting Agreement and Irrevocable Proxy between Mr. Vasquez and Intrepid, pursuant to which Intrepid is authorized to vote and exercise all voting rights with respect to such shares; 155,000 shares of common stock issuable upon the exercise of options held by Mr. Toghraie that are exercisable within 60 days of August 6, 2024; and 772,838 shares of common stock that may be acquired upon the conversion of Series A Preferred Stock held directly by Intrepid, over which Mr. Toghraie and Intrepid have shared dispositive power. The terms of the Voting Agreement and Irrevocable Proxy will expire on the earlier of: (i) October 17, 2026, (ii) such date and time designated by Intrepid in a written notice to Mr. Vasquez or (iii) the written agreement of Intrepid and Mr. Vasquez to terminate such agreement. The Series A Preferred Stock is convertible into shares of common stock on a twenty-for-one basis, at the option of the holder, at any time after the second anniversary of the date that the Company first issued shares of Series A Preferred Stock, or June 16, 2022; provided, that the holder may not convert that number of shares of Series A Preferred Stock which would cause the holder to become the beneficial owner of more than 5% of the common stock, as determined in accordance with Sections 13(d) and (g) of the Exchange Act and the rules and regulations thereunder. The principal business office of Intrepid is located at 325 N. Maple Drive, #5114, Beverly Hills, California 90210.

 

(2)

Based on a Schedule 13D/A filed with the SEC on April 24, 2024 by Jeff Toghraie, Intrepid, and Don Frank Nathaniel Vasquez, Mr. Vasquez has sole voting power over 1,251 shares of common stock, sole dispositive power over 1,276,251 shares of common stock and shared voting power over 1,275,000 shares of common stock with Intrepid and Mr. Toghraie, pursuant to a Voting Agreement and Irrevocable Proxy between Mr. Vasquez and Intrepid, pursuant to which Intrepid is authorized to vote and exercise all voting rights with respect to such shares. The terms of the Voting Agreement and Irrevocable Proxy will expire on the earlier of: (i) October 17, 2026, (ii) such date and time designated by Intrepid in a written notice to Mr. Vasquez or (iii) the written agreement of Intrepid and Mr. Vasquez to terminate such agreement. The principal business address of Mr. Vasquez is 4700 Summerville Lane, Prosper, Texas 75078.

 

(3)

The principal address of Shircoo, Inc. is 2350 Allview Terrace East, Los Angeles, California 90068.

 

(4)

Includes 110,000 shares of common stock underlying stock options that are exercisable within 60 days of August 6, 2024.

 

(5)

Ms. Diaz Brickell, a former executive officer who is listed in the Summary Compensation Table, previously served as Chief Financial Officer until April 30, 2024. The number of shares is based on the Company’s records.

 

(6)

Includes 5,000 shares of unvested restricted stock, which will vest on February 14, 2025.

 

(7)

Includes 5,000 shares of unvested restricted stock, which will vest on February 14, 2025.

 

(8)

Includes 5,000 shares of unvested restricted stock, which will vest on February 14, 2025, and 10,000 shares held by Anarjay Concepts Inc., of which Mr. Ohri is the principal.

 

(9)

Includes 15,000 shares of unvested restricted common stock, options to purchase 265,000 shares of common stock that are exercisable within 60 days of August 6, 2024, and 772,838 shares of common stock that may be acquired upon the conversion of Series A Preferred Stock. This group includes all current directors and executive officers as of August 6, 2024, including Mr. Starace.

 

Equity Compensation Plan Information 

 

The following table sets forth equity compensation plan information as of May 31, 2024:

 

Plan category		Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)				Weighted-average exercise price of outstanding options, warrants and rights (b)				Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c)
Equity compensation plans approved by security holders(1)			268,750			$	1.84				981,250
Equity compensation plans not approved by security holders			-			$	-				-
Total			268,750			$	1.84				981,250

 

(1)

Represents shares of common stock to be issued upon exercise of outstanding options to purchase common stock granted pursuant to our Plan as of May 31, 2024. The Plan provides for an annual increase on April 1 of each calendar year, beginning in 2022 and ending in 2031, subject to the approval of the Plan administrator on or prior to such date. Such increase may be equal to the lesser of (i) 4% of the total number of shares of the Company’s common stock outstanding on May 31 of the immediately preceding fiscal year and (ii) such smaller number of shares as determined by the Plan’s administrator. The number of shares authorized for issuance under the Plan will not change unless the Plan’s administrator affirmatively approves an increase in the number of shares authorized for issuance prior to April 1 of the applicable year. All shares available for future issuance are under the Plan.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

 

Director Independence

 

We were previously quoted on the OTCQB market and not listed on a national securities exchange, during which time we were not subject to certain corporate governance requirements that apply to exchange-listed companies. Our common stock began trading on the NYSE American stock exchange on February 14, 2024. As a result, we are now subject to the corporate governance requirements of the NYSE American and apply the rules of the SEC and the NYSE American to evaluate the independence of our directors. In connection with our NYSE American listing, three new directors were appointed to the Board, and the Board determined that, of the five Board members, each of Mr. Dunne, Ms. Hundt, and Mr. Ohri qualified as independent under the NYSE American listing standards. Accordingly, our Board is currently comprised of a majority of directors who qualify as independent directors under the rules adopted by the SEC and NYSE American, and all Board committee members are independent for the purposes of the committees on which they serve. In making such independence determinations, our Board considered the relationships that each non-employee director has with us and all other facts and circumstances that our Board deemed relevant in determining their independence.

 

Related Party Transactions 

 

The following is a description of transactions or series of transactions since June 1, 2022, to which we were or will be a party, in which:

 

·

the amount involved in the transaction exceeds the lesser of (i) $120,000 or (ii) 1% of the average of our total assets at year end for the last two completed fiscal years; and

·

in which any of our executive officers, directors, director nominees or holders of 5% or more of any class of our voting capital stock, or any immediate family member of any of the foregoing, had or will have a direct or indirect material interest.

 

The Company’s Chief Executive Officer, Jeff Toghraie, is the managing director of Intrepid. Intrepid has, from time to time, provided advances to the Company for working capital purposes. At May 31, 2024, and 2023, the Company had amounts payable to Intrepid of $11,798 and $158,072, respectively. These advances were short-term in nature and non-interest bearing. Additionally, pursuant to a voting agreement, effective June 16, 2022, as amended effective November 7, 2022, with A&A and Intrepid Global Advisors, we were subject to certain limitations on our ability to sell our capital stock until June 2024. 

 

During the fiscal years ended May 31, 2024 and 2023, the Company paid $231,470 and $218,696, respectively, as consulting fee for product development to Weston T. Harris, a major stockholder of A&A. The Company also paid $146,546 and $126,097, respectively, to immediate family members of the major stockholder as compensation for services relating to packaging design and affiliate marketing during the fiscal years ended May 31, 2024 and 2023. In addition, in March 2024, the Company entered into a repurchase agreement with an entity managed by Mr. Harris, pursuant to which the Company repurchased 142,021,750 shares of Series A Preferred Stock from the entity for an aggregate purchase price of $852,130.

 

On June 16, 2022, the Company and its wholly owned subsidiary Reviv3 Acquisition Corporation completed the acquisition of both (i) the hearing protection business of A&A, consisting of ear plugs and ear muffs, and (ii) A&A’s ear bud business pursuant to the Asset Purchase Agreement, dated May 1, 2022, as amended on June 15, 2022 and September 8, 2022, by and among the Company, Reviv3 Acquisition Corporation, A&A and certain stockholders of A&A. One of the stockholders of A&A was Intrepid. As of May 31, 2024, Intrepid did not hold any shares of A&A and held approximately 21.26% of the outstanding common stock of the Company (excluding shares of common stock that may be acquired upon the conversion of shares of Series A Preferred Stock).

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.

  

Our current Audit Committee was formed in August 2023, at which time the Audit Committee also adopted a new charter. Since the formation of our current Audit Committee, and on a going-forward basis, the Audit Committee has and will pre-approve all auditing services and permitted non-audit services to be performed for us by our independent registered public accounting firm, including the fees and terms thereof (subject to the de minimis exceptions for non-audit services described in the Exchange Act that are approved by the Audit Committee prior to the completion of the audit). Prior to the formation of the Audit Committee, our Board pre-approved all services provided by our independent registered public accounting firm. 

 

Fees

 

The following table sets forth the fees paid to Salberg & Company, P.A., for the fiscal years ended May 31, 2024 and 2023: 

 

		Fiscal Year Ended May 31, 2024				Fiscal Year Ended May 31, 2023
Audit fees (1)		$	126,000			$	117,100
Audit related fees (2)			—				700
Tax fees			—				—
All other fees			—				—
Total		$	126,000			$	117,800

 

(1)

These fees relate to the audit of our annual financial statements and the review of our interim quarterly financial statements.

(2)

These fees relate to audit related consulting.

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

 

AXIL BRANDS, INC. AND SUBSIDIARY

 

CONSOLIDATED FINANCIAL STATEMENTS 

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS  

 

May 31, 2024 and 2023 

 

CONTENTS

 

Report of Independent Registered Public Accounting Firm (PCAOB ID: 106)	F-1
Financial Statements:
Consolidated Balance Sheets - As of May 31, 2024 and 2023	F-2
Consolidated Statements of Operations - For the fiscal years ended May 31, 2024 and 2023	F-3
Consolidated Statements of Changes in Stockholders’ Equity - For the fiscal years ended May 31, 2024 and 2023	F-4
Consolidated Statements of Cash Flows - For the fiscal years ended May 31, 2024 and 2023	F-5
Notes to Consolidated Financial Statements	F-6

 

 

 

Report of Independent Registered Public Accounting Firm  

 

To the Stockholders and the Board of Directors of:

Axil Brands, Inc..

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of AXIL Brands, Inc. and subsidiary (the “Company”) as of May 31, 2024 and 2023, the related consolidated statements of operations, changes in stockholders’ equity and cash flows for each of the two years in the period ended May 31, 2024, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of May 31, 2024 and 2023, and the consolidated results of its operations and its cash flows for each of the two years in the period ended May 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

The critical audit matters are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

 

/s/ Salberg & Company, P.A.

 

SALBERG & COMPANY, P.A.

We have served as the Company’s auditor since 2017.

Boca Raton, Florida

August 15, 2024

 

2295 NW Corporate Blvd., Suite 240 ● Boca Raton, FL 33431-7328
Phone: (561) 995-8270 ● Toll Free: (866) CPA-8500 ● Fax: (561) 995-1920
www.salbergco.com ● info@salbergco.com
Member National Association of Certified Valuation Analysts ● Registered with the PCAOB
Member CPAConnect with Affiliated Offices Worldwide ● Member AICPA Center for Audit Quality

 

AXIL BRANDS, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

 

		May 31, 2024				May 31, 2023
ASSETS
CURRENT ASSETS:
Cash		$	3,253,876			$	4,832,682
Accounts receivable, net			509,835				417,016
Inventory, net			3,394,023				1,311,864
Prepaid expenses and other current assets			809,126				801,360
Total Current Assets			7,966,860				7,362,922
OTHER ASSETS:
Property and equipment, net			260,948				157,463
Deferred tax asset			231,587
Intangible assets, net			309,104				382,674
Right of use asset			36,752				101,845
Other assets			16,895				12,195
Goodwill			2,152,215				2,152,215
Total Other Assets			3,007,501				2,806,392
TOTAL ASSETS		$	10,974,361			$	10,169,314
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable		$	967,596			$	908,606
Customer deposits			154,762				183,688
Equipment payable, current			-				2,200
Contract liabilities- current			905,311				827,106
Notes payable			146,594				172,588
Due to related party			11,798				158,072
Lease liability, current			36,752				65,824
Income tax liability			242,296				230,913
Other current liabilities			332,936				305,664
Total Current Liabilities			2,798,045				2,854,661
LONG TERM LIABILITIES:
Lease liability- long term			-				36,752
Contract liabilities- long term			480,530				605,942
Total Long Term Liabilities			480,530				642,694
Total Liabilities			3,278,575				3,497,355
Commitments and contingencies (see Note 11)			-				-
STOCKHOLDERS' EQUITY:
Preferred stock, $0.0001 par value; 300,000,000 shares authorized; 42,251,750 and 250,000,000 shares issued and outstanding as of May 31, 2024 and 2023, respectively			4,225				25,000
Common stock, $0.0001 par value: 450,000,000 shares authorized; 5,908,939 and 5,863,939 shares issued, issuable and outstanding as of May 31, 2024 and 2023, respectively			591				586
Additional paid-in capital			7,825,240				10,113,365
Accumulated deficit			(134,270	)			(3,466,992	)
Total Stockholders' Equity			7,695,786				6,671,959
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY		$	10,974,361			$	10,169,314

 

See accompanying notes to these consolidated financial statements.

 

AXIL BRANDS, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE YEARS ENDED MAY 31, 2024 AND 2023

 

		2024				2023
Sales, net		$	27,498,539			$	23,521,027
Cost of sales			7,304,602				5,810,216
Gross profit			20,193,937				17,710,811
OPERATING EXPENSES:
Sales and marketing			13,449,054				11,675,206
Compensation and related taxes			965,931				1,347,839
Professional and consulting			2,589,496				1,420,990
General and administrative			1,686,076				1,282,565
Total Operating Expenses			18,690,557				15,726,600
INCOME FROM OPERATIONS			1,503,380				1,984,211
OTHER INCOME (EXPENSE):
Gain on debt settlement			79,182				50,500
Other income			22,534				16,829
Interest income			182,225				6,469
Interest expense and other finance charges			(4,392	)			(2,521	)
Other Income (Expense), Net			279,549				71,277
INCOME BEFORE PROVISION FOR INCOME TAXES			1,782,929				2,055,488
Provision (benefit) for income taxes			(220,205	)			230,913
NET INCOME		$	2,003,134			$	1,824,575
Deemed dividend on preferred stock buyback		$	1,329,588			$	-
Net income available to common shareholders		$	3,332,722			$	1,824,575
NET INCOME PER COMMON SHARE:
Basic		$	0.57			$	0.32
Diluted		$	0.21			$	0.10
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic			5,868,570				5,644,771
Diluted			16,168,181				17,869,264

 

See accompanying notes to these consolidated financial statements.

 

AXIL BRANDS, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

FOR THE YEARS ENDED MAY 31, 2024 AND 2023

 

										Common Stock																Total
		Preferred Stock								Issued/Issuable								Additional Paid-in				Accumulated				Stockholders'
		Shares				Amount				Shares				Amount				Capital				Deficit				Equity
Balance, May 31, 2022			-			$	-				2,107,385			$	211			$	5,476,068			$	(5,291,567	)		$	184,712
Shares issued for acquisition of business			250,000,000				25,000				3,659,195				366				3,982,114				-				4,007,480
Stock options expense			-				-				-				-				207,342				-				207,342
Shares to be issued for cash			-				-				97,359				9				447,841				-				447,850
Net income for the year ended May 31, 2023			-				-				-				-				-				1,824,575				1,824,575
Balance, May 31, 2023			250,000,000				25,000				5,863,939				586				10,113,365				(3,466,992	)			6,671,959
Stock options expense			-				-				-				-				204,429				-				204,429
Restricted stock awards			-				-				45,000				5				62,749				-				62,754
Preferred stock buyback			(207,748,250	)			(20,775	)			-				-				(2,555,303	)			1,329,588				(1,246,490	)
Net income for the year ended May 31, 2024			-				-				-				-				-				2,003,134				2,003,134
Balance, May 31, 2024			42,251,750			$	4,225				5,908,939			$	591			$	7,825,240			$	(134,270	)		$	7,695,786

 

See accompanying notes to these consolidated financial statements.

 

AXIL BRANDS, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED MAY 31, 2024 AND 2023

 

		May 31,
		2024				2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income		$	2,003,134			$	1,824,575
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			130,610				95,179
Bad debts			25,471				76,969
Inventory obsolescence			46,895				-
Stock-based compensation			267,183				207,342
Gain on debt settlement			(79,182	)			(50,500	)
Deferred income taxes			(231,587	)			-
Change in operating assets and liabilities:
Accounts receivable			(118,290	)			(160,277	)
Inventory			(2,129,054	)			353,985
Prepaid expenses and other current assets			(7,766	)			(661,115	)
Deposits			-				(3,810	)
Accounts payable and accrued expenses			138,172				215,175
Other current liabilities			4,298				630,897
Contract liabilities			(47,207	)			389,716
NET CASH PROVIDED BY OPERATING ACTIVITIES			2,677				2,918,136
CASH FLOWS FROM INVESTING ACTIVITIES
Cash acquired on business acquisition			-				1,066,414
Purchase of intangibles			(22,080	)			-
Purchase of property and equipment			(138,445	)			(65,650	)
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES			(160,525	)			1,000,764
CASH FLOWS FROM FINANCING ACTIVITIES
Cash raised for common stock to be issued			-				447,850
Repurchase of preferred stock			(1,246,490	)			-
Repayment of equipment financing			(2,200	)			(3,300	)
Repayment of note payable			(25,994	)			(37,119	)
Advances (payments) from a related party			(146,274	)			132,620
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES			(1,420,958	)			540,051
NET INCREASE (DECREASE) IN CASH			(1,578,806	)			4,458,951
CASH - Beginning of year			4,832,682				373,731
CASH - End of year		$	3,253,876			$	4,832,682
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the year for:
Interest		$	6,907			$	2,521
Income taxes		$	-			$	-
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock issued for asset purchase agreement		$	-			$	4,007,480
Right of use assets recognized as lease liability		$	-			$	131,970
Tangible assets (excluding cash) acquired in business combination		$	-			$	1,740,729
Intangible assets acquired in business combination		$	-			$	456,945
Goodwill acquired in business combination		$	-			$	2,152,215
Liabilities assumed in business combination		$	-			$	1,408,823

 

See accompanying notes to these consolidated financial statements.

 

AXIL BRANDS INC. AND SUBSIDIARY
NOTES  TO CONSOLIDATED FINANCIAL STATEMENTS
MAY 31, 2024 AND 2023

 

Note 1 – Organization

 

As part of AXIL Brands, Inc.’s (together with its subsidiary, the “Company,” “we,” “us” or “our”) ongoing rebranding efforts, the Company changed its name from Reviv3 Procare Company to AXIL Brands, Inc. effective February 14, 2024. Reviv3 was incorporated in the State of Delaware on May 21, 2015 as a reorganization of Reviv3 Procare, LLC which was organized on July 31, 2013. The Company’s corporate headquarters are located at 901 S. Fremont Avenue, Unit 158, Alhambra, California 91803. Its phone number is (888) 638-8883. In March 2022, the Company incorporated a subsidiary “Reviv3 Acquisition Corporation” (now known as “AXIL Distribution Company”) and in June 2022, completed the acquisition of certain assets of Axil & Associated Brands Corp. (“A&A”). The Company is engaged in the manufacturing, marketing, sale and distribution of high-tech hearing and audio enhancement and protection products that provide cutting edge solutions for consumers, with varied applications across many industries; as well as professional quality hair and skin care products. These products lines are both sold throughout the United States, Canada, Europe and Asia. On February 14, 2024, the Company successfully completed efforts to uplist from the over-the-counter, or OTC, markets to the NYSE American stock exchange (“NYSE American”).

 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies

 

Basis of Presentation and Principles of Consolidation

 

The consolidated financial statements for the fiscal years ended May 31, 2024 and 2023 have been prepared by us in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and include the accounts of the Company and its consolidated subsidiary. All significant intercompany accounts and transactions have been eliminated in consolidation. 

 

Reverse Stock Split

 

Effective as of January 16, 2024, the Company effected a reverse stock split (the “Reverse Stock Split”) of the Company’s issued shares of common stock at a ratio of 1-for-20, as approved by the Company’s Board of Directors (the “Board”). The Reverse Stock Split did not affect the total number of shares of common stock that the Company is authorized to issue and any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share. The accompanying consolidated financial statements and notes to the financial statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.  

 

F-6

Table of Contents 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Use of estimates

 

The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. Estimates made by management include, but are not limited to, the allowance for doubtful accounts, inventory valuations and classifications, the useful life of property and equipment, the valuation of deferred tax assets, the value of stock-based compensation, contract liability, allowance on sales returns, valuation of lease liabilities and related right of use assets, fair value of securities issued for business combinations, fair value of assets acquired and liabilities assumed in business combinations and the fair value of non-cash common stock issuances. 

 

Cash and cash equivalents

 

The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company maintains cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. (See Note 14)

 

Accounts receivable and allowance for doubtful accounts

 

On June 1, 2023, the Company adopted ASC 326, "Financial Instruments - Credit Losses". In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting from the possible inability of customers to make required payments (current expected losses). The amount of the allowance is determined principally on the basis of past collection experience and known financial factors regarding specific customers.

 

Accounts receivables comprise of receivables from customers and receivables from merchant processors. The Company has a policy of providing an allowance for doubtful accounts based on its best estimate of the amount of probable credit losses in its existing accounts receivable. The Company periodically reviews its accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may indicate that the realization of an account may be in doubt. Account balances deemed to be uncollectible are charged to bad debt expense and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

 

Prepaid expenses and other current assets

 

Prepaid expenses and other current assets consist primarily of cash prepayments to vendors for inventory and prepayments for trade shows and marketing events which will be utilized within a year, prepayments on credit cards and the right to recover assets (for the cost of goods sold) associated with the right of returns for products sold.

 

Inventory

 

The Company values inventory, consisting of finished goods and raw materials, at the lower of cost and net realizable value. Cost is determined using an average cost method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its net realizable value. The Company evaluates its current level of inventory considering historical sales and other factors and, based on this evaluation, classifies inventory markdowns in the statement of operations as a component of cost of goods sold. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions, customer demand or competition differ from expectations. The Company continuously evaluates the levels of inventory held and any inventory held above the expected level of sales in the next twelve months, is classified as non-current inventory.

 

F-7

Table of Contents 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Property and Equipment

 

Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the statement of operations.

  

Product warranty

 The Company provides a one-year, two-year or three-year limited warranty on its hearing enhancement and hearing protection products. The Company records the costs of repairs and replacements, as they are incurred, to the cost of sales.  

 

Revenue recognition

 

The Company follows Accounting Standards Codification (“ASC”) 606, Revenue From Contracts With Customers. This revenue recognition standard (new guidance) has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied.

 

The Company sells a variety of hair and skin care products and electronic hearing and enhancement products. The Company recognizes revenue for the agreed upon sales price when a purchase order is received from the customer and subsequently the product is shipped to the customer, which satisfies the performance obligation. Consideration paid to the customer to promote and sell the Company’s products is typically recorded as a reduction in revenues.

 

The five steps for revenue recognition are as follows:

 

Identify the contract with a customer. The Company generally considers completion of a sales order (which requires customer acceptance of the Company’s click-through terms and conditions for website sales and authorization of payment through credit card or another form of payment for sales made over the phone) or purchase orders from non-consumer customers as a customer contract provided that collection is considered probable. For payments that are not made upfront by credit card, the Company assesses customer creditworthiness based on credit checks, payment history, and/or other circumstances. For payments involving third party financier payors, the Company validates customer eligibility and reimbursement amounts prior to shipping the product.

 

Identify the performance obligations in the contract. Product performance obligations include shipment of products and related accessories and service performance obligations include extended warranty coverage.

 

However, as the historical redemption rate under our warranty policy has been low, the option is not accounted for as a separate performance obligation. The Company does not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.

 

Determine the transaction price and allocation to performance obligations. The transaction price in the Company’s customer contracts consists of both fixed and variable consideration. Fixed consideration includes amounts to be contractually billed to the customer while variable consideration includes the 30-days and 60-days right of return that applies to the hearing protection and enhancement segment and hair care and skin care segment, respectively. To estimate product returns, the Company analyzes historical return levels, current economic trends, and changes in customer demand. Based on this information, the Company reserves a percentage of product sale revenue and accounts for the estimated impact as a reduction in the transaction price.

 

Allocate the transaction price to the performance obligations in the contract. For contracts that contain multiple performance obligations, the Company allocates the transaction price to the performance obligations on a relative standalone selling price basis.

 

Recognize revenue when or as the Company satisfies a performance obligation. Revenue for products is recognized at a point in time, which is generally upon shipment. Revenue for services (extended warranty) is recognized over time on a ratable basis over the warranty period.

 

F-8

Table of Contents 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

As of May 31, 2024 and May 31, 2023, contract liabilities amounted to $1,385,841 and $1,433,048, respectively. Contract liabilities associated with product invoiced but not received by customers at the balance sheet date was $0 and $0, respectively; contract liabilities associated with unfulfilled performance obligations for warranty services offered for a period of one to three years was $1,251,710 and $1,320,401, respectively, and contract liabilities associated with unfulfilled performance obligations for customers’ right of return was $130,201 and $112,647, respectively. Our contract liabilities amounts are expected to be recognized over a period of one year to three years. Approximately $771,180 is expected to be recognized in year 1, $420,630 is expected to be recognized in year 2, and $59,900 is expected to be recognized in year 3. Contract liabilities associated with gift cards purchased by customers amounted to $3,930 as of May 31, 2024.

  

Revenue recognized, during the fiscal year ended May 31, 2023, that was included in the contract liability balance at the beginning of period (acquisition of AXIL) was $391,204

  

Cost of Sales

 

The primary components of cost of sales include the cost of the product and shipping fees.

  

Shipping and Handling Costs

 

The Company accounts for shipping and handling fees in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping products to customers are classified in marketing and selling expenses as incurred. Shipping costs included in marketing and selling expense were $1,163,954 and $1,001,261 for the fiscal years ended May 31, 2024 and 2023, respectively.

 

Marketing, selling and advertising

 

Sales, marketing and advertising costs are expensed as incurred.

 

Customer Deposits

 

Customer deposits consisted of prepayments from customers to the Company. The Company will recognize the prepayments as revenue upon delivery of products in compliance with its revenue recognition policy.

 

Fair value measurements and fair value of financial instruments

 

The Company adopted ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”), for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company’s financial position or operating results, but did expand certain disclosures. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below: 

 

Level 1:	Observable inputs such as quoted market prices in active markets for identical assets or liabilities.
Level 2:	Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3:	Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

 

The Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s (“FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

The estimated fair value of certain financial instruments, including prepaid expenses, deposits, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.

 

F-9

Table of Contents 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Business Combinations

 

For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets acquired and liabilities assumed of the acquired business, at their fair values.

 

Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from business combinations and are expensed as incurred. If the business combination provides for contingent consideration, the Company records the contingent consideration at fair value at the acquisition date. Changes in fair value of contingent consideration resulting from events after the acquisition date, such as earn-outs, are recognized as follows: (1) if the contingent consideration is classified as equity, the contingent consideration is not re-measured and its subsequent settlement is accounted for within equity, or (2) if the contingent consideration is classified as a liability, the changes in fair value and accretion costs are recognized in earnings. The increases or decreases in the fair value of contingent consideration can result from changes in anticipated revenue levels and changes in assumed discount periods and rates.

 

Goodwill

 

Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur, or circumstances indicate the fair value of a reporting unit is below its carrying value.

 

The Company performs its annual goodwill impairment assessment on May 31st of each year or as impairment indicators dictate.

 

When evaluating the potential impairment of goodwill, management first assesses a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company’s reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to the quantitative impairment testing methodology primarily using the income approach (discounted cash flow method).

 

Under the quantitative method we compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If the carrying value of a reporting unit exceeds its fair value, then the amount of impairment to be recognized is recognized as the amount by which the carrying amount exceeds the fair value.

 

When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results. 

 

Income Taxes

 

The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes” (“ASC 740-10”), which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.

  

F-10

Table of Contents 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.

 

Tax positions that meet the more likely than not recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.

 

The Company has adopted ASC 740-10-25, “Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the IRS and state taxing authorities, generally for three years after they are filed.

 

Impairment of long-lived assets  

 

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. The Company did not record any impairment loss during the fiscal years ended May 31, 2024 and 2023.

 

Stock-based compensation

 

Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718, “Compensation — Stock Compensation” (“ASC 718”), which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.

 

For non-employee stock option based awards, the Company follows ASU 2018-7, which substantially aligns share based compensation for employees and non-employees.

 

Net income (loss) per share of common stock

 

Basic net income (loss) per share is computed by dividing the net income or loss by the weighted average number of common shares during the period. Diluted net loss per share is computed using the weighted average number of common shares and potentially dilutive securities outstanding during the period. The following table presents a reconciliation of basic and diluted net income per common share:

 

F-11

Table of Contents 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Schedule of net loss per share
		For the Year Ended
		May 31,				May 31,
		2024				2023
Net income		$	2,003,134			$	1,824,575
Gain on redemption of preferred shares			1,329,588				-
Income available to common shareholders		$	3,332,722			$	1,824,575
Weighted average basic shares			5,868,570				5,644,771
Dilutive securities:
Convertible preferred stock			10,030,861				11,952,055
Stock options			268,750				272,438
Weighted average dilutive shares			16,168,181				17,869,264
Earnings per share:
Basic		$	0.57			$	0.32
Diluted		$	0.21			$	0.10

 

Lease Accounting

 

In February 2016, the FASB issued ASU No. 2016-02, Leases (ASU 2016-02), which requires lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements classified as operating leases under the prior guidance (ASC Topic 840). Under the new guidance, codified as ASC Topic 842, the lease liability must be measured initially based on the present value of future lease payments, subject to certain conditions. The right-of-use asset must be measured initially based on the amount of the liability, plus certain initial direct costs. The new guidance further requires that leases be classified at inception as either (a) operating leases or (b) finance leases. For operating leases, periodic expense generally is flat (straight-line) throughout the life of the lease. For finance leases, periodic expense declines over the life of the lease. The new standard, as amended, provides an option for entities to use the cumulative-effect transition method. As permitted, the Company adopted ASC Topic 842 effective June 1, 2019.

 

The Company renewed its lease for its corporate headquarters commencing December 1, 2022, under lease agreements classified as an operating lease. Please see Note 11 – “Commitments and Contingencies” under “Leases” below for more information about the Company’s leases.

 

Segment Reporting

 

The Company follows ASC Topic 280, Segment Reporting. The Company’s management reviews the Company’s consolidated financial results when making decisions about allocating resources and assessing the performance of the Company as a whole and has determined that the Company’s reportable segments are: (a) the sale of hearing protection and hearing enhancement products, and (b) the sale of hair care and skin care products. See Note 15 – “Business Segment And Geographic Area Information for more information about the Company’s reportable segments.

 

F-12

Table of Contents 

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies (continued)

 

Recently Issued Accounting Pronouncements

 

In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain convertible instruments. Among other things, under ASU 2020-06, the embedded conversion features no longer must be separated from the host contract for convertible instruments with conversion features not required to be accounted for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also eliminates the use of the treasury stock method when calculating the impact of convertible instruments on diluted Earnings per Share. The Company adopted the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the accompanying consolidated financial statements.

 

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This guidance requires additional annual and interim disclosures for reportable segments. This new standard does not affect the recognition, measurement or financial statement presentation. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company adopted the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the accompanying consolidated financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

Note 3 – Accounts Receivable, net

 

Accounts receivable, consisted of the following:

 

Schedule of accounts receivable
		May 31, 2024				May 31, 2023
Customers receivable		$	524,730			$	345,264
Merchant processor receivable			78,417				167,232
Less: Allowance for credit losses			(93,312	)			(95,480	)
Accounts receivables, net		$	509,835			$	417,016

  

The Company recorded bad debt expense of $25,471 and $76,969 during the fiscal years ended May 31, 2024 and 2023, respectively.

 

Note 4 – Inventory, net

 

Inventory consisted of the following:

 

Schedule of Inventory
		May 31, 2024				May 31, 2023
Finished Goods		$	3,190,344			$	1,198,218
Raw Materials			203,679				113,646
Inventory, net		$	3,394,023			$	1,311,864

 

At May 31, 2024 and 2023, inventory held at third party locations amounted to $58,242 and $0, respectively. At May 31, 2024 and 2023, there was $15,738 and $135,482 inventory in- transit, respectively. As of May 31, 2024 the Company provided $46,895 as obsolescence reserve on some slow-moving inventory. As of May 31, 2023 there was no slow-moving inventory.

 

F-13

Table of Contents 

Note 5 – Property and Equipment

 

Property and equipment, stated at cost, consisted of the following:

 

Schedule of property and equipment
		Estimated Life		May 31, 2024				May 31, 2023
Promotional display racks		2 years		$	30,709			$	-
Furniture and Fixtures		5 years			5,759				14,598
Computer Equipment		3 years			22,130				33,146
Plant Equipment		5-10 years			264,168				165,778
Office equipment		5-10 years			8,838				-
Automobile		5 years			24,347				15,000
Less: Accumulated Depreciation					(95,003	)			(71,059	)
Total Property, plant and equipment, net				$	260,948			$	157,463

 

Depreciation expense amounted to $34,961 and $20,908 for the fiscal years ended May 31, 2024 and 2023, respectively.

 

Note 6 – Intangible Assets

 

The Company acquired intangible assets through the Business Combination. (See Note 13). These intangible assets consisted of the following: 

 

Schedule of intangible assets
		Estimated Life		May 31, 2024				May 31, 2023
Licensing rights		3 years		$	34,024			$	11,945
Customer Relationships		3 years			70,000				70,000
Trade Names		10 years			275,000				275,000
Website		5 years			100,000				100,000
Less:Accumulated Amortization					(169,920	)			(74,271	)
Intangible assets, net				$	309,104			$	382,674

 

Goodwill arising through the business combination was $2,152,215 at May 31, 2024 and 2023 (see Note 13).

 

Amortization expense amounted to $95,649 and $74,271 for the fiscal years ended May 31, 2024 and 2023, respectively.

 

Note 7 – Other Current Liabilities

 

Other current liabilities comprised of the following:

 

Schedule of other current liabilities
		May 31, 2024				May 31, 2023
Credit Cards		$	5,734			$	833
Royalty Payment Accrual			3,376				8,792
Affiliate Accrual			-				27,673
Sales Tax Payable			231,283				258,023
Accrued Interest			-				10,343
Accrued expenses			92,543				-
Total other current liabilities		$	332,936			$	305,664

 

F-14

Table of Contents 

Note 8 – Equipment Payable

 

During the fiscal year ended May 31, 2019, the Company purchased a forklift under an installment purchase plan. The loan amount was $16,500 payable in 60 monthly installment payments of $317 comprising of principal payment of $275 and interest payment of $42. The loan was fully paid off during the year ended May 31, 2024. As at May 31, 2024 and 2023, the balance outstanding on the loan was $0 and $2,200, respectively. The Company recorded an interest expense of $500 and $500, associated with the equipment financing during the fiscal years ended May 31, 2024 and 2023, on the loan in the accompanying consolidated financial statements.

 

Note 9 – Notes Payable

 

During the fiscal year ended May 31, 2020, a commercial bank granted to the Company a loan (the “Loan”) in the amount of $150,000, which is administered under the authority and regulations of the U.S. Small Business Administration pursuant to the Economic Injury Disaster Loan Program (the “EIDL”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The Loan, which is evidenced by a note dated May 18, 2020, bears interest at an annual rate of 3.75% and is payable installments of $731 per month, beginning May 18, 2021 until May 13, 2050. The Company has to maintain a hazard insurance policy including fire, lightning, and extended coverage on all items used to secure this loan to at least 80% of the insurable value. Proceeds from loans granted under the CARES Act are intended to be used for payroll, costs to continue employee group health care benefits, rent, utilities, and certain other qualified costs (collectively, “qualifying expenses”). The Company used the loan proceeds for qualifying expenses. The Company received a loan forgiveness for $10,000 during the fiscal year ended May 31, 2022. During the fiscal year ended May 31, 2022, the Company received additional $10,000 of borrowings under the program. The Company recorded, on the accompanying consolidated financial statements, and paid interest of $5,776 and $10,342, as of May 31, 2024 and 2023, respectively.

 

During the fiscal year ended May 31, 2023 the Company obtained insurance financing of $53,337 on the general liability and excess liability insurance policies. The loan has a finance charge of $3,164 and is payable in 10 monthly installments of $5,650 each beginning November 1, 2022. As of May 31, 2024, the loan has been paid off.

 

Notes Payable as of May 31, 2024 and 2023

 

Schedule of notes payable
		May 31, 2024				May 31, 2023
Insurance Financing		$	-			$	21,335
Financing charges			-				1,253
Economic Injury Disaster Loan Program (EIDL)			146,594				150,000
Total			146,594				172,588
Less: Current portion			(146,594	)			(172,588	)
Non-current portion		$	-			$	-

 

The amounts of loan payments due in the next fiscal year ended May 31, are as follows:

 

Schedule of notes payments due in the next five years
		Total
2025		$	146,594
Total		$	146,594

 

F-15

Table of Contents 

Note 10 – Stockholders’ Equity

 

Shares Authorized

 

As of May 31, 2024, the authorized capital of the Company consists of 450,000,000 shares of common stock, par value $0.0001 per share and 300,000,000 shares of preferred stock, par value $0.0001 per share. The total number of shares of common stock that the Company is authorized to issue remained unchanged and any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share.

 

Effective as of January 16, 2024, the Company effected a reverse stock split (the “Reverse Stock Split”) of the Company’s issued shares of common stock at a ratio of 1-for-20, as approved by the Company’s Board of Directors (the “Board”). The Reverse Stock Split did not change the par value of the common stock, modify any voting rights or other terms of the common stock. The total number of shares of common stock that the Company is authorized to issue remained unchanged and any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share. The accompanying consolidated financial statements and notes to the financial statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.

 

Preferred Stock

 

The Preferred Stock may be issued from time to time in one or more series. The Board of Directors of the Company is expressly authorized to provide for the issuance of all or any of the shares of the preferred stock in one or more series, and to fix the number of shares and to determine or alter, for each such series, such voting powers, full or limited, or no voting powers and such designations, preferences, and relative, participating, optional, or other rights and such qualifications, limitations, or restrictions thereof, as shall be stated and expressed in the resolution adopted by the Board of Directors providing the issuance of such shares. The Board of Directors is also expressly authorized to increase or decrease the number of shares of any series subsequent to the issue of shares of that series. In case the number of shares of any such series shall be so decreased, the decrease shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series.

 

During the fiscal year ended May 31, 2023, the Company issued 250,000,000 shares of non-voting Series A Preferred Stock, which are convertible into shares of Company Common Stock on a twenty-to-one ratio, post Reverse Stock Split, pursuant to the Asset Purchase Agreement (See Note 13 and Common Stock section below). These 250,000,000 shares of non-voting Series A Preferred Stock were valued at the fair market value of $3,100,000 at issuance.

 

The holders of shares of Series A Preferred Stock shall have no rights to dividends with respect to such shares. No dividends or other distributions shall be declared or paid on the Common Stock unless and until dividends at the same rate shall have been paid or declared and set apart upon the Series A Preferred Stock, based upon the number of shares of Common Stock into which the Series A Preferred Stock may then be converted. Upon the dissolution, liquidation, or winding up of the Company, whether voluntary or involuntary, the holders of the Series A Preferred Stock are entitled to receive out of the assets of the Company the sum of $0.0001 per share before any payment or distribution shall be made on our shares of Common Stock. The Series A Preferred Stock shall not be subject to redemption at the option, election or request of the Corporation or any holder or holders of the Series A Preferred Stock. The shares of Series A Preferred Stock are convertible at the option of the holder thereof, at any time after the second anniversary of the date of the first issuance of the shares of Series A Preferred Stock, into one fully paid and nonassessable share of Common Stock for each 20 shares of Series A Preferred Stock; provided, however, that the holder may not convert that number of shares of Series A Preferred Stock which would cause the holder to become the beneficial owner of more than 5% of the Company’s Common Stock as determined in accordance with Sections 13(d) and (g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the applicable rules and regulations thereunder. 

 

The conversion provisions of the Company’s Series A Preferred Stock were proportionately adjusted in connection with the Reverse Stock Split but did not adjust the number of shares issued and outstanding.

 

On March 5, 2024, the Company entered into repurchase agreements with certain stockholders of the Company to purchase in the aggregate 207,748,250 shares of Series A Preferred Stock of the Company (equivalent, in aggregate, to 10,387,413 shares of the Company’s common stock on an as converted basis) for the aggregate cash consideration of $1,246,490. Such repurchase was approved by the Company’s Board of Directors. Following the repurchase, 42,251,750 shares of Series A Preferred Stock remain outstanding. The Company recorded a credit of $1,329,588 to the retained earnings, in the accompanying consolidated financial statements, for the difference between the carrying value of the preferred stock repurchased and the cash paid to the stockholders.

 

As of May 31, 2024 and 2023, 42,251,750 and 250,000,000 shares of Series A Preferred Stock were issued and outstanding, respectively.

 

F-16

Table of Contents 

Note 10 – Stockholders’ Equity (continued)

 

Common Stock

 

As of May 31, 2024, 5,908,939 shares of common stock were issued and outstanding. 

 

45,000 restricted stock awards were issued during the year ended May 31, 2024 (See below).

 

During the fiscal year ended May 31, 2023, the Company issued 3,659,195 shares of Common Stock, valued at $907,481, as consideration pursuant to the Asset Purchase agreement (See Note 13 and Preferred Stock section above).

 

During the fiscal year ended May 31, 2023, the Company sold 97,359 shares of Common Stock at $4.60 per share for a total of $447,850 under several private placement agreements.

 

Stock Options

 

Effective February 14, 2024, the Board amended the Company’s original 2022 Equity Incentive Plan (as amended, the “Plan”), which was originally approved on March 21, 2022. The effective date of the amended Plan is October 31, 2023. Under the Plan, equity-based awards may be made to employees, officers, directors, non-employee directors and consultants of the Company and its Affiliates (as defined in the Plan) in the form of (i) Incentive Stock Options (to eligible employees only); (ii) Nonqualified Stock Options; (iii) Restricted Stock; (iv) Stock Awards; (v) Performance Shares; or (vi) any combination of the foregoing. The Plan will terminate upon the close of business on the day next preceding March 21, 2032, unless terminated earlier in accordance with the terms of the Plan. The Board serves as the Plan administrator and may amend or terminate the Plan without stockholder approval, subject to certain exceptions.

 

The total number of shares initially authorized for issuance under the Plan was 500,000 shares. The Plan was amended to increase the number of shares authorized for issuance under the Plan to 1,250,000 shares of common stock. The Plan provides for an annual increase on April 1 of each calendar year, beginning in 2022 and ending in 2031, subject to Board approval prior to such date. Such potential increase may be equal to the lesser of (i) 4% of the total number of shares of the Company’s common stock outstanding on May 31 of the immediately preceding fiscal year and (ii) such smaller number of shares as determined by the Board. The number of shares authorized for issuance under the Plan will not change unless the Board affirmatively approves an increase in the number of shares authorized for issuance prior to April 1 of the applicable year. Shares surrendered or withheld to pay the exercise price of a stock option or to satisfy tax withholding requirements will not be added back to the number of shares available under the Plan. To the extent that any shares of common stock awarded or subject to issuance or purchase pursuant to awards under the Plan are not delivered or purchased, or are reacquired by the Company, for any reason, including a forfeiture of restricted stock or failure to earn performance shares, or the termination, expiration or cancellation of a stock option, or any other termination of an award without payment being made in the form of shares of common stock will be added to the number of shares available for awards under the Plan. The number of shares available for issuance under the Plan will be adjusted for any increase or decrease in the number of outstanding shares of common stock resulting from payment of a stock dividend on common stock, a stock split or subdivision or combination of shares of common stock, or a reorganization or reclassification of common stock, or any other change in the structure of shares of common stock, as determined by the Board. Shares available for awards under the Plan will consist of authorized and unissued shares.

 

Two types of options may be granted under the Plan: (1) Incentive Stock Options, which may only be issued to eligible employees of the Company and are required to have exercise price of the option not less than the fair market value of the common stock on the grant date, or, in the case of an Incentive Stock Option granted to a Ten Percent Stockholder, 110% of the fair market value of the common stock on the grant date; and (2) Non-qualified Stock Options, which may be issued to participants under the Plan and which may have an exercise price less than the fair market value of the common stock on the grant date, but not less than par value of the stock.

 

The Board may grant or sell restricted stock to participants (i.e., shares that are subject to a subject to restrictions or limitations as to the participant’s ability to sell, transfer, pledge or assign such shares) under the Plan. Except for these restrictions and any others imposed by the Board, upon the grant of restricted stock, the recipient generally will have rights of a stockholder with respect to the restricted stock. During the applicable restriction period, the recipient may not sell, exchange, transfer, pledge or otherwise dispose of the restricted stock. The Board may also grant awards of common stock to participants under the Plan, as well as awards of performance shares, which are awards for which the payout is subject to achievement of such performance objectives established by the Board. Performance shares may be settled in cash.

 

Each equity-based award granted under the Plan will be evidenced by an award agreement that specifies the terms of the award and such additional limitations, terms and conditions as the Board may determine, consistent with the provisions of the Plan.

 

F-17

Table of Contents 

Note 10 – Stockholders’ Equity (continued)

 

Upon the occurrence of a change in control, unless otherwise provided in an award agreement: (i) all outstanding stock options will become immediately exercisable in full; (ii) all outstanding performance shares will vest in full as if the applicable performance conditions were achieved in full, subject to certain adjustments, and will be paid out as soon as practicable; and (iii) all restricted stock will immediately vest in full. The Plan defines a change in control as (i) the adoption of a plan of merger or consolidation of the Company with any other corporation or association as a result of which the holders of the voting capital stock of the Company as a group would receive less than 50% of the voting capital stock of the surviving or resulting corporation; (ii) the approval by the Board of an agreement providing for the sale or transfer (other than as security for obligations of the Company) of substantially all the assets of the Company; or (iii) in the absence of prior Board approval, the acquisition of more than 20% of the Company’s voting capital stock by any person within the meaning of Rule 13d-3 under the Exchange Act (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with, the Company).

 

Subject to the Plan’s terms, the Board has full power and authority to determine whether, to what extent and under what circumstances any outstanding award will be terminated, canceled, forfeited or suspended. Awards to that are subject to any restriction or have not been earned or exercised in full by the recipient will be terminated and canceled if such recipient is terminated for cause, as determined by the Board in its sole discretion.

 

The Company estimates the fair value of share-based compensation utilizing the Black-Scholes option pricing model, which is dependent upon several variables such as the expected option term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected option term and expected dividend yield rate over the expected option term. The Company believes this valuation methodology is appropriate for estimating the fair value of stock options granted to employees and directors which are subject to ASC Topic 718 requirements. These amounts are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes compensation on a straight-line basis over the requisite service period for each award.

 

The Company utilizes the simplified method to estimate the expected life for stock options granted to employees. The simplified method was used as the Company does not have sufficient historical data regarding stock option exercises. The expected volatility is based on historical volatility. The risk-free interest rate is based on the U.S. Treasury yields with terms equivalent to the expected life of the related option at the time of the grant. Dividend yield is based on historical trends. While the Company believes these estimates are reasonable, the compensation expense recorded would increase if the expected life was increased, a higher expected volatility was used, or if the expected dividend- yield increased.

 

Pursuant to the Plan, on May 10, 2022, the Company issued to two Company officers non-statutory stock options to purchase, in the aggregate, up to 265,000 shares of its Common Stock, at an exercise price of $1.80 per share valued at $477,000 and expiring on April 20, 2032. The options vest over time with 25% of the options vesting on September 1, 2022 and thereafter vesting 1/24^th on the 1^st of every month. As of May 31, 2024, 231,875 of the options were vested.

 

Pursuant to the Plan, on November 1, 2022, the Company issued non-statutory stock options, to a former executive officer of the Company, to purchase, in the aggregate, up to 15,000 shares of its Common Stock, at an exercise price of $4.00 per share valued at approximately $60,000 and expiring on October 31, 2032. 3,750 shares vested as of January 29, 2023, and the remaining 11,250 options were forfeited in April 2023 when the executive officer left the Company. The fair value of the 3,750 vested options was $15,000.

 

The Company computed the grant date fair value using the Black-Scholes option pricing model, which is being recorded as stock-based compensation expense over the vesting period. During the fiscal years ended May 31, 2024 and 2023, the Company recorded a stock-based compensation expense of $204,429 and $207,342 respectively, for these options in the accompanying consolidated financial statements. 

 

F-18

Table of Contents 

Note 10 – Stockholders’ Equity (continued)

 

The Black-Scholes options pricing model used the following assumptions:

 

Schedule of stock option assumptions
		2024				2023
Risk free interest rate			-				4.07	%
Expected life			-				6 years
Expected volatility			-				457	%
Expected dividend			-				-

 

The following table summarizes the activity relating to the Company’s stock options:

 

Schedule of summarizes relating to the Company’s stock
		Number of Options				Weighted Average Exercise Price				Weighted Average Remaining Term
Outstanding as of June 1, 2022			265,000			$	1.80				9.92
Granted			15,000			$	4.00				9.68
Exercised			-				-				0
Forfeited			(11,250	)		$	4.00				9.68
Outstanding as of May 31, 2023			268,750			$	1.83				7.81
Granted			-				-				-
Exercised/Forfeited			-				-				-
Less: Unvested at May 31, 2024			(33,125	)		$	1.80				7.89
Vested at May 31, 2024			235,625			$	1.84				7.90

 

Restricted Stock Awards

 

The Company’s non-employee directors participate in the Company’s non-employee director compensation arrangements. Under the terms of those arrangements and pursuant to the Plan, on February 14, 2024, the Company granted each of its three non-employee Board members 5,000 restricted stock awards for an aggregate of 15,000 shares of the Company’s common stock that will vest on the one-year anniversary of the grant, subject to the respective director’s continued service as a member of the Board, with a total grant date fair value of $195,000.

 

Effective May 28, 2024, a former officer entered into a Separation Agreement and Release (the “Release”), which includes a standard release of claims and confidentiality and non-disparagement provisions. As consideration for signing the Release, the Company entered into a Consulting Agreement, dated May 28, 2024, with the former officer (the “Consulting Agreement”), pursuant to which the former officer agreed to provide transition services to the Company through October 31, 2024, unless the Consulting Agreement is terminated earlier. Pursuant to the Consulting Agreement, as compensation for services as a consultant, the former officer was granted 30,000 shares of restricted common stock valued at $298,800, which vested upon grant.

 

The fair value of the stock grants is being recorded over the term of the service related to each grant. During the years ended May 31, 2024 and 2023, the Company recorded a stock-based compensation expense related to the restricted stock awards of $62,754 and $0, respectively.

 

F-19

Table of Contents 

Note 11 – Commitments and Contingencies

 

Leases

 

As discussed in Note 2 above, the Company adopted ASU No. 2016-02, Leases on June 1, 2019, which require lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements classified as operating leases under the prior guidance. The Company has a lease agreement in connection with its office and warehouse facility in California under an operating lease which expired in October 2019. On December 1, 2019, the Company signed an extension of the lease for 3 years. The rent was $7,567 per month for the first year and increased by a certain amount each year. In November 2022, the Company entered into an extension of the lease for a two-year term beginning December 1, 2022. The rent is $6,098 per month for the first year and will increase by a certain amount the following year.

 

The Company treats a contract as a lease when the contract conveys the right to use a physically distinct asset for a period of time in exchange for consideration, or the Company directs the use of the asset and obtains substantially all the economic benefits of the asset. These leases are recorded as right-of-use (“ROU”) assets and lease obligation liabilities for leases with terms greater than 12 months. ROU assets represent the Company’s right to use an underlying asset for the entirety of the lease term. Lease liabilities represent the Company’s obligation to make payments over the life of the lease. A ROU asset and a lease liability are recognized at commencement of the lease based on the present value of the lease payments over the life of the lease. Initial direct costs are included as part of the ROU asset upon commencement of the lease. Since the interest rate implicit in a lease is generally not readily determinable for the operating leases, the Company uses an incremental borrowing rate to determine the present value of the lease payments. The incremental borrowing rate represents the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar lease term to obtain an asset of similar value.

 

The Company reviews the impairment of ROU assets consistent with the approach applied for the Company’s other long-lived assets. The Company reviews the recoverability of long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on the Company’s ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations.

 

Lease expense is recognized on a straight-line basis over the lease term, while variable lease payments are expensed as incurred. Variable payments change due to facts or circumstances occurring after the commencement date, other than the passage of time, and do not result in a remeasurement of lease liabilities. The Company’s lease agreements do not contain any residual value guarantees or restrictive covenants.

 

Pursuant to the new standard, the Company recorded an initial lease liability of $235,748 and an initial ROU asset in the same amount in 2019. The Company computed another initial lease liability of $131,970 for the new lease agreement and an initial ROU asset in the same amount which was recorded on books at the commencement of the new lease on December 1, 2022. During the fiscal years ended May 31, 2024 and 2023, the Company recorded a lease expense in the amount of $74,635 and $84,435, respectively. As of May 31, 2024, the lease liability balance was $36,752 and the right of use asset balance was $36,752. A lease term of three years and a discount rate of 12% was used.

 

Supplemental balance sheet information related to leases was as follows:

 

Schedule of supplemental balance sheet information
Assets		May 31, 2024				May 31, 2023
Right of use assets		$	131,970			$	131,970
Accumulated reduction			(95,218	)			(30,125	)
Operating lease assets, net		$	36,752			$	101,845
Liabilities
Lease liability		$	131,970			$	131,970
Accumulated reduction			(95,218	)			(29,394	)
Total lease liability, net			36,752				102,576
Current portion			(36,752	)			(65,824	)
Non-current portion		$	-			$	36,752

 

F-20

Table of Contents 

Note 11 – Commitments and Contingencies (continued)

 

Maturities of operating lease liabilities were as follows as of May 31, 2024: 

 

Schedule of maturities of operating lease liabilities
Operating Lease
2025		$	38,049
Total		$	38,049
Less: Imputed interest		$	(1,297	)
Present value of lease liabilities		$	36,752

  

Contingencies

 

From time to time, we become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. While the ultimate resolution is unknown, we do not expect that these lawsuits will individually, or in the aggregate, have a material adverse effect to our results of operations, financial condition, or cash flows. However, the outcome of any litigation is inherently uncertain and there can be no assurance that any expense, liability, or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular period, depending upon the size of the loss or our income for that particular period. Where it is probable that we will incur a loss and the amount of the loss can be reasonably estimated, we record a liability in our financial statements. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters progress over time. These legal accruals may be increased or decreased to reflect any relevant developments on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, we do not record an accrual, consistent with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be predicted with certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on our results of operations, financial position or cash flows, and the amounts accrued for any individual matter are not material. However, legal proceedings are inherently uncertain. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular period, depending upon the size of the loss or our income for that particular period.

 

On November 23, 2020, the Company was served a copy of a complaint filed by Jacksonfill, LLC in the Fourth Circuit Court for Duval County, Florida. The complaint alleged breach of agreement for non-payments for certain products against the Company. On September 2, 2023, Jacksonfill, LLC and the Company settled the dispute in the Circuit Court of the Fourth Judicial Circuit in Duval County, Florida per a binding settlement agreement. There is no admission of liability by the Company and on September 27, 2023 the Company paid attorneys on behalf of Jacksonfill, LLC the settlement in the amount of $125,000. The reserve that was provided in the financial statements in excess of the final settlement payment was recorded as a gain on settlement and is included as other income in the amount of $79,182, in the accompanying financial statements.

 

F-21

Table of Contents 

Note 12 – Related Party Transactions

 

The Company’s Chief Executive Officer, Jeff Toghraie, is the managing director of Intrepid Global Advisors (“Intrepid”). Intrepid has, from time to time, provided advances to the Company for working capital purposes. At May 31, 2024, and 2023, the Company had amounts payable to Intrepid of $11,798 and $158,072, respectively. These advances were short-term in nature and non-interest bearing. Additionally, pursuant to a voting agreement, effective June 16, 2022 as amended effective November 7, 2022, with A&A and Intrepid Global Advisors, we were subject to certain limitations on our ability to sell our capital stock until June 2024. 

 

During the fiscal years ended May 31, 2024 and 2023, the Company paid $231,470 and $218,696, respectively, as consulting fee for product development to Weston T. Harris, a major stockholder of A&A. The Company also paid $146,546 and $126,097, respectively, to immediate family members of the major stockholder as compensation for services relating to packaging design and affiliate marketing during the fiscal years ended May 31, 2024 and 2023. In addition, in March 2024, the Company entered into a repurchase agreement with an entity managed by Mr. Harris, pursuant to which the Company repurchased 142,021,750 shares of Series A Preferred Stock from the entity for an aggregate purchase price of $852,130. 

 

On June 16, 2022, the Company and its wholly owned subsidiary Reviv3 Acquisition Corporation (now known as AXIL Distribution Company) completed the acquisition of both (i) the hearing protection business of A&A, consisting of ear plugs and ear muffs, and (ii) A&A’s ear bud business pursuant to the Asset Purchase Agreement, dated May 1, 2022, as amended on June 15, 2022 and September 8, 2022, by and among the Company, Reviv3 Acquisition Corporation, A&A and certain stockholders of A&A. One of the stockholders of A&A was Intrepid. As of May 31, 2024, Intrepid did not hold any shares of A&A and held approximately 21.26% of the outstanding common stock of the Company (excluding shares of common stock that may be acquired upon the conversion of shares of Series A Preferred Stock).

 

Note 13 – Business Combination

 

On June 16, 2022, the Company completed the acquisition of certain assets of Axil & Associated Brands Corp., or A&A, a Delaware corporation, pursuant to the Asset Purchase Agreement dated May 1, 2022 and amended on June 15, 2022 and September 8, 2022, by and among the Company, its subsidiary, A&A, and certain of A&A’s stockholders, providing for the acquisition of assets relating to AXIL’s hearing protection business and ear bud business. The assets constituted substantially all of the business operations of AXIL but did not include AXIL’s hearing aid line of business.

 

One of the stockholders of AXIL is Intrepid Global Advisors (“Intrepid”). As of June 16, 2022, Intrepid held 4.68% of the outstanding common stock of AXIL and 22.33% of the outstanding Common Stock of the Company. As of May 31, 2024 and 2023, Intrepid held no outstanding common shares of A&A, as they were distributed with the Asset Purchase Agreement. Jeff Toghraie, Chairman and Chief Executive Officer of the Company, is a managing director of Intrepid.

 

As consideration for the Asset Purchase, A&A received a total of 253,659,195 shares comprised of (a) 3,659,195 shares of the Company’s Common Stock and (b) 250,000,000 shares of the company’s non-voting Series A Preferred Stock, which are convertible into shares of Company Common Stock on a 20-to-1 ratio. The Preferred Shares may not be converted or transferred for a period of two years following the closing of the acquisition. Thereafter, no holder of Preferred Shares may convert such shares into a number of shares of Company Common Stock that would cause the holder to beneficially own more than 5% of the Company’s Common Stock, as determined in accordance with Sections 13(d) and (g) of the Exchange Act. The purchase price was computed to be $4,007,480 based on a fair value of $0.0248 per common share on the date of acquisition.

 

The Company is utilizing the A&A assets to expand into the hearing enhancement business through its subsidiary.

 

The acquisition was accounted for by the Company in accordance with the acquisition method of accounting pursuant to ASC 805 “Business Combinations” and pushdown accounting is applied to record the fair value of the assets acquired by the Company. Under this method, the purchase price is allocated to the identifiable assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. Any excess of the amount paid over the estimated fair values of the identifiable net assets acquired was allocated to goodwill.

 

F-22

Table of Contents 

Note 13 – Business Combination (continued)

 

The following is a summary of the fair value of the assets acquired and liabilities assumed at the date of acquisition:

 

Schedule of estimated fair value of the assets acquired
Cash		$	1,066,414
Accounts receivable			227,786
Inventory			1,342,461
Prepaid expenses			62,452
Other assets			108,030
Accounts payable			(285,665	)
Contract liabilities			(1,043,332	)
Other current liabilities			(79,826	)
Net tangible assets acquired		$	1,398,320
Identifiable intangible assets
Licensing rights		$	11,945
Customer relationships			70,000
Tradenames			275,000
Website			100,000
Total Identifiable intangible assets		$	456,945
Consideration paid		$	4,007,480
Total net assets acquired			1,855,265
Goodwill purchased		$	2,152,215

 

F-23

Table of Contents 

Note 14 – Concentrations

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of trade accounts receivable and cash deposits, investments and cash equivalents instruments. The Company maintains its cash in bank deposits accounts. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At May 31, 2024 and 2023, the Company held cash in various accounts of approximately $3,003,876 and $4,582,682, respectively, in excess of federally insured limits. The Company has not experienced any losses in such accounts through May 31, 2024.

 

Concentration of Revenue, Accounts Receivable, Product Line, and Supplier – Hair and Skin Care Products

 

During the fiscal year ended May 31, 2024 hair and skin care product sales to three customers, which each represented over 10% of our total sales, aggregated to approximately 47% of the Company’s net sales at 27%, 10% and 10%. During the fiscal year ended May 31, 2023 hair and skin care product sales to three customers, which each represented over 10% of our total sales, aggregated to approximately 94% of the Company’s net sales at 61%, 12% and 21%.

 

During the fiscal year ended May 31, 2024 hair and skin care product sales to customers outside the United States represented approximately 29% which consisted of 28% from Canada and 1% from Italy and during the fiscal year ended May 31, 2023 hair and skin care product sales to customers outside the United States represented approximately 25% which consisted of 20% from Canada and 5% from Italy.

 

During the fiscal year ended May 31, 2024, hair and skin care product sales by product line which each represented over 10% of sales consisted of approximately 22% from sales of hair shampoo, and 17% from sales of hair conditioner and 23% from bundle kits. During the fiscal year ended May 31, 2023, hair and skin care product sales by product line which each represented over 10% of sales consisted of approximately 15% from sales of hair shampoo, and 10% from sales of hair conditioner and 7% from bundle kits.

 

During the fiscal years ended May 31, 2024 and 2023 sales for the hair and skin care product lines comprised of the following:

 

Schedule of sales by product line
		For the Fiscal Years ended
Hair Care Products		May 31, 2024				May 31, 2023
Shampoos and Conditioners			72	%			77	%
Ancillary Products			28	%			23	%
Total			100	%			100	%

 

At May 31, 2024, there was no accounts receivable for hair and skin care products that accounted for more than 10% of sales transactions which is due to the fact that products are sold primarily through direct-to-consumer. At May 31, 2023, accounts receivable for hair and skin care products from one customer accounted for more than 10% of sales transactions, which was Amazon and the second largest customer accounted for 8%, which is due to the fact that products are sold primarily through direct-to-consumer.

 

Hair and skin care product purchased inventories and products from two vendors totaling approximately $346,796 (97% of the purchases at 77% and 20%) during the fiscal year ended May 31, 2024 and three vendors totaling approximately $297,833 (95% of the purchases at 61%, 12% and 22%) during the fiscal year ended May 31, 2023.

 

Concentration of Revenue, Accounts Receivable, Product Line, and Supplier – Hearing Protection and Enhancement Products

 

The majority of hearing protection and enhancement products are sold direct-to-consumer, therefore, during the fiscal years ended May 31, 2024 and 2023, 91.2% and 97.3% of sales, respectively, were direct to customers. There was no single customer that accounted for greater than 10% of total sales.

 

F-24

Table of Contents 

Note 14 – Concentrations (continued)

 

During the fiscal year ended May 31, 2024 hearing protection and enhancement sales to customers outside the United States represented approximately 4% which consisted of 3.5% from Canada and the remaining from various countries. During the fiscal year ended May 31, 2023 hearing protection and enhancement sales to customers outside the United States represented approximately 4.5% which consisted of 3.7% from Canada and the remaining from various countries.

 

Manufacturing is outsourced primarily overseas via a number of third-party vendors, the largest vendor accounting for 87% of all purchases for the year ended May 31, 2024 and two vendors accounting for 82% and 10% of all purchases for the year ended May 31, 2023.

 

During the fiscal year ended May 31, 2024, the sale of ear buds for PSAP (personal sound amplification product) and hearing protection by product line which each represented over 10% of sales consisted approximately 38% from Bluetooth Earbuds ($15.8 million), 48% from Ghost Stryke ($19.9 million) and 13% of sales of Trackr earmuffs ($5.5 million). During the fiscal year ended May 31, 2023, the sale of ear buds for PSAP (personal sound amplification product) and hearing protection by product line which each represented over 10% of sales consisted approximately 87% from Ghost Stryke Extreme model GS-X ($18.1 million) and 9% of sales of Trackr earmuffs ($1.9 million).

 

During the fiscal year ended May 31, 2024 and 2023 sales of hearing enhancement and protection products comprised of the following: 

 

Schedule of sales by product comprised
		For The Years Ended May 31,
Ear Protection and Enhancement Products		2024				2023
Ghost Stryke			48	%			86.7	%
Trackr Earmuffs			13	%			9.1	%
Bluetooth Earbuds			38	%			3.9	%
Accessories and others			1	%			0.3	%
Total			100	%			100	%

 

F-25

Table of Contents 

Note 15 – Business Segment and Geographic Area Information

 

Business Segments

 

The Company, directly or through its subsidiaries, markets and sells its products and services directly to consumers and through its dealers. In June 2022, the Company acquired a hearing enhancement and hearing protection business. The Company’s determination of its reportable segments is based on how its chief operating decision makers manage the business.

 

The Company’s segment information is as follows: 

 

Schedule of segment information
		Year ended May 31,
		2024				2023
Net Sales
Hair care and skin care		$	1,382,877			$	1,588,958
Hearing enhancement and protection			26,115,662				21,932,069
Total net sales		$	27,498,539			$	23,521,027
Operating earnings (loss)
Segment gross profit:
Hair care and skin care		$	875,230			$	1,076,834
Hearing enhancement and protection			19,318,707				16,633,977
Total segment gross profit			20,193,937				17,710,811
Selling and Marketing			13,449,054				11,675,206
General and Administrative			5,241,503				4,051,394
Consolidated operating income (loss)		$	1,503,380			$	1,984,211
Total Assets:
Hair care and skin care		$	3,172,079			$	3,785,732
Hearing enhancement and protection			7,802,282				6,383,582
Consolidated total assets		$	10,974,361			$	10,169,314
Payments for property and equipment
Hair care and skin care		$	-			$	-
Hearing enhancement and protection			138,445				65,650
Consolidated total payments for property and equipment		$	138,445			$	65,650
Depreciation and amortization
Hair care and skin care		$	5,553			$	5,675
Hearing enhancement and protection			125,057				89,504
Consolidated total depreciation and amortization		$	130,610			$	95,179

 

Geographic Area Information

 

During the fiscal years ended May 31, 2024 and 2023, approximately 95% and 94%, respectively, of our consolidated net sales were to customers located in the U.S. (based on the customer’s shipping address). All Company assets are located in the U.S.

 

F-26

Table of Contents 

Note 16 – Income Taxes

 

The Company is subject to U.S. federal rate of 21.0% and California state tax rate of 8.84% and Utah State tax rate of 4.65%.

 

The income taxes expense (benefit) for years ended May 31, 2024 and 2023 consists of the following:

 

Schedule of income taxes expense (benefit)
		For The Fiscal Years Ended May 31,
		2024				2023
Current
Federal		$	92,406			$	84,619
State			81,870				146,294
Deferred
Federal and state			(394,481	)			-
		$	(220,205	)		$	230,913

 

The Company’s tax expense differs from the “expected” tax expense for federal income tax purposes (computed by applying the United States federal tax rate of 21% to loss before taxes) as follows:

 

Schedule of federal income tax
		For The Fiscal Years Ended May 31,
		2024				2023
Tax expense (benefit) computed at statutory rate of 21%		$	374,415			$	431,653
State tax expense (benefit) blended rate			81,870				297,928
Permanent differences			87,614				(49,773	)
Deferred tax true up			(366,891	)			3,929
Net operating loss benefit			(397,213	)			(452,824	)
Tax expense (benefit)		$	(220,205	)		$	230,913

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

 

The effects of temporary differences that gave rise to significant portions of deferred tax assets and liabilities at May 31, are as follows:

 

Schedule of deferred tax assets and liabilities
		For The Fiscal Years Ended May 31,
		2024				2023
Deferred tax assets
Net operating loss carryforward		$	231,587			$	-
Total gross deferred tax assets			231,587				-
Less: Deferred tax asset valuation allowance			-				-
Deferred tax liabilities			-				-
Total net deferred tax assets (liabilities)		$	231,587			$	-

 

There was no valuation allowance at May 31, 2024 and 2023.

 

At May 31, 2024, the Company has net operating loss carry forwards of approximately $1.9 million available to offset future net income indefinitely subject to annual usage limitations. The utilization of the net operating loss carryforwards is dependent upon the ability of the Company to generate sufficient taxable income during the carryforward period. Management believes that the realization of the benefits from these losses appears more than likely due to the Company’s current year net income results and should be able to fully utilize that benefit in the current year tax filings. Management will not provide a valuation allowance for the losses as they appear to be fully realized.

 

Note 17 – Subsequent Events

 

Subsequent to the year ended May 31, 2024, two preferred stockholders tendered notice to convert 10,000,000 shares of their preferred stock into common stock. On August 6, 2024, the Company issued 500,000 shares of common stock pursuant to the conversion notices received from the two preferred stockholders.

  

(b) Exhibits

 

Incorporated by Reference

Exhibit Number

Exhibit Description

Filed herewith

Furnished herewith

Form

Period Ending

Exhibit

Filing Date

2.1+

Asset Purchase Agreement, dated as of May 1, 2022, among AXIL Brands, Inc. (f/k/a Reviv3 Procare Company), AXIL Distribution Company (f/k/a Reviv3 Acquisition Corporation), Axil & Associated Brands Corp., and Certain Stockholders of Axil & Associated Brands Corp.

8-K

10.1

6/22/2022

2.2

Amendment Number 1 to Asset Purchase Agreement, effective as of June 10, 2022, among AXIL Brands, Inc. (f/k/a Reviv3 Procare Company), AXIL Distribution Company (f/k/a Reviv3 Acquisition Corporation), Axil & Associated Brands Corp., and Certain Stockholders of Axil & Associated Brands Corp.

8-K

10.2

6/22/2022

2.3

Amendment to Asset Purchase Agreement, dated September 8, 2022, between AXIL Brands, Inc. (f/k/a Reviv3 Procare Company), AXIL Distribution Company (f/k/a Reviv3 Acquisition Corporation), and Axil & Associated Brands Corp. and Certain Stockholders of Axil & Associated Brands Corp.

10-Q

8/31/2022

10.2

10/12/2022

3.1

Amended and Restated Certificate of Incorporation

S-1

3.3

10/6/2017

3.2

Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective as of June 13, 2022)

10-K

5/31/2022

3.3

8/25/2022

3.3

Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective as of January 16, 2024)

8-K

3.1

1/16/2024

3.4

Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective as of February 14, 2024)

8-K

3.1

2/12/2024

3.5

Bylaws

S-1

3.2

10/6/2017

3.6

Amendment to the Bylaws (effective as of February 14, 2024)

8-K

3.2

2/12/2024

4.1

Description of the Company’s Registered Securities

X

4.2

Form of Common Stock Certificate of AXIL Brands, Inc.

X

10.1

Contribution Agreement between Reviv3 Procare, LLC and AXIL Brands, Inc. (f/k/a Reviv3 Procare Company), dated June 1, 2015

S-1

10.1

10/6/2017

10.2

Second Draw Paycheck Protection Program Term Note, dated February 7, 2021

10-K

5/31/2022

10.4

8/25/2022

10.3+

Loan Authorization and Agreement (Economic Injury Disaster Loan), dated May 18, 2020, between the U.S. Small Business Administration and the Company

10-K

5/31/2022

10.5

8/25/2022

10.4

Note (Secured Disaster Loans), entered into by the Company, as Borrower, for the benefit of the U.S. Small Business Administration, as of May 18, 2020

10-K

5/31/2022

10.6

8/25/2022

10.5

Security Agreement, dated May 18, 2020, between the U.S. Small Business Administration and the Company

10-K

5/31/2022

10.7

8/25/2022

10.6*

2022 Equity Incentive Plan (March 2022)

10-K

5/31/2022

10.8

8/25/2022

10.7*

Amendment to the 2022 Equity Incentive Plan (effective as of February 14, 2024)

8-K

10.1

2/15/2024

 

10.8*

Form of Option Award Agreement (2022)

10-K

5/31/2022

10.9

8/25/2022

10.9*

Form of Stock Option Agreement (2023)

10-K

5/31/2023

10.9

8/21/2023

10.10*

Form of Restricted Stock Grant Agreement (2023)

10-K

5/31/2023

10.10

8/21/2023

10.11*

Form of Performance Restricted Stock Unit Agreement (2023)

10-K

5/31/2023

10.11

8/21/2023

10.12+

Standard Industrial/Commercial Multi-Tenant Lease, dated November 9, 2022, between Vicky Lien and AXIL Brands, Inc. (f/k/a Reviv3 Procare Company)

10-Q

11/30/2022

10.4

1/10/2023

10.13

Form of Securities Purchase Agreement

10-Q

11/30/2022

10.5

1/10/2023

10.14

Form of Securities Purchase Agreement

8-K

10.1

3/3/2023

10.15

Repurchase Agreement, dated March 5, 2024, by and between AXIL Brands, Inc. and Teton 360, LLC

8-K

10.1

3/11/2024

10.16

Repurchase Agreement, dated March 5, 2024, by and between AXIL Brands, Inc. and L Grant Foster TTEE - The Williams Family Irrevocable Trust

8-K

10.2

3/11/2024

10.17*

Separation Agreement and Release, dated May 28, 2024, between AXIL Brands, Inc. and Monica Diaz Brickell

8-K

10.1

5/29/2024

10.18*

Consulting Agreement, dated May 28, 2024, between AXIL Brands, Inc. and Monica Diaz Brickell

8-K

10.2

5/29/2024

21.1

Subsidiaries of the Company

X

31.1

Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

X

31.2

Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

X

32.1

Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

X

32.2

Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

X

97.1

Clawback Policy

X

101

The following consolidated financial statements from the Annual Report on Form 10-K for the fiscal year ended May 31, 2024 are formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Balance Sheets, (ii) Statements of Operations, (iii) Statements of Changes in Stockholders’ Equity, (iv) Statements of Cash Flows, and (v) the Notes to Financial Statements

X

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

X

 

*

Management compensatory plan or arrangement.

 

+

The schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K and the Company agrees to furnish to the SEC a copy of any omitted schedules or exhibits upon request.

 

ITEM 16. Form 10-K Summary

 

None.

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	AXIL BRANDS, INC.
Date: August 15, 2024	BY:	/s/ Jeff Toghraie
		Jeff Toghraie
		Chief Executive Officer and Chairman of the Board of Directors (principal executive officer)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature	Title	Date
/s/ Jeff Toghraie	Chief Executive Officer and Chairman of the Board of Directors (principal executive officer)	August 15, 2024
Jeff Toghraie
/s/ Jeff Brown	Chief Financial Officer, Chief Operating Officer and Director (principal accounting officer and principal financial officer)	August 15, 2024
Jeff Brown
/s/ Peter Dunne	Director	August 15, 2024
Peter Dunne
/s/ Nancy Hundt	Director	August 15, 2024
Nancy Hundt
/s/ Manu Ohri	Director	August 15, 2024
Manu Ohri

 

 

Exhibit 4.1

 

DESCRIPTION OF AXIL BRANDS, INC. COMMON STOCK

 

August 2024

 

The following summarizes the terms and provisions of the common stock of AXIL Brands, Inc., a Delaware corporation (the “Company”), which common stock is registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The following summary does not purport to be complete and is qualified in its entirety by reference to the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), and Bylaws, as amended (the “Bylaws”), which the Company has previously filed with the Securities and Exchange Commission, and applicable Delaware law.

 

Authorized Capital

 

The Company’s authorized capital stock consists of 450,000,000 shares of common stock, $0.0001 par value per share (the “Common Stock”), and 300,000,000 shares of preferred stock, $0.0001 par value per share (the “Preferred Stock”).

 

Under Delaware law, stockholders generally are not personally liable for a corporation’s acts or debts.

 

Common Stock

 

Dividend Rights

 

Subject to preferences that may be applicable to any then-outstanding shares of Preferred Stock, the holders of Common Stock are entitled to receive such dividends, if any, as may be declared from time to time by the Company’s Board of Directors out of legally available funds.

 

Voting Rights

 

Holders of Common Stock are entitled to one vote for each share. There is no cumulative voting with respect to the election of directors. Directors are elected by a plurality of the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors. Except as otherwise required by law or the Company’s Certificate of Incorporation or Bylaws, all other matters brought to a vote of the holders of Common Stock are determined by the affirmative vote of a majority of the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote. Except as otherwise required by law or as may be provided with respect to any other outstanding class or series of the Company’s Preferred Stock, the holders of shares of Common Stock possess the exclusive voting power.

 

Liquidation

 

In the event of the Company’s liquidation, dissolution or winding up, the holders of Common Stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of the Company’s known debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then-outstanding shares of Preferred Stock.

 

Rights and Preferences

 

All outstanding shares of Common Stock are duly authorized, fully paid and non-assessable. Holders of Common Stock have no preemptive, conversion, subscription or other rights, and there are no redemption or sinking fund provisions applicable to the Common Stock. The rights, preferences, and privileges of the holders of Common Stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of Preferred Stock that the Company may designate in the future.

 

Quotation

 

The Common Stock is listed on the NYSE American stock exchange under the symbol “AXIL.”

 

 

Preferred Stock

 

The Board of Directors has the authority, without further action by the holders of Common Stock, to issue up to 300,000,000 shares of Preferred Stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of such series, any or all of which may be greater than the rights of Common Stock. The issuance of Preferred Stock could adversely affect the voting power of holders of Common Stock and the likelihood that such holders will receive dividend payments and payments upon liquidation. In addition, the issuance of Preferred Stock could have the effect of delaying, deferring, or preventing a change of control of the Company or other corporate action. As of May 31, 2024, the Company had designated 250,000,000 shares of the Preferred Stock as Series A Preferred Stock (“Series A Preferred”), of which 42,251,750 were outstanding.

 

Series A Preferred

 

The Series A Preferred are convertible into shares of Common Stock on a twenty-for-one basis, at the option of the holder; provided, that the holder may not convert that number of shares of Series A Preferred which would cause the holder to become the beneficial owner of more than 5% of the Common Stock, as determined in accordance with Sections 13(d) and (g) of the Exchange Act and the applicable rules and regulations thereunder. Holders of the Series A Preferred have no dividend rights; however, no dividends or other distributions will be declared or paid on the Common Stock unless dividends at the same rate have been paid or declared on the Series A Preferred, based on the number of shares of Common Stock into which the Series A Preferred may then be converted. The Series A Preferred has no voting rights and is not subject to redemption. The Series A Preferred ranks senior to the Common Stock with respect to payments upon the liquidation, dissolution and winding up of the Company. The number of shares of Series A Preferred, and the Common Stock conversion ratio, are subject to adjustment upon the declaration of a dividend on the Common Stock payable in shares of Common Stock, any split of the Common Stock or any combination or recapitalization of the outstanding Common Stock into a different number of shares.

 

Anti-Takeover Effects of Provisions of Delaware Law, the Company’s Certificate of Incorporation and Bylaws and Other Agreements

 

Certificate of Incorporation and Bylaws

 

The Company’s Certificate of Incorporation and Bylaws provide that the Company’s Bylaws may be altered, amended, repealed or replaced by the Board of Directors without stockholder approval, to the extent permitted by law; provided, however, that an amendment to the Bylaws adopted by stockholders that specifies the votes necessary for the election of directors will not be further amended or repealed by the Board of Directors.

 

The Company’s Certificate of Incorporation provides for the Company’s Board of Directors to be divided into three classes with staggered three-year terms. Only one class of directors will be elected at each annual meeting of stockholders, with the other classes continuing for the remainder of their respective three-year terms. Because the Company’s stockholders do not have cumulative voting rights, its stockholders holding a majority of the shares of Common Stock outstanding will be able to elect all of its directors. In addition, the Company’s Bylaws allow the Company’s directors to establish the size of the Board of Directors and fill vacancies on the Board, including those created by an increase in the number of directors (subject to the rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances). The Company’s Bylaws also establish advance notice procedures for stockholders to submit proposals and nominations of candidates for election to the Board of Directors to be brought before a stockholders’ meeting. The combination of the classification of the Board of Directors, the lack of cumulative voting, the ability of the Board of Directors to fill vacancies, and the advance notice provisions make it difficult for the Company’s existing stockholders to replace its Board of Directors, as well as for another party to obtain control of the Company by replacing its Board of Directors. In addition, the Company’s Board of Directors has the power to retain and discharge its officers, which could make it more difficult for existing stockholders or another party to effect a change in management. Further, the authorization of undesignated Preferred Stock makes it possible for the Company’s Board of Directors to issue Preferred Stock with voting or other rights or preferences that could impede the success of any attempt to change the Company’s control.

 

 

The provisions described above may have the effect of deterring hostile takeovers or delaying changes in the Company’s control or management.

 

Delaware Anti-Takeover Law

 

The Company is subject to Section 203 of the Delaware General Corporation Law (“Section 203”), which generally prohibits a public Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a period of three years after the date of the transaction in which the person became an interested stockholder unless:

 

·

prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;

 

·

upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned by (i) persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or

 

·

on or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock that is not owned by the interested stockholder.

 

In general, Section 203 defines “business combination” to include the following:

 

·

any merger or consolidation involving the corporation and the interested stockholder;

 

·

any sale, lease, exchange, mortgage, pledge, transfer or other disposition (in one transaction or a series of transactions), except proportionately as a stockholder of such corporation, to or with the interested stockholder, of assets of the corporation, which assets have an aggregate market value equal to 10% or more of either the aggregate market value of all the assets of the corporation determined on a consolidated basis or the aggregate market value of all the outstanding stock of the corporation;

 

·

subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;

 

·

subject to certain exceptions, any transaction involving the corporation that has the effect, directly or indirectly, of increasing the interested stockholder’s proportionate share of the stock of any class or series, or securities convertible into the stock of any class or series, of the corporation; and

 

·

any receipt by the interested stockholder of the benefit, directly or indirectly (except proportionately as a stockholder of such corporation), of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.

 

In general, Section 203 defines an “interested stockholder” as an entity or person that, together with the person’s affiliates and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation.

 

Authorized and Unissued Shares

 

The Company’s authorized and unissued shares of Common Stock are available for future issuance without stockholder approval except as may otherwise be required by applicable regulations or Delaware law.  The Company may issue additional shares for a variety of purposes, including future offerings to raise additional capital, to fund acquisitions and as director, employee and consultant compensation. The existence of authorized but unissued shares of Common Stock could render more difficult, or discourage an attempt, to obtain control of the Company by means of a proxy contest, tender offer, merger or otherwise.

 

 

The issuance of shares of authorized and unissued Preferred Stock by the Company could have certain anti-takeover effects under certain circumstances, and could enable the Board of Directors to render more difficult or discourage an attempt to obtain control of the Company by means of a merger, tender offer or other business combination transaction directed at the Company by, among other things, placing shares of Preferred Stock with investors who might align themselves with the Board of Directors.

 

 

Exhibit 4.2 Form of Common Stock Certificate of AXIL Brands, Inc.

 

 

 

 

 

 

Exhibit 21.1

 

AXIL BRANDS, INC.

List of Subsidiaries

 

Name of Subsidiary		Jurisdiction of Incorporation
AXIL Distribution Company		Delaware

 

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a), AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Jeff Toghraie, certify that: 

 

1.

I have reviewed this annual report on Form 10-K of Axil Brands, Inc.;

  

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

  

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 15, 2024	By:	/s/ Jeff Toghraie
	Name:	Jeff Toghraie
	Title:	Chief Executive Officer (principal executive officer)

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a), AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Jeff Brown, certify that: 

 

1.

I have reviewed this annual report on Form 10-K of Axil Brands, Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 15, 2024	By:	/s/ Jeff Brown
	Name:	Jeff Brown
	Title:	Chief Financial Officer (principal accounting officer and principal financial officer)

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of Axil Brands, Inc. (the “Company”) for the year ended May 31, 2024 (the “Report”), I, Jeff Toghraie, Chief Executive Officer, certify as follows:

 

A)

the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and

 

B)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods covered by the Report.

 

This statement is authorized to be attached as an exhibit to the Report so that this statement will accompany the Report at such time as the Report is filed with the Securities and Exchange Commission, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350. Pursuant to Securities and Exchange Commission Release 33-8238, dated June 5, 2003, this certification is being furnished and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any registration statement of the Company filed under the Securities Act of 1933, as amended, except to the extent that the Company specifically incorporates it by reference. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. 

 

Date: August 15, 2024	By:	/s/ Jeff Toghraie
	Name:	Jeff Toghraie
	Title:	Chief Executive Officer (principal executive officer)

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of Axil Brands, Inc. (the “Company”) for the year ended May 31, 2024 (the “Report”), I, Jeff Brown, Chief Financial Officer, certify as follows:

 

A)

the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and

 

B)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods covered by the Report.

 

This statement is authorized to be attached as an exhibit to the Report so that this statement will accompany the Report at such time as the Report is filed with the Securities and Exchange Commission, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350. Pursuant to Securities and Exchange Commission Release 33-8238, dated June 5, 2003, this certification is being furnished and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any registration statement of the Company filed under the Securities Act of 1933, as amended, except to the extent that the Company specifically incorporates it by reference. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

Date: August 15, 2024	By:	/s/ Jeff Brown
	Name:	Jeff Brown
	Title:	Chief Financial Officer (principal accounting officer and principal financial officer)

 

Exhibit 97.1

 

CLAWBACK POLICY

 

OFFICER ACKNOWLEDGEMENT AND AGREEMENT
PERTAINING TO CLAWBACK POLICY

 

This Acknowledgement and Agreement (the “Acknowledgement”) is delivered by the undersigned officer (“Executive”), as the date set forth below, to AXIL Brands, Inc., a Delaware corporation (the “Company”). Executive is an officer (as defined under Section 16 of the Securities Exchange Act of 1934, as amended) of the Company and an employee of the Company or one of its subsidiaries.

 

The Board of Directors of the Company (the “Board”) has adopted a clawback policy, amended and restated effective as of February 14, 2024, which is attached as Exhibit A hereto (as further amended, restated, supplemented or otherwise modified from time-to-time by the Board (the “Clawback Policy”)). The Clawback Policy provides for the recoupment of certain compensation from Executive officers in the event of (i) an accounting restatement resulting from material non-compliance with financial reporting requirements under the securities laws, or (ii) other detrimental conduct that has caused or is likely to cause material financial, operational or reputational harm to the Company.

 

In consideration of the continued benefits to be received from the Company (and/or any subsidiary of the Company) and Executive’s right to participate in, and as a condition to the receipt of, Incentive Compensation (as defined in the Clawback Policy), Executive hereby acknowledges and agrees to the following:

 

1.

Executive has read and understands the Clawback Policy and has had an opportunity to ask questions to the Company regarding the Clawback Policy.

 

2.

Executive agrees to be bound by and to abide by the terms of the Clawback Policy and intends for the Clawback Policy to be applied to the fullest extent of the law.

 

3.

The Clawback Policy shall apply to any and all Incentive Compensation that is approved, awarded, granted to or received by Executive on or after February 14, 2024 and any Incentive Compensation that is outstanding as of February 14, 2024.

 

4.

In the event of any inconsistency between the provisions of the Clawback Policy and this Acknowledgement or any applicable incentive-based compensation arrangements, employment agreement, equity agreement or similar agreement or arrangement setting forth the terms and conditions of any Incentive Compensation, the terms of the Clawback Policy shall govern.

 

No modifications, waivers or amendments of the terms of this Acknowledgement shall be effective unless signed in writing by Executive and the Company. The provisions of this Acknowledgement shall inure to the benefit of the Company, and shall be binding upon, the successors, administrators, heirs, legal representatives and assigns of Executive.

 

 

By signing below, Executive agrees to the application of the Clawback Policy and the other terms of this Acknowledgement.

 

 

(Signature)		(Date)

 

EXHIBIT A

 

CLAWBACK POLICY

 

Introduction

 

The Board of Directors of AXIL Brands, Inc. (the “Board”) believes that it is in the best interests of AXIL Brands, Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”) and its stockholders to create and maintain a culture that emphasizes integrity and accountability, that reinforces the Company’s pay-for-performance compensation philosophy and deters wrongdoing. The Board has therefore adopted this Clawback Policy (this “Policy”) which provides for the recoupment of certain compensation in the event of (i) an accounting restatement resulting from material non-compliance with financial reporting requirements under the federal securities laws, or (ii) other detrimental conduct that has caused or is likely to cause material financial, operational or reputational harm to the Company. The provisions of this Policy concerning recoupment in the event of an Accounting Restatement (as defined below) are intended to comply with Section 10D of the Securities Exchange Act of 1934 (the “Exchange Act”), the rules of the Securities and Exchange Commission (the “Commission”) promulgated thereunder and the listing requirements of the NYSE American LLC, or such other national securities exchange on which the Company’s securities may be listed from time to time (the “Exchange”).

 

Administration

 

This Policy shall be administered by the Board or, if so designated by the Board, the Compensation Committee of the Board (the “Compensation Committee”), in which case references herein to the Board shall be deemed references to the Compensation Committee. Any determinations made by the Board shall be final and binding on all affected individuals.

 

Covered Executives

 

This Policy applies to any current or former officer of the Company who is (or was at any time from and after the Effective Time (as defined below)) subject to Section 16 of the Securities Exchange Act of 1934, as amended from time-to-time (each, a “Covered Executive”).

 

Recoupment; Accounting Restatement

 

In the event the Company is required to prepare a restatement of its financial statements due in whole or in part to the Company’s material non-compliance with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (“Accounting Restatement”), the Board will require reimbursement or forfeiture of any Excess Incentive Compensation (as defined below) deemed to have been received by any Covered Executive during the three (3) completed fiscal years immediately preceding the date on which the Company is required to prepare an accounting restatement (the “Covered Period”).

 

For the avoidance of doubt, an “Accounting Restatement” shall not be deemed to include changes to the Company’s financial statements that do not involve the correction of an error resulting from material non-compliance with financial reporting requirements, as determined in accordance with applicable accounting standards and guidance. By way of example, based on current accounting standards and guidance, an “Accounting Restatement” would not include changes to the Company’s financial statements resulting solely from: (i) retrospective application of a change in accounting principles; (ii) retrospective revision to reportable segment information due to a change in the structure of the Company’s internal organization; (iii) retrospective reclassification due to a discontinued operation; (iv) retrospective application of a change in reporting entity, such as from a reorganization of entities under common control; or (v) retrospective revision for stock splits, stock dividends, reverse stock splits or other changes in capital structure.

 

For purposes of this Policy, “Incentive Compensation” means any compensation that is granted, earned or vested based (in whole or in part) on the attainment of one or more “financial reporting measures.” For these purposes, “financial reporting measures” are any measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures, including, without limitation, (i) revenue, (ii) net income, (iii) earnings before interest, tax, depreciation and amortization, (iv) return on equity, (v) cash flows, (vi) stock price, and (vii) measures of shareholder return, in each case, whether absolute or relative. For the avoidance of doubt, a financial reporting measure need not be presented within the financial statements or included in a filing with the Commission.

 

Incentive Compensation will be deemed to have been “received” in the fiscal period during which the applicable financial reporting measure (as specified in the terms of the award) is attained, even if the payment occurs after the end of that fiscal period. In addition, the date on which the Company is required to prepare an Accounting Restatement will be deemed to have occurred on the earlier of (A) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes or reasonably should have concluded that the Company is required to prepare an Accounting Restatement, and (B) the date a court, regulator, or other legally authorized body directs the Company to prepare an Accounting Restatement.

 

Recoupment; Detrimental Conduct

 

In the event that a Covered Executive engages in Detrimental Conduct (as defined below) that, in the sole discretion of the Board, is likely to cause or has caused material financial, operational, or reputational harm to the Company, the Board may recover Incentive Compensation received by the Covered Executive from and after the date on which such Detrimental Conduct occurred.

 

“Detrimental Conduct” consists of:

 

i.

the commission of an act of fraud, misappropriation or embezzlement in the course of employment;

 

ii.

the commission of a criminal act, whether or not in the course of employment or in the workplace, that constitutes a felony (or substantial equivalent thereof in a non-U.S. jurisdiction) or other serious crime involving moral turpitude, dishonesty, or fraud;

 

iii.

the material violation of a non-compete, non-solicitation, or confidentiality agreement;

 

iv.

the material breach of the Company’s Code of Business Conduct and Ethics (the “Code”) that could give rise to dismissal under the Code; or

 

v.

any act or omission that resulted in such Covered Executive’s termination for Cause (as defined below).

 

For the purposes of this Policy, “Cause” shall, as of any applicable date of determination, have the meaning ascribed to such term in the agreement and/or plan governing the most recent equity (or other long-term incentive) award granted to the applicable Covered Executive.

 

Amount and Method of Recovery; No Additional Payments

 

The Board shall determine the amount of Incentive Compensation paid to be recovered as follows:

 

i.

In the event of recoupment due to an Accounting Restatement:

 

A.

The Board shall cause the Company to recover reasonably promptly the amount (if any) of Incentive Compensation received by the Executive Officer that exceeds the amount of Incentive Compensation that otherwise would have been received had it been determined based on the restated amounts, computed without regard to any taxes paid (“Excess Incentive Compensation”). For Incentive Compensation based in part or whole on stock price or measures of shareholder return, Excess Incentive Compensation will be calculated based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or shareholder return upon which the Incentive Compensation was received, and the Company will maintain documentation of the determination of that reasonable estimate and provide such documentation to the Exchange. Notwithstanding the foregoing, the Company shall not be required to recover Excess Incentive Compensation solely to the extent that (I) the Company’s committee of independent directors responsible for executive compensation decision (or in the absence of such a committee, a majority of the independent directors serving on the Board) has made a determination that recovery would be impracticable, and (II) either (a) the direct expense paid to a third party to assist in enforcing the policy would exceed the amount to be recovered (determined after the Company has made a reasonable attempt to recover such Excess Incentive Compensation, and has provided documentation of such reasonable attempt to recover the Excess Incentive Compensation to the Exchange), or (b) recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue Code and regulations thereunder.

 

B.

To the extent that the Board determines that the Accounting Restatement is due in any material respect to the actions, or failure to taken action, of a Covered Executive, then, in addition to those amounts required to be recovered pursuant to paragraph (i)(A) above, the Board, in its sole discretion, may cause the Company to recover any costs incurred by the Company in connection with such Accounting Restatement (including, without limitation, any legal, audit and accounting fees incurred in investigating and preparing such Accounting Restatement, any fees incurred in responding or defending any claims relating in whole or in part to the Accounting Restatement or the facts or circumstances relating thereto, and any amounts paid in settlement of or on account of any judgment relating to any such claims).

 

ii.

In the event of recoupment due to Detrimental Conduct, the Board, in its sole discretion, may cause the Company to recover an amount of Incentive Compensation up to and based upon the Covered Person’s relative degree of fault or involvement, the impact of the conduct on the Company, the magnitude of any loss caused and other relevant facts and circumstances.

 

In no event shall the Company be required to award Covered Executives an additional payment if the restated or accurate financial results would have resulted in a higher incentive compensation payment.

 

If Incentive Compensation in the form of an equity award is recoverable pursuant to this Policy, then, in addition to any other method of recoupment that may be determined by the Board, the Company will be entitled to: (A) if the equity award is still outstanding, cause the Covered Executive to forfeit the award; (B) if the equity award has been exercised or settled into shares (the “Underlying Shares”) and the Covered Executive still holds the Underlying Shares, recover the number of Underlying Shares (less any exercise price, if any, paid in cash for the Underlying Shares); and (C) if the Underlying Shares have been sold by the Covered Executive, recover the after-tax portion of the proceeds received by the Covered Executive from the sale of the Underlying Shares (less any exercise price, if any, paid in cash for the Underlying Shares.

 

In addition, the Board may determine, in its sole discretion, any additional method for recouping Incentive Compensation hereunder, provided in any case that any such method provides for reasonably prompt recovery and otherwise complies with any requirements of the Exchange and applicable law, which methods may include, without limitation: (A) requiring reimbursement of cash Incentive Compensation previously paid; (B) offsetting the recouped amount from any compensation otherwise owed by the Company to the Covered Executive; or (C) taking any other remedial and recovery action permitted by law, as determined by the Board.

 

No Indemnification

 

The Company shall not indemnify any Covered Executives against (i) the loss of any incorrectly awarded Incentive Compensation or any Incentive Compensation that is recouped pursuant to the terms of this Policy, or (ii) any claims relating to the Company’s enforcement of its rights under this Policy.

 

Interpretation

 

The Board is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy. The provisions of this Policy concerning recoupment in the event of an Accounting Restatement shall be interpreted and construed so as to comply with Section 10D of the Exchange Act, the rules of the Commission promulgated thereunder and the listing requirements of the Exchange.

 

Effective Date

 

This Policy, as amended and restated as set forth herein effective as of February 14, 2024 (the “Effective Date”), shall apply to any and all Incentive Compensation that is approved, awarded, granted to or received by Covered Executives on or after the Effective Date and any Incentive Compensation that is outstanding as of the Effective Date.

 

Amendment; Termination

 

The Board may amend this Policy from time-to-time in its discretion and shall amend this Policy as it deems necessary, including as and when it determines that it is legally required by Commission rule or the rules of any national securities exchange on which the Company’s securities are listed. The Board may terminate this Policy at any time.

 

Other Recoupment Rights; No Additional Payments

 

The Board intends that this Policy will be applied to the fullest extent of the law. The Board may require that any employment agreement, equity award agreement, or similar agreement entered into on or after the Effective Date shall, as a condition to the grant of any benefit thereunder, require a Covered Executive to agree to abide by the terms of this Policy. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company pursuant to the terms of any similar policy in any employment agreement, equity award agreement, or similar agreement and any other legal remedies available to the Company.

 

Successors

 

This Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives.

 

Originally adopted by the Board of Directors on January 26, 2024 and amended and restated by the Board of Directors on August __, 2024, effective as of February 14, 2024.

 

 

v3.24.2.u1

Cover - USD ($)	12 Months Ended
	May 31, 2024	Aug. 06, 2024	Nov. 30, 2023
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	May 31, 2024
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--05-31
Entity File Number	001-41958
Entity Registrant Name	AXIL BRANDS, INC.
Entity Central Index Key	0001718500
Entity Tax Identification Number	47-4125218
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	901 S Fremont Avenue
Entity Address, Address Line Two	Unit 158
Entity Address, City or Town	Alhambra
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	91803
City Area Code	(888)
Local Phone Number	638-8883
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	AXIL
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 29,428,114
Entity Common Stock, Shares Outstanding		6,393,939
Documents Incorporated by Reference [Text Block]	None
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	false
Auditor Firm ID	106
Auditor Name	SALBERG & COMPANY, P.A
Auditor Location	Boca Raton, Florida

v3.24.2.u1

CONSOLIDATED BALANCE SHEETS - USD ($)	May 31, 2024	May 31, 2023
CURRENT ASSETS:
Cash	$ 3,253,876	$ 4,832,682
Accounts receivable, net	509,835	417,016
Inventory, net	3,394,023	1,311,864
Prepaid expenses and other current assets	809,126	801,360
Total Current Assets	7,966,860	7,362,922
OTHER ASSETS:
Property and equipment, net	260,948	157,463
Deferred tax asset	231,587
Intangible assets, net	309,104	382,674
Right of use asset	36,752	101,845
Other assets	16,895	12,195
Goodwill	2,152,215	2,152,215
Total Other Assets	3,007,501	2,806,392
TOTAL ASSETS	10,974,361	10,169,314
CURRENT LIABILITIES:
Accounts payable	967,596	908,606
Customer deposits	154,762	183,688
Equipment payable, current		2,200
Contract liabilities- current	905,311	827,106
Notes payable	146,594	172,588
Due to related party	11,798	158,072
Lease liability, current	36,752	65,824
Income tax liability	242,296	230,913
Other current liabilities	332,936	305,664
Total Current Liabilities	2,798,045	2,854,661
LONG TERM LIABILITIES:
Lease liability- long term		36,752
Contract liabilities- long term	480,530	605,942
Total Long Term Liabilities	480,530	642,694
Total Liabilities	3,278,575	3,497,355
Commitments and contingencies (see Note 11)
STOCKHOLDERS' EQUITY:
Preferred stock, $0.0001 par value; 300,000,000 shares authorized; 42,251,750 and 250,000,000 shares issued and outstanding as of May 31, 2024 and 2023, respectively	4,225	25,000
Common stock, $0.0001 par value: 450,000,000 shares authorized; 5,908,939 and 5,863,939 shares issued, issuable and outstanding as of May 31, 2024 and 2023, respectively	591	586
Additional paid-in capital	7,825,240	10,113,365
Accumulated deficit	(134,270)	(3,466,992)
Total Stockholders' Equity	7,695,786	6,671,959
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 10,974,361	$ 10,169,314

v3.24.2.u1

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	May 31, 2024	May 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	300,000,000	300,000,000
Preferred stock, shares issued	42,251,750	250,000,000
Preferred stock, shares outstanding	42,251,750	250,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	450,000,000	450,000,000
Common stock, shares issued	5,908,939	5,863,939
Common stock, shares outstanding	5,908,939	5,863,939

v3.24.2.u1

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
Income Statement [Abstract]
Sales, net	$ 27,498,539	$ 23,521,027
Cost of sales	7,304,602	5,810,216
Gross profit	20,193,937	17,710,811
OPERATING EXPENSES:
Sales and marketing	13,449,054	11,675,206
Compensation and related taxes	965,931	1,347,839
Professional and consulting	2,589,496	1,420,990
General and administrative	1,686,076	1,282,565
Total Operating Expenses	18,690,557	15,726,600
INCOME FROM OPERATIONS	1,503,380	1,984,211
OTHER INCOME (EXPENSE):
Gain on debt settlement	79,182	50,500
Other income	22,534	16,829
Interest income	182,225	6,469
Interest expense and other finance charges	(4,392)	(2,521)
Other Income (Expense), Net	279,549	71,277
INCOME BEFORE PROVISION FOR INCOME TAXES	1,782,929	2,055,488
Provision (benefit) for income taxes	(220,205)	230,913
NET INCOME	2,003,134	1,824,575
Deemed dividend on preferred stock buyback	1,329,588
Net income available to common shareholders	$ 3,332,722	$ 1,824,575
NET INCOME PER COMMON SHARE:
Basic	$ 0.57	$ 0.32
Diluted	$ 0.21	$ 0.10
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic	5,868,570	5,644,771
Diluted	16,168,181	17,869,264

v3.24.2.u1

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at May. 31, 2022		$ 211	$ 5,476,068	$ (5,291,567)	$ 184,712
Beginning balance, shares at May. 31, 2022		2,107,385
Shares issued for acquisition of business	$ 25,000	$ 366	3,982,114		4,007,480
Shares issued for acquisition of business, shares	250,000,000	3,659,195
Stock options expense			207,342		207,342
Shares to be issued for cash		$ 9	447,841		447,850
Shares to be issued for cash, shares		97,359
Net income				1,824,575	1,824,575
Ending balance, value at May. 31, 2023	$ 25,000	$ 586	10,113,365	(3,466,992)	6,671,959
Ending balance, shares at May. 31, 2023	250,000,000	5,863,939
Stock options expense			204,429		204,429
Restricted stock awards		$ 5	62,749		62,754
Restricted stock awards, shares		45,000
Preferred stock buyback	$ (20,775)		(2,555,303)	1,329,588	(1,246,490)
Preferred stock buyback, shares	(207,748,250)
Net income				2,003,134	2,003,134
Ending balance, value at May. 31, 2024	$ 4,225	$ 591	$ 7,825,240	$ (134,270)	$ 7,695,786
Ending balance, shares at May. 31, 2024	42,251,750	5,908,939

v3.24.2.u1

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 2,003,134	$ 1,824,575
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	130,610	95,179
Bad debts	25,471	76,969
Inventory obsolescence	46,895
Stock-based compensation	267,183	207,342
Gain on debt settlement	(79,182)	(50,500)
Deferred income taxes	(231,587)
Change in operating assets and liabilities:
Accounts receivable	(118,290)	(160,277)
Inventory	(2,129,054)	353,985
Prepaid expenses and other current assets	(7,766)	(661,115)
Deposits		(3,810)
Accounts payable and accrued expenses	138,172	215,175
Other current liabilities	4,298	630,897
Contract liabilities	(47,207)	389,716
NET CASH PROVIDED BY OPERATING ACTIVITIES	2,677	2,918,136
CASH FLOWS FROM INVESTING ACTIVITIES
Cash acquired on business acquisition		1,066,414
Purchase of intangibles	(22,080)
Purchase of property and equipment	(138,445)	(65,650)
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	(160,525)	1,000,764
CASH FLOWS FROM FINANCING ACTIVITIES
Cash raised for common stock to be issued		447,850
Repurchase of preferred stock	(1,246,490)
Repayment of equipment financing	(2,200)	(3,300)
Repayment of note payable	(25,994)	(37,119)
Advances (payments) from a related party	(146,274)	132,620
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	(1,420,958)	540,051
NET INCREASE (DECREASE) IN CASH	(1,578,806)	4,458,951
CASH - Beginning of year	4,832,682	373,731
CASH - End of year	3,253,876	4,832,682
Cash paid during the year for:
Interest	6,907	2,521
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock issued for asset purchase agreement		4,007,480
Right of use assets recognized as lease liability		131,970
Tangible assets (excluding cash) acquired in business combination		1,740,729
Intangible assets acquired in business combination		456,945
Goodwill acquired in business combination		2,152,215
Liabilities assumed in business combination		$ 1,408,823

v3.24.2.u1

Pay vs Performance Disclosure - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss)	$ 2,003,134	$ 1,824,575

v3.24.2.u1

Insider Trading Arrangements	15 Months Ended
	May 31, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

v3.24.2.u1

Organization	12 Months Ended
	May 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Note 1 – Organization   As part of AXIL Brands, Inc.’s (together with its subsidiary, the “Company,” “we,” “us” or “our”) ongoing rebranding efforts, the Company changed its name from Reviv3 Procare Company to AXIL Brands, Inc. effective February 14, 2024. Reviv3 was incorporated in the State of Delaware on May 21, 2015 as a reorganization of Reviv3 Procare, LLC which was organized on July 31, 2013. The Company’s corporate headquarters are located at 901 S. Fremont Avenue, Unit 158, Alhambra, California 91803. Its phone number is (888) 638-8883. In March 2022, the Company incorporated a subsidiary “Reviv3 Acquisition Corporation” (now known as “AXIL Distribution Company”) and in June 2022, completed the acquisition of certain assets of Axil & Associated Brands Corp. (“A&A”). The Company is engaged in the manufacturing, marketing, sale and distribution of high-tech hearing and audio enhancement and protection products that provide cutting edge solutions for consumers, with varied applications across many industries; as well as professional quality hair and skin care products. These products lines are both sold throughout the United States, Canada, Europe and Asia. On February 14, 2024, the Company successfully completed efforts to uplist from the over-the-counter, or OTC, markets to the NYSE American stock exchange (“NYSE American”).

v3.24.2.u1

Basis of Presentation and Summary of Significant Accounting Policies	12 Months Ended
	May 31, 2024
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Note 2 – Basis of Presentation and Summary of Significant Accounting Policies   Basis of Presentation and Principles of Consolidation   The consolidated financial statements for the fiscal years ended May 31, 2024 and 2023 have been prepared by us in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and include the accounts of the Company and its consolidated subsidiary. All significant intercompany accounts and transactions have been eliminated in consolidation.    Reverse Stock Split   Effective as of January 16, 2024, the Company effected a reverse stock split (the “Reverse Stock Split”) of the Company’s issued shares of common stock at a ratio of 1-for-20, as approved by the Company’s Board of Directors (the “Board”). The Reverse Stock Split did not affect the total number of shares of common stock that the Company is authorized to issue and any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share. The accompanying consolidated financial statements and notes to the financial statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.     Use of estimates   The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. Estimates made by management include, but are not limited to, the allowance for doubtful accounts, inventory valuations and classifications, the useful life of property and equipment, the valuation of deferred tax assets, the value of stock-based compensation, contract liability, allowance on sales returns, valuation of lease liabilities and related right of use assets, fair value of securities issued for business combinations, fair value of assets acquired and liabilities assumed in business combinations and the fair value of non-cash common stock issuances.    Cash and cash equivalents   The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company maintains cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. (See Note 14)   Accounts receivable and allowance for doubtful accounts   On June 1, 2023, the Company adopted ASC 326, "Financial Instruments - Credit Losses". In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting from the possible inability of customers to make required payments (current expected losses). The amount of the allowance is determined principally on the basis of past collection experience and known financial factors regarding specific customers.   Accounts receivables comprise of receivables from customers and receivables from merchant processors. The Company has a policy of providing an allowance for doubtful accounts based on its best estimate of the amount of probable credit losses in its existing accounts receivable. The Company periodically reviews its accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may indicate that the realization of an account may be in doubt. Account balances deemed to be uncollectible are charged to bad debt expense and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.   Prepaid expenses and other current assets   Prepaid expenses and other current assets consist primarily of cash prepayments to vendors for inventory and prepayments for trade shows and marketing events which will be utilized within a year, prepayments on credit cards and the right to recover assets (for the cost of goods sold) associated with the right of returns for products sold.   Inventory   The Company values inventory, consisting of finished goods and raw materials, at the lower of cost and net realizable value. Cost is determined using an average cost method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its net realizable value. The Company evaluates its current level of inventory considering historical sales and other factors and, based on this evaluation, classifies inventory markdowns in the statement of operations as a component of cost of goods sold. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions, customer demand or competition differ from expectations. The Company continuously evaluates the levels of inventory held and any inventory held above the expected level of sales in the next twelve months, is classified as non-current inventory.   Property and Equipment   Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the statement of operations.    Product warranty  The Company provides a one-year, two-year or three-year limited warranty on its hearing enhancement and hearing protection products. The Company records the costs of repairs and replacements, as they are incurred, to the cost of sales.     Revenue recognition   The Company follows Accounting Standards Codification (“ASC”) 606, Revenue From Contracts With Customers. This revenue recognition standard (new guidance) has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied.   The Company sells a variety of hair and skin care products and electronic hearing and enhancement products. The Company recognizes revenue for the agreed upon sales price when a purchase order is received from the customer and subsequently the product is shipped to the customer, which satisfies the performance obligation. Consideration paid to the customer to promote and sell the Company’s products is typically recorded as a reduction in revenues.   The five steps for revenue recognition are as follows:   Identify the contract with a customer. The Company generally considers completion of a sales order (which requires customer acceptance of the Company’s click-through terms and conditions for website sales and authorization of payment through credit card or another form of payment for sales made over the phone) or purchase orders from non-consumer customers as a customer contract provided that collection is considered probable. For payments that are not made upfront by credit card, the Company assesses customer creditworthiness based on credit checks, payment history, and/or other circumstances. For payments involving third party financier payors, the Company validates customer eligibility and reimbursement amounts prior to shipping the product.   Identify the performance obligations in the contract. Product performance obligations include shipment of products and related accessories and service performance obligations include extended warranty coverage.   However, as the historical redemption rate under our warranty policy has been low, the option is not accounted for as a separate performance obligation. The Company does not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.   Determine the transaction price and allocation to performance obligations. The transaction price in the Company’s customer contracts consists of both fixed and variable consideration. Fixed consideration includes amounts to be contractually billed to the customer while variable consideration includes the 30-days and 60-days right of return that applies to the hearing protection and enhancement segment and hair care and skin care segment, respectively. To estimate product returns, the Company analyzes historical return levels, current economic trends, and changes in customer demand. Based on this information, the Company reserves a percentage of product sale revenue and accounts for the estimated impact as a reduction in the transaction price.   Allocate the transaction price to the performance obligations in the contract. For contracts that contain multiple performance obligations, the Company allocates the transaction price to the performance obligations on a relative standalone selling price basis.   Recognize revenue when or as the Company satisfies a performance obligation. Revenue for products is recognized at a point in time, which is generally upon shipment. Revenue for services (extended warranty) is recognized over time on a ratable basis over the warranty period.   As of May 31, 2024 and May 31, 2023, contract liabilities amounted to $1,385,841 and $1,433,048, respectively. Contract liabilities associated with product invoiced but not received by customers at the balance sheet date was $0 and $0, respectively; contract liabilities associated with unfulfilled performance obligations for warranty services offered for a period of one to three years was $1,251,710 and $1,320,401, respectively, and contract liabilities associated with unfulfilled performance obligations for customers’ right of return was $130,201 and $112,647, respectively. Our contract liabilities amounts are expected to be recognized over a period of one year to three years. Approximately $771,180 is expected to be recognized in year 1, $420,630 is expected to be recognized in year 2, and $59,900 is expected to be recognized in year 3. Contract liabilities associated with gift cards purchased by customers amounted to $3,930 as of May 31, 2024. Revenue recognized, during the fiscal year ended May 31, 2023, that was included in the contract liability balance at the beginning of period (acquisition of AXIL) was $391,204    Cost of Sales   The primary components of cost of sales include the cost of the product and shipping fees.    Shipping and Handling Costs   The Company accounts for shipping and handling fees in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping products to customers are classified in marketing and selling expenses as incurred. Shipping costs included in marketing and selling expense were $1,163,954 and $1,001,261 for the fiscal years ended May 31, 2024 and 2023, respectively.   Marketing, selling and advertising   Sales, marketing and advertising costs are expensed as incurred.   Customer Deposits   Customer deposits consisted of prepayments from customers to the Company. The Company will recognize the prepayments as revenue upon delivery of products in compliance with its revenue recognition policy.   Fair value measurements and fair value of financial instruments   The Company adopted ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”), for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company’s financial position or operating results, but did expand certain disclosures. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.   Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:    Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities.     Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.     Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.   The Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s (“FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.   The estimated fair value of certain financial instruments, including prepaid expenses, deposits, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.   Business Combinations   For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets acquired and liabilities assumed of the acquired business, at their fair values.   Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from business combinations and are expensed as incurred. If the business combination provides for contingent consideration, the Company records the contingent consideration at fair value at the acquisition date. Changes in fair value of contingent consideration resulting from events after the acquisition date, such as earn-outs, are recognized as follows: (1) if the contingent consideration is classified as equity, the contingent consideration is not re-measured and its subsequent settlement is accounted for within equity, or (2) if the contingent consideration is classified as a liability, the changes in fair value and accretion costs are recognized in earnings. The increases or decreases in the fair value of contingent consideration can result from changes in anticipated revenue levels and changes in assumed discount periods and rates.   Goodwill   Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur, or circumstances indicate the fair value of a reporting unit is below its carrying value.   The Company performs its annual goodwill impairment assessment on May 31st of each year or as impairment indicators dictate.   When evaluating the potential impairment of goodwill, management first assesses a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company’s reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to the quantitative impairment testing methodology primarily using the income approach (discounted cash flow method).   Under the quantitative method we compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If the carrying value of a reporting unit exceeds its fair value, then the amount of impairment to be recognized is recognized as the amount by which the carrying amount exceeds the fair value.   When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results.    Income Taxes   The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes” (“ASC 740-10”), which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.   The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.   Tax positions that meet the more likely than not recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.   The Company has adopted ASC 740-10-25, “Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the IRS and state taxing authorities, generally for three years after they are filed.   Impairment of long-lived assets     The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. The Company did not record any impairment loss during the fiscal years ended May 31, 2024 and 2023.   Stock-based compensation   Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718, “Compensation — Stock Compensation” (“ASC 718”), which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.   For non-employee stock option based awards, the Company follows ASU 2018-7, which substantially aligns share based compensation for employees and non-employees.   Net income (loss) per share of common stock   Basic net income (loss) per share is computed by dividing the net income or loss by the weighted average number of common shares during the period. Diluted net loss per share is computed using the weighted average number of common shares and potentially dilutive securities outstanding during the period. The following table presents a reconciliation of basic and diluted net income per common share:   Schedule of net loss per share                     For the Year Ended     May 31,   May 31,     2024   2023           Net income   $ 2,003,134     $ 1,824,575   Gain on redemption of preferred shares     1,329,588       -   Income available to common shareholders   $ 3,332,722     $ 1,824,575                     Weighted average basic shares     5,868,570       5,644,771   Dilutive securities:                 Convertible preferred stock     10,030,861       11,952,055   Stock options     268,750       272,438   Weighted average dilutive shares     16,168,181       17,869,264                     Earnings per share:                 Basic   $ 0.57     $ 0.32   Diluted   $ 0.21     $ 0.10     Lease Accounting   In February 2016, the FASB issued ASU No. 2016-02, Leases (ASU 2016-02), which requires lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements classified as operating leases under the prior guidance (ASC Topic 840). Under the new guidance, codified as ASC Topic 842, the lease liability must be measured initially based on the present value of future lease payments, subject to certain conditions. The right-of-use asset must be measured initially based on the amount of the liability, plus certain initial direct costs. The new guidance further requires that leases be classified at inception as either (a) operating leases or (b) finance leases. For operating leases, periodic expense generally is flat (straight-line) throughout the life of the lease. For finance leases, periodic expense declines over the life of the lease. The new standard, as amended, provides an option for entities to use the cumulative-effect transition method. As permitted, the Company adopted ASC Topic 842 effective June 1, 2019.   The Company renewed its lease for its corporate headquarters commencing December 1, 2022, under lease agreements classified as an operating lease. Please see Note 11 – “Commitments and Contingencies” under “Leases” below for more information about the Company’s leases.   Segment Reporting   The Company follows ASC Topic 280, Segment Reporting. The Company’s management reviews the Company’s consolidated financial results when making decisions about allocating resources and assessing the performance of the Company as a whole and has determined that the Company’s reportable segments are: (a) the sale of hearing protection and hearing enhancement products, and (b) the sale of hair care and skin care products. See Note 15 – “Business Segment And Geographic Area Information for more information about the Company’s reportable segments.   Recently Issued Accounting Pronouncements   In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain convertible instruments. Among other things, under ASU 2020-06, the embedded conversion features no longer must be separated from the host contract for convertible instruments with conversion features not required to be accounted for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also eliminates the use of the treasury stock method when calculating the impact of convertible instruments on diluted Earnings per Share. The Company adopted the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the accompanying consolidated financial statements.   In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This guidance requires additional annual and interim disclosures for reportable segments. This new standard does not affect the recognition, measurement or financial statement presentation. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company adopted the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the accompanying consolidated financial statements.   Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

v3.24.2.u1

Accounts Receivable, net	12 Months Ended
	May 31, 2024
Credit Loss [Abstract]
Accounts Receivable, net	Note 3 – Accounts Receivable, net   Accounts receivable, consisted of the following:   Schedule of accounts receivable                     May 31, 2024   May 31, 2023 Customers receivable   $ 524,730     $ 345,264   Merchant processor receivable     78,417       167,232   Less: Allowance for credit losses     (93,312 )     (95,480 ) Accounts receivables, net   $ 509,835     $ 417,016      The Company recorded bad debt expense of $25,471 and $76,969 during the fiscal years ended May 31, 2024 and 2023, respectively.

v3.24.2.u1

Inventory, net	12 Months Ended
	May 31, 2024
Inventory Disclosure [Abstract]
Inventory, net	Note 4 – Inventory, net   Inventory consisted of the following:   Schedule of Inventory                     May 31, 2024   May 31, 2023 Finished Goods   $ 3,190,344     $ 1,198,218   Raw Materials     203,679       113,646   Inventory, net   $ 3,394,023     $ 1,311,864     At May 31, 2024 and 2023, inventory held at third party locations amounted to $58,242 and $0, respectively. At May 31, 2024 and 2023, there was $15,738 and $135,482 inventory in- transit, respectively. As of May 31, 2024 the Company provided $46,895 as obsolescence reserve on some slow-moving inventory. As of May 31, 2023 there was no slow-moving inventory.

v3.24.2.u1

Property and Equipment	12 Months Ended
	May 31, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 5 – Property and Equipment   Property and equipment, stated at cost, consisted of the following:   Schedule of property and equipment                         Estimated Life   May 31, 2024   May 31, 2023 Promotional display racks   2 years   $ 30,709     $ -   Furniture and Fixtures   5 years     5,759       14,598   Computer Equipment   3 years     22,130       33,146   Plant Equipment   5-10 years     264,168       165,778   Office equipment   5-10 years     8,838       -   Automobile   5 years     24,347       15,000   Less: Accumulated Depreciation         (95,003 )     (71,059 ) Total Property, plant and equipment, net       $ 260,948     $ 157,463     Depreciation expense amounted to $34,961 and $20,908 for the fiscal years ended May 31, 2024 and 2023, respectively.

v3.24.2.u1

Intangible Assets	12 Months Ended
	May 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 6 – Intangible Assets   The Company acquired intangible assets through the Business Combination. (See Note 13). These intangible assets consisted of the following:    Schedule of intangible assets                         Estimated Life   May 31, 2024   May 31, 2023 Licensing rights   3 years   $ 34,024     $ 11,945   Customer Relationships   3 years     70,000       70,000   Trade Names   10 years     275,000       275,000   Website   5 years     100,000       100,000   Less:Accumulated Amortization         (169,920 )     (74,271 ) Intangible assets, net       $ 309,104     $ 382,674     Goodwill arising through the business combination was $2,152,215 at May 31, 2024 and 2023 (see Note 13).   Amortization expense amounted to $95,649 and $74,271 for the fiscal years ended May 31, 2024 and 2023, respectively.

v3.24.2.u1

Other Current Liabilities	12 Months Ended
	May 31, 2024
Payables and Accruals [Abstract]
Other Current Liabilities	Note 7 – Other Current Liabilities   Other current liabilities comprised of the following:   Schedule of other current liabilities                     May 31, 2024   May 31, 2023 Credit Cards   $ 5,734     $ 833   Royalty Payment Accrual     3,376       8,792   Affiliate Accrual     -       27,673   Sales Tax Payable     231,283       258,023   Accrued Interest     -       10,343   Accrued expenses     92,543       -   Total other current liabilities   $ 332,936     $ 305,664

v3.24.2.u1

Equipment Payable	12 Months Ended
	May 31, 2024
Equipment Payable
Equipment Payable	Note 8 – Equipment Payable   During the fiscal year ended May 31, 2019, the Company purchased a forklift under an installment purchase plan. The loan amount was $16,500 payable in 60 monthly installment payments of $317 comprising of principal payment of $275 and interest payment of $42. The loan was fully paid off during the year ended May 31, 2024. As at May 31, 2024 and 2023, the balance outstanding on the loan was $0 and $2,200, respectively. The Company recorded an interest expense of $500 and $500, associated with the equipment financing during the fiscal years ended May 31, 2024 and 2023, on the loan in the accompanying consolidated financial statements.

v3.24.2.u1

Notes Payable	12 Months Ended
	May 31, 2024
Debt Disclosure [Abstract]
Notes Payable	Note 9 – Notes Payable   During the fiscal year ended May 31, 2020, a commercial bank granted to the Company a loan (the “Loan”) in the amount of $150,000, which is administered under the authority and regulations of the U.S. Small Business Administration pursuant to the Economic Injury Disaster Loan Program (the “EIDL”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The Loan, which is evidenced by a note dated May 18, 2020, bears interest at an annual rate of 3.75% and is payable installments of $731 per month, beginning May 18, 2021 until May 13, 2050. The Company has to maintain a hazard insurance policy including fire, lightning, and extended coverage on all items used to secure this loan to at least 80% of the insurable value. Proceeds from loans granted under the CARES Act are intended to be used for payroll, costs to continue employee group health care benefits, rent, utilities, and certain other qualified costs (collectively, “qualifying expenses”). The Company used the loan proceeds for qualifying expenses. The Company received a loan forgiveness for $10,000 during the fiscal year ended May 31, 2022. During the fiscal year ended May 31, 2022, the Company received additional $10,000 of borrowings under the program. The Company recorded, on the accompanying consolidated financial statements, and paid interest of $5,776 and $10,342, as of May 31, 2024 and 2023, respectively.   During the fiscal year ended May 31, 2023 the Company obtained insurance financing of $53,337 on the general liability and excess liability insurance policies. The loan has a finance charge of $3,164 and is payable in 10 monthly installments of $5,650 each beginning November 1, 2022. As of May 31, 2024, the loan has been paid off. Notes Payable as of May 31, 2024 and 2023   Schedule of notes payable                     May 31, 2024   May 31, 2023 Insurance Financing   $ -     $ 21,335   Financing charges     -       1,253   Economic Injury Disaster Loan Program (EIDL)     146,594       150,000   Total     146,594       172,588   Less: Current portion     (146,594 )     (172,588 ) Non-current portion   $ -     $ -     The amounts of loan payments due in the next fiscal year ended May 31, are as follows:   Schedule of notes payments due in the next five years             Total 2025   $ 146,594   Total   $ 146,594

v3.24.2.u1

Stockholders’ Equity	12 Months Ended
	May 31, 2024
Equity [Abstract]
Stockholders’ Equity	Note 10 – Stockholders’ Equity   Shares Authorized   As of May 31, 2024, the authorized capital of the Company consists of 450,000,000 shares of common stock, par value $0.0001 per share and 300,000,000 shares of preferred stock, par value $0.0001 per share. The total number of shares of common stock that the Company is authorized to issue remained unchanged and any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share.   Effective as of January 16, 2024, the Company effected a reverse stock split (the “Reverse Stock Split”) of the Company’s issued shares of common stock at a ratio of 1-for-20, as approved by the Company’s Board of Directors (the “Board”). The Reverse Stock Split did not change the par value of the common stock, modify any voting rights or other terms of the common stock. The total number of shares of common stock that the Company is authorized to issue remained unchanged and any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share. The accompanying consolidated financial statements and notes to the financial statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.   Preferred Stock   The Preferred Stock may be issued from time to time in one or more series. The Board of Directors of the Company is expressly authorized to provide for the issuance of all or any of the shares of the preferred stock in one or more series, and to fix the number of shares and to determine or alter, for each such series, such voting powers, full or limited, or no voting powers and such designations, preferences, and relative, participating, optional, or other rights and such qualifications, limitations, or restrictions thereof, as shall be stated and expressed in the resolution adopted by the Board of Directors providing the issuance of such shares. The Board of Directors is also expressly authorized to increase or decrease the number of shares of any series subsequent to the issue of shares of that series. In case the number of shares of any such series shall be so decreased, the decrease shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series.   During the fiscal year ended May 31, 2023, the Company issued 250,000,000 shares of non-voting Series A Preferred Stock, which are convertible into shares of Company Common Stock on a twenty-to-one ratio, post Reverse Stock Split, pursuant to the Asset Purchase Agreement (See Note 13 and Common Stock section below). These 250,000,000 shares of non-voting Series A Preferred Stock were valued at the fair market value of $3,100,000 at issuance.   The holders of shares of Series A Preferred Stock shall have no rights to dividends with respect to such shares. No dividends or other distributions shall be declared or paid on the Common Stock unless and until dividends at the same rate shall have been paid or declared and set apart upon the Series A Preferred Stock, based upon the number of shares of Common Stock into which the Series A Preferred Stock may then be converted. Upon the dissolution, liquidation, or winding up of the Company, whether voluntary or involuntary, the holders of the Series A Preferred Stock are entitled to receive out of the assets of the Company the sum of $0.0001 per share before any payment or distribution shall be made on our shares of Common Stock. The Series A Preferred Stock shall not be subject to redemption at the option, election or request of the Corporation or any holder or holders of the Series A Preferred Stock. The shares of Series A Preferred Stock are convertible at the option of the holder thereof, at any time after the second anniversary of the date of the first issuance of the shares of Series A Preferred Stock, into one fully paid and nonassessable share of Common Stock for each 20 shares of Series A Preferred Stock; provided, however, that the holder may not convert that number of shares of Series A Preferred Stock which would cause the holder to become the beneficial owner of more than 5% of the Company’s Common Stock as determined in accordance with Sections 13(d) and (g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the applicable rules and regulations thereunder.    The conversion provisions of the Company’s Series A Preferred Stock were proportionately adjusted in connection with the Reverse Stock Split but did not adjust the number of shares issued and outstanding.   On March 5, 2024, the Company entered into repurchase agreements with certain stockholders of the Company to purchase in the aggregate 207,748,250 shares of Series A Preferred Stock of the Company (equivalent, in aggregate, to 10,387,413 shares of the Company’s common stock on an as converted basis) for the aggregate cash consideration of $1,246,490. Such repurchase was approved by the Company’s Board of Directors. Following the repurchase, 42,251,750 shares of Series A Preferred Stock remain outstanding. The Company recorded a credit of $1,329,588 to the retained earnings, in the accompanying consolidated financial statements, for the difference between the carrying value of the preferred stock repurchased and the cash paid to the stockholders.   As of May 31, 2024 and 2023, 42,251,750 and 250,000,000 shares of Series A Preferred Stock were issued and outstanding, respectively.   Common Stock   As of May 31, 2024, 5,908,939 shares of common stock were issued and outstanding.    45,000 restricted stock awards were issued during the year ended May 31, 2024 (See below).   During the fiscal year ended May 31, 2023, the Company issued 3,659,195 shares of Common Stock, valued at $907,481, as consideration pursuant to the Asset Purchase agreement (See Note 13 and Preferred Stock section above).   During the fiscal year ended May 31, 2023, the Company sold 97,359 shares of Common Stock at $4.60 per share for a total of $447,850 under several private placement agreements. Stock Options   Effective February 14, 2024, the Board amended the Company’s original 2022 Equity Incentive Plan (as amended, the “Plan”), which was originally approved on March 21, 2022. The effective date of the amended Plan is October 31, 2023. Under the Plan, equity-based awards may be made to employees, officers, directors, non-employee directors and consultants of the Company and its Affiliates (as defined in the Plan) in the form of (i) Incentive Stock Options (to eligible employees only); (ii) Nonqualified Stock Options; (iii) Restricted Stock; (iv) Stock Awards; (v) Performance Shares; or (vi) any combination of the foregoing. The Plan will terminate upon the close of business on the day next preceding March 21, 2032, unless terminated earlier in accordance with the terms of the Plan. The Board serves as the Plan administrator and may amend or terminate the Plan without stockholder approval, subject to certain exceptions.   The total number of shares initially authorized for issuance under the Plan was 500,000 shares. The Plan was amended to increase the number of shares authorized for issuance under the Plan to 1,250,000 shares of common stock. The Plan provides for an annual increase on April 1 of each calendar year, beginning in 2022 and ending in 2031, subject to Board approval prior to such date. Such potential increase may be equal to the lesser of (i) 4% of the total number of shares of the Company’s common stock outstanding on May 31 of the immediately preceding fiscal year and (ii) such smaller number of shares as determined by the Board. The number of shares authorized for issuance under the Plan will not change unless the Board affirmatively approves an increase in the number of shares authorized for issuance prior to April 1 of the applicable year. Shares surrendered or withheld to pay the exercise price of a stock option or to satisfy tax withholding requirements will not be added back to the number of shares available under the Plan. To the extent that any shares of common stock awarded or subject to issuance or purchase pursuant to awards under the Plan are not delivered or purchased, or are reacquired by the Company, for any reason, including a forfeiture of restricted stock or failure to earn performance shares, or the termination, expiration or cancellation of a stock option, or any other termination of an award without payment being made in the form of shares of common stock will be added to the number of shares available for awards under the Plan. The number of shares available for issuance under the Plan will be adjusted for any increase or decrease in the number of outstanding shares of common stock resulting from payment of a stock dividend on common stock, a stock split or subdivision or combination of shares of common stock, or a reorganization or reclassification of common stock, or any other change in the structure of shares of common stock, as determined by the Board. Shares available for awards under the Plan will consist of authorized and unissued shares.   Two types of options may be granted under the Plan: (1) Incentive Stock Options, which may only be issued to eligible employees of the Company and are required to have exercise price of the option not less than the fair market value of the common stock on the grant date, or, in the case of an Incentive Stock Option granted to a Ten Percent Stockholder, 110% of the fair market value of the common stock on the grant date; and (2) Non-qualified Stock Options, which may be issued to participants under the Plan and which may have an exercise price less than the fair market value of the common stock on the grant date, but not less than par value of the stock.   The Board may grant or sell restricted stock to participants (i.e., shares that are subject to a subject to restrictions or limitations as to the participant’s ability to sell, transfer, pledge or assign such shares) under the Plan. Except for these restrictions and any others imposed by the Board, upon the grant of restricted stock, the recipient generally will have rights of a stockholder with respect to the restricted stock. During the applicable restriction period, the recipient may not sell, exchange, transfer, pledge or otherwise dispose of the restricted stock. The Board may also grant awards of common stock to participants under the Plan, as well as awards of performance shares, which are awards for which the payout is subject to achievement of such performance objectives established by the Board. Performance shares may be settled in cash.   Each equity-based award granted under the Plan will be evidenced by an award agreement that specifies the terms of the award and such additional limitations, terms and conditions as the Board may determine, consistent with the provisions of the Plan.   Upon the occurrence of a change in control, unless otherwise provided in an award agreement: (i) all outstanding stock options will become immediately exercisable in full; (ii) all outstanding performance shares will vest in full as if the applicable performance conditions were achieved in full, subject to certain adjustments, and will be paid out as soon as practicable; and (iii) all restricted stock will immediately vest in full. The Plan defines a change in control as (i) the adoption of a plan of merger or consolidation of the Company with any other corporation or association as a result of which the holders of the voting capital stock of the Company as a group would receive less than 50% of the voting capital stock of the surviving or resulting corporation; (ii) the approval by the Board of an agreement providing for the sale or transfer (other than as security for obligations of the Company) of substantially all the assets of the Company; or (iii) in the absence of prior Board approval, the acquisition of more than 20% of the Company’s voting capital stock by any person within the meaning of Rule 13d-3 under the Exchange Act (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with, the Company).   Subject to the Plan’s terms, the Board has full power and authority to determine whether, to what extent and under what circumstances any outstanding award will be terminated, canceled, forfeited or suspended. Awards to that are subject to any restriction or have not been earned or exercised in full by the recipient will be terminated and canceled if such recipient is terminated for cause, as determined by the Board in its sole discretion.   The Company estimates the fair value of share-based compensation utilizing the Black-Scholes option pricing model, which is dependent upon several variables such as the expected option term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected option term and expected dividend yield rate over the expected option term. The Company believes this valuation methodology is appropriate for estimating the fair value of stock options granted to employees and directors which are subject to ASC Topic 718 requirements. These amounts are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes compensation on a straight-line basis over the requisite service period for each award.   The Company utilizes the simplified method to estimate the expected life for stock options granted to employees. The simplified method was used as the Company does not have sufficient historical data regarding stock option exercises. The expected volatility is based on historical volatility. The risk-free interest rate is based on the U.S. Treasury yields with terms equivalent to the expected life of the related option at the time of the grant. Dividend yield is based on historical trends. While the Company believes these estimates are reasonable, the compensation expense recorded would increase if the expected life was increased, a higher expected volatility was used, or if the expected dividend- yield increased.   Pursuant to the Plan, on May 10, 2022, the Company issued to two Company officers non-statutory stock options to purchase, in the aggregate, up to 265,000 shares of its Common Stock, at an exercise price of $1.80 per share valued at $477,000 and expiring on April 20, 2032. The options vest over time with 25% of the options vesting on September 1, 2022 and thereafter vesting 1/24th on the 1st of every month. As of May 31, 2024, 231,875 of the options were vested.   Pursuant to the Plan, on November 1, 2022, the Company issued non-statutory stock options, to a former executive officer of the Company, to purchase, in the aggregate, up to 15,000 shares of its Common Stock, at an exercise price of $4.00 per share valued at approximately $60,000 and expiring on October 31, 2032. 3,750 shares vested as of January 29, 2023, and the remaining 11,250 options were forfeited in April 2023 when the executive officer left the Company. The fair value of the 3,750 vested options was $15,000.   The Company computed the grant date fair value using the Black-Scholes option pricing model, which is being recorded as stock-based compensation expense over the vesting period. During the fiscal years ended May 31, 2024 and 2023, the Company recorded a stock-based compensation expense of $204,429 and $207,342 respectively, for these options in the accompanying consolidated financial statements.    The Black-Scholes options pricing model used the following assumptions:   Schedule of stock option assumptions                     2024   2023 Risk free interest rate     -     4.07 % Expected life     -       6 years   Expected volatility     -     457 % Expected dividend     -       -     The following table summarizes the activity relating to the Company’s stock options:   Schedule of summarizes relating to the Company’s stock                             Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Term Outstanding as of June 1, 2022     265,000     $ 1.80       9.92   Granted     15,000     $ 4.00       9.68   Exercised     -       -       0   Forfeited     (11,250 )   $ 4.00       9.68   Outstanding as of May 31, 2023     268,750     $ 1.83       7.81   Granted     -       -       -   Exercised/Forfeited     -       -       -   Less: Unvested at May 31, 2024     (33,125 )   $ 1.80       7.89   Vested at May 31, 2024     235,625     $ 1.84       7.90     Restricted Stock Awards   The Company’s non-employee directors participate in the Company’s non-employee director compensation arrangements. Under the terms of those arrangements and pursuant to the Plan, on February 14, 2024, the Company granted each of its three non-employee Board members 5,000 restricted stock awards for an aggregate of 15,000 shares of the Company’s common stock that will vest on the one-year anniversary of the grant, subject to the respective director’s continued service as a member of the Board, with a total grant date fair value of $195,000.   Effective May 28, 2024, a former officer entered into a Separation Agreement and Release (the “Release”), which includes a standard release of claims and confidentiality and non-disparagement provisions. As consideration for signing the Release, the Company entered into a Consulting Agreement, dated May 28, 2024, with the former officer (the “Consulting Agreement”), pursuant to which the former officer agreed to provide transition services to the Company through October 31, 2024, unless the Consulting Agreement is terminated earlier. Pursuant to the Consulting Agreement, as compensation for services as a consultant, the former officer was granted 30,000 shares of restricted common stock valued at $298,800, which vested upon grant.   The fair value of the stock grants is being recorded over the term of the service related to each grant. During the years ended May 31, 2024 and 2023, the Company recorded a stock-based compensation expense related to the restricted stock awards of $62,754 and $0, respectively.

v3.24.2.u1

Commitments and Contingencies	12 Months Ended
	May 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 11 – Commitments and Contingencies   Leases   As discussed in Note 2 above, the Company adopted ASU No. 2016-02, Leases on June 1, 2019, which require lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements classified as operating leases under the prior guidance. The Company has a lease agreement in connection with its office and warehouse facility in California under an operating lease which expired in October 2019. On December 1, 2019, the Company signed an extension of the lease for 3 years. The rent was $7,567 per month for the first year and increased by a certain amount each year. In November 2022, the Company entered into an extension of the lease for a two-year term beginning December 1, 2022. The rent is $6,098 per month for the first year and will increase by a certain amount the following year.   The Company treats a contract as a lease when the contract conveys the right to use a physically distinct asset for a period of time in exchange for consideration, or the Company directs the use of the asset and obtains substantially all the economic benefits of the asset. These leases are recorded as right-of-use (“ROU”) assets and lease obligation liabilities for leases with terms greater than 12 months. ROU assets represent the Company’s right to use an underlying asset for the entirety of the lease term. Lease liabilities represent the Company’s obligation to make payments over the life of the lease. A ROU asset and a lease liability are recognized at commencement of the lease based on the present value of the lease payments over the life of the lease. Initial direct costs are included as part of the ROU asset upon commencement of the lease. Since the interest rate implicit in a lease is generally not readily determinable for the operating leases, the Company uses an incremental borrowing rate to determine the present value of the lease payments. The incremental borrowing rate represents the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar lease term to obtain an asset of similar value. The Company reviews the impairment of ROU assets consistent with the approach applied for the Company’s other long-lived assets. The Company reviews the recoverability of long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on the Company’s ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations.   Lease expense is recognized on a straight-line basis over the lease term, while variable lease payments are expensed as incurred. Variable payments change due to facts or circumstances occurring after the commencement date, other than the passage of time, and do not result in a remeasurement of lease liabilities. The Company’s lease agreements do not contain any residual value guarantees or restrictive covenants.   Pursuant to the new standard, the Company recorded an initial lease liability of $235,748 and an initial ROU asset in the same amount in 2019. The Company computed another initial lease liability of $131,970 for the new lease agreement and an initial ROU asset in the same amount which was recorded on books at the commencement of the new lease on December 1, 2022. During the fiscal years ended May 31, 2024 and 2023, the Company recorded a lease expense in the amount of $74,635 and $84,435, respectively. As of May 31, 2024, the lease liability balance was $36,752 and the right of use asset balance was $36,752. A lease term of three years and a discount rate of 12% was used.   Supplemental balance sheet information related to leases was as follows:   Schedule of supplemental balance sheet information                 Assets   May 31, 2024   May 31, 2023 Right of use assets   $ 131,970     $ 131,970   Accumulated reduction     (95,218 )     (30,125 ) Operating lease assets, net   $ 36,752     $ 101,845                     Liabilities                 Lease liability   $ 131,970     $ 131,970   Accumulated reduction     (95,218 )     (29,394 ) Total lease liability, net     36,752       102,576   Current portion     (36,752 )     (65,824 ) Non-current portion   $ -     $ 36,752     Maturities of operating lease liabilities were as follows as of May 31, 2024:    Schedule of maturities of operating lease liabilities         Operating Lease     2025   $  38,049   Total   $ 38,049   Less: Imputed interest   $ (1,297 )  Present value of lease liabilities   $ 36,752      Contingencies   From time to time, we become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. While the ultimate resolution is unknown, we do not expect that these lawsuits will individually, or in the aggregate, have a material adverse effect to our results of operations, financial condition, or cash flows. However, the outcome of any litigation is inherently uncertain and there can be no assurance that any expense, liability, or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular period, depending upon the size of the loss or our income for that particular period. Where it is probable that we will incur a loss and the amount of the loss can be reasonably estimated, we record a liability in our financial statements. In evaluating matters for accrual and disclosure purposes, we take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters progress over time. These legal accruals may be increased or decreased to reflect any relevant developments on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, we do not record an accrual, consistent with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be predicted with certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on our results of operations, financial position or cash flows, and the amounts accrued for any individual matter are not material. However, legal proceedings are inherently uncertain. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular period, depending upon the size of the loss or our income for that particular period.   On November 23, 2020, the Company was served a copy of a complaint filed by Jacksonfill, LLC in the Fourth Circuit Court for Duval County, Florida. The complaint alleged breach of agreement for non-payments for certain products against the Company. On September 2, 2023, Jacksonfill, LLC and the Company settled the dispute in the Circuit Court of the Fourth Judicial Circuit in Duval County, Florida per a binding settlement agreement. There is no admission of liability by the Company and on September 27, 2023 the Company paid attorneys on behalf of Jacksonfill, LLC the settlement in the amount of $125,000. The reserve that was provided in the financial statements in excess of the final settlement payment was recorded as a gain on settlement and is included as other income in the amount of $79,182, in the accompanying financial statements.

v3.24.2.u1

Related Party Transactions	12 Months Ended
	May 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Note 12 – Related Party Transactions   The Company’s Chief Executive Officer, Jeff Toghraie, is the managing director of Intrepid Global Advisors (“Intrepid”). Intrepid has, from time to time, provided advances to the Company for working capital purposes. At May 31, 2024, and 2023, the Company had amounts payable to Intrepid of $11,798 and $158,072, respectively. These advances were short-term in nature and non-interest bearing. Additionally, pursuant to a voting agreement, effective June 16, 2022 as amended effective November 7, 2022, with A&A and Intrepid Global Advisors, we were subject to certain limitations on our ability to sell our capital stock until June 2024.    During the fiscal years ended May 31, 2024 and 2023, the Company paid $231,470 and $218,696, respectively, as consulting fee for product development to Weston T. Harris, a major stockholder of A&A. The Company also paid $146,546 and $126,097, respectively, to immediate family members of the major stockholder as compensation for services relating to packaging design and affiliate marketing during the fiscal years ended May 31, 2024 and 2023. In addition, in March 2024, the Company entered into a repurchase agreement with an entity managed by Mr. Harris, pursuant to which the Company repurchased 142,021,750 shares of Series A Preferred Stock from the entity for an aggregate purchase price of $852,130.    On June 16, 2022, the Company and its wholly owned subsidiary Reviv3 Acquisition Corporation (now known as AXIL Distribution Company) completed the acquisition of both (i) the hearing protection business of A&A, consisting of ear plugs and ear muffs, and (ii) A&A’s ear bud business pursuant to the Asset Purchase Agreement, dated May 1, 2022, as amended on June 15, 2022 and September 8, 2022, by and among the Company, Reviv3 Acquisition Corporation, A&A and certain stockholders of A&A. One of the stockholders of A&A was Intrepid. As of May 31, 2024, Intrepid did not hold any shares of A&A and held approximately 21.26% of the outstanding common stock of the Company (excluding shares of common stock that may be acquired upon the conversion of shares of Series A Preferred Stock).

v3.24.2.u1

Business Combination	12 Months Ended
	May 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Business Combination	Note 13 – Business Combination   On June 16, 2022, the Company completed the acquisition of certain assets of Axil & Associated Brands Corp., or A&A, a Delaware corporation, pursuant to the Asset Purchase Agreement dated May 1, 2022 and amended on June 15, 2022 and September 8, 2022, by and among the Company, its subsidiary, A&A, and certain of A&A’s stockholders, providing for the acquisition of assets relating to AXIL’s hearing protection business and ear bud business. The assets constituted substantially all of the business operations of AXIL but did not include AXIL’s hearing aid line of business.   One of the stockholders of AXIL is Intrepid Global Advisors (“Intrepid”). As of June 16, 2022, Intrepid held 4.68% of the outstanding common stock of AXIL and 22.33% of the outstanding Common Stock of the Company. As of May 31, 2024 and 2023, Intrepid held no outstanding common shares of A&A, as they were distributed with the Asset Purchase Agreement. Jeff Toghraie, Chairman and Chief Executive Officer of the Company, is a managing director of Intrepid.   As consideration for the Asset Purchase, A&A received a total of 253,659,195 shares comprised of (a) 3,659,195 shares of the Company’s Common Stock and (b) 250,000,000 shares of the company’s non-voting Series A Preferred Stock, which are convertible into shares of Company Common Stock on a 20-to-1 ratio. The Preferred Shares may not be converted or transferred for a period of two years following the closing of the acquisition. Thereafter, no holder of Preferred Shares may convert such shares into a number of shares of Company Common Stock that would cause the holder to beneficially own more than 5% of the Company’s Common Stock, as determined in accordance with Sections 13(d) and (g) of the Exchange Act. The purchase price was computed to be $4,007,480 based on a fair value of $0.0248 per common share on the date of acquisition.   The Company is utilizing the A&A assets to expand into the hearing enhancement business through its subsidiary.   The acquisition was accounted for by the Company in accordance with the acquisition method of accounting pursuant to ASC 805 “Business Combinations” and pushdown accounting is applied to record the fair value of the assets acquired by the Company. Under this method, the purchase price is allocated to the identifiable assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. Any excess of the amount paid over the estimated fair values of the identifiable net assets acquired was allocated to goodwill.   The following is a summary of the fair value of the assets acquired and liabilities assumed at the date of acquisition:   Schedule of estimated fair value of the assets acquired         Cash   $ 1,066,414   Accounts receivable     227,786   Inventory     1,342,461   Prepaid expenses     62,452   Other assets     108,030   Accounts payable     (285,665 ) Contract liabilities     (1,043,332 ) Other current liabilities     (79,826 ) Net tangible assets acquired   $ 1,398,320             Identifiable intangible assets         Licensing rights   $ 11,945   Customer relationships     70,000   Tradenames     275,000   Website     100,000   Total Identifiable intangible assets   $ 456,945             Consideration paid   $ 4,007,480   Total net assets acquired     1,855,265   Goodwill purchased   $ 2,152,215

v3.24.2.u1

Concentrations	12 Months Ended
	May 31, 2024
Risks and Uncertainties [Abstract]
Concentrations	Note 14 – Concentrations   Concentration of Credit Risk   Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of trade accounts receivable and cash deposits, investments and cash equivalents instruments. The Company maintains its cash in bank deposits accounts. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At May 31, 2024 and 2023, the Company held cash in various accounts of approximately $3,003,876 and $4,582,682, respectively, in excess of federally insured limits. The Company has not experienced any losses in such accounts through May 31, 2024.   Concentration of Revenue, Accounts Receivable, Product Line, and Supplier – Hair and Skin Care Products   During the fiscal year ended May 31, 2024 hair and skin care product sales to three customers, which each represented over 10% of our total sales, aggregated to approximately 47% of the Company’s net sales at 27%, 10% and 10%. During the fiscal year ended May 31, 2023 hair and skin care product sales to three customers, which each represented over 10% of our total sales, aggregated to approximately 94% of the Company’s net sales at 61%, 12% and 21%.   During the fiscal year ended May 31, 2024 hair and skin care product sales to customers outside the United States represented approximately 29% which consisted of 28% from Canada and 1% from Italy and during the fiscal year ended May 31, 2023 hair and skin care product sales to customers outside the United States represented approximately 25% which consisted of 20% from Canada and 5% from Italy.   During the fiscal year ended May 31, 2024, hair and skin care product sales by product line which each represented over 10% of sales consisted of approximately 22% from sales of hair shampoo, and 17% from sales of hair conditioner and 23% from bundle kits. During the fiscal year ended May 31, 2023, hair and skin care product sales by product line which each represented over 10% of sales consisted of approximately 15% from sales of hair shampoo, and 10% from sales of hair conditioner and 7% from bundle kits.   During the fiscal years ended May 31, 2024 and 2023 sales for the hair and skin care product lines comprised of the following:   Schedule of sales by product line                     For the Fiscal Years ended Hair Care Products   May 31, 2024   May 31, 2023 Shampoos and Conditioners     72 %     77 % Ancillary Products     28 %     23 % Total     100 %     100 %   At May 31, 2024, there was no accounts receivable for hair and skin care products that accounted for more than 10% of sales transactions which is due to the fact that products are sold primarily through direct-to-consumer. At May 31, 2023, accounts receivable for hair and skin care products from one customer accounted for more than 10% of sales transactions, which was Amazon and the second largest customer accounted for 8%, which is due to the fact that products are sold primarily through direct-to-consumer.   Hair and skin care product purchased inventories and products from two vendors totaling approximately $346,796 (97% of the purchases at 77% and 20%) during the fiscal year ended May 31, 2024 and three vendors totaling approximately $297,833 (95% of the purchases at 61%, 12% and 22%) during the fiscal year ended May 31, 2023.   Concentration of Revenue, Accounts Receivable, Product Line, and Supplier – Hearing Protection and Enhancement Products   The majority of hearing protection and enhancement products are sold direct-to-consumer, therefore, during the fiscal years ended May 31, 2024 and 2023, 91.2% and 97.3% of sales, respectively, were direct to customers. There was no single customer that accounted for greater than 10% of total sales.   During the fiscal year ended May 31, 2024 hearing protection and enhancement sales to customers outside the United States represented approximately 4% which consisted of 3.5% from Canada and the remaining from various countries. During the fiscal year ended May 31, 2023 hearing protection and enhancement sales to customers outside the United States represented approximately 4.5% which consisted of 3.7% from Canada and the remaining from various countries.   Manufacturing is outsourced primarily overseas via a number of third-party vendors, the largest vendor accounting for 87% of all purchases for the year ended May 31, 2024 and two vendors accounting for 82% and 10% of all purchases for the year ended May 31, 2023.   During the fiscal year ended May 31, 2024, the sale of ear buds for PSAP (personal sound amplification product) and hearing protection by product line which each represented over 10% of sales consisted approximately 38% from Bluetooth Earbuds ($15.8 million), 48% from Ghost Stryke ($19.9 million) and 13% of sales of Trackr earmuffs ($5.5 million). During the fiscal year ended May 31, 2023, the sale of ear buds for PSAP (personal sound amplification product) and hearing protection by product line which each represented over 10% of sales consisted approximately 87% from Ghost Stryke Extreme model GS-X ($18.1 million) and 9% of sales of Trackr earmuffs ($1.9 million). During the fiscal year ended May 31, 2024 and 2023 sales of hearing enhancement and protection products comprised of the following:    Schedule of sales by product comprised                     For The Years Ended May 31, Ear Protection and Enhancement Products   2024   2023 Ghost Stryke     48 %     86.7 % Trackr Earmuffs     13 %     9.1 % Bluetooth Earbuds     38 %     3.9 % Accessories and others     1 %     0.3 % Total     100 %     100 %

v3.24.2.u1

Business Segment and Geographic Area Information	12 Months Ended
	May 31, 2024
Segment Reporting [Abstract]
Business Segment and Geographic Area Information	Note 15 – Business Segment and Geographic Area Information   Business Segments   The Company, directly or through its subsidiaries, markets and sells its products and services directly to consumers and through its dealers. In June 2022, the Company acquired a hearing enhancement and hearing protection business. The Company’s determination of its reportable segments is based on how its chief operating decision makers manage the business.   The Company’s segment information is as follows:    Schedule of segment information                     Year ended May 31,     2024   2023 Net Sales                 Hair care and skin care   $ 1,382,877     $ 1,588,958   Hearing enhancement and protection     26,115,662       21,932,069   Total net sales   $ 27,498,539     $ 23,521,027                     Operating earnings (loss)                 Segment gross profit:                 Hair care and skin care   $ 875,230     $ 1,076,834   Hearing enhancement and protection     19,318,707       16,633,977   Total segment gross profit     20,193,937       17,710,811   Selling and Marketing     13,449,054       11,675,206   General and Administrative     5,241,503       4,051,394   Consolidated operating income (loss)   $ 1,503,380     $ 1,984,211                     Total Assets:                 Hair care and skin care   $ 3,172,079     $ 3,785,732   Hearing enhancement and protection     7,802,282       6,383,582   Consolidated total assets   $ 10,974,361     $ 10,169,314                     Payments for property and equipment                 Hair care and skin care   $ -     $ -   Hearing enhancement and protection     138,445       65,650   Consolidated total payments for property and equipment   $ 138,445     $ 65,650                     Depreciation and amortization                 Hair care and skin care   $ 5,553     $ 5,675   Hearing enhancement and protection     125,057       89,504   Consolidated total depreciation and amortization   $ 130,610     $ 95,179   Geographic Area Information   During the fiscal years ended May 31, 2024 and 2023, approximately 95% and 94%, respectively, of our consolidated net sales were to customers located in the U.S. (based on the customer’s shipping address). All Company assets are located in the U.S.

v3.24.2.u1

Income Taxes	12 Months Ended
	May 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Note 16 – Income Taxes   The Company is subject to U.S. federal rate of 21.0% and California state tax rate of 8.84% and Utah State tax rate of 4.65%.   The income taxes expense (benefit) for years ended May 31, 2024 and 2023 consists of the following:   Schedule of income taxes expense (benefit)           For The Fiscal Years Ended May 31,     2024   2023           Current                 Federal   $ 92,406     $ 84,619   State     81,870       146,294                   Deferred                 Federal and state     (394,481 )     -       $ (220,205 )   $ 230,913     The Company’s tax expense differs from the “expected” tax expense for federal income tax purposes (computed by applying the United States federal tax rate of 21% to loss before taxes) as follows:   Schedule of federal income tax                     For The Fiscal Years Ended May 31,     2024   2023 Tax expense (benefit) computed at statutory rate of 21%   $ 374,415     $ 431,653   State tax expense (benefit) blended rate     81,870       297,928   Permanent differences     87,614       (49,773 ) Deferred tax true up     (366,891 )     3,929   Net operating loss benefit     (397,213 )     (452,824 ) Tax expense (benefit)   $ (220,205 )   $ 230,913     Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.   The effects of temporary differences that gave rise to significant portions of deferred tax assets and liabilities at May 31, are as follows:   Schedule of deferred tax assets and liabilities             For The Fiscal Years Ended May 31,     2024   2023           Deferred tax assets                 Net operating loss carryforward   $ 231,587     $ -   Total gross deferred tax assets     231,587       -   Less: Deferred tax asset valuation allowance     -       -                     Deferred tax liabilities     -       -   Total net deferred tax assets (liabilities)   $  231,587     $ -     There was no valuation allowance at May 31, 2024 and 2023.   At May 31, 2024, the Company has net operating loss carry forwards of approximately $1.9 million available to offset future net income indefinitely subject to annual usage limitations. The utilization of the net operating loss carryforwards is dependent upon the ability of the Company to generate sufficient taxable income during the carryforward period. Management believes that the realization of the benefits from these losses appears more than likely due to the Company’s current year net income results and should be able to fully utilize that benefit in the current year tax filings. Management will not provide a valuation allowance for the losses as they appear to be fully realized.

v3.24.2.u1

Subsequent Events	12 Months Ended
	May 31, 2024
Subsequent Events [Abstract]
Subsequent Events	Note 17 – Subsequent Events   Subsequent to the year ended May 31, 2024, two preferred stockholders tendered notice to convert 10,000,000 shares of their preferred stock into common stock. On August 6, 2024, the Company issued 500,000 shares of common stock pursuant to the conversion notices received from the two preferred stockholders.

v3.24.2.u1

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	May 31, 2024
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation   The consolidated financial statements for the fiscal years ended May 31, 2024 and 2023 have been prepared by us in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and include the accounts of the Company and its consolidated subsidiary. All significant intercompany accounts and transactions have been eliminated in consolidation.
Reverse Stock Split	Reverse Stock Split   Effective as of January 16, 2024, the Company effected a reverse stock split (the “Reverse Stock Split”) of the Company’s issued shares of common stock at a ratio of 1-for-20, as approved by the Company’s Board of Directors (the “Board”). The Reverse Stock Split did not affect the total number of shares of common stock that the Company is authorized to issue and any fractional shares remaining after the Reverse Stock Split were rounded up to the nearest whole share. The accompanying consolidated financial statements and notes to the financial statements give retroactive effect to the Reverse Stock Split for all periods presented, unless otherwise specified.
Use of estimates	Use of estimates   The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. Estimates made by management include, but are not limited to, the allowance for doubtful accounts, inventory valuations and classifications, the useful life of property and equipment, the valuation of deferred tax assets, the value of stock-based compensation, contract liability, allowance on sales returns, valuation of lease liabilities and related right of use assets, fair value of securities issued for business combinations, fair value of assets acquired and liabilities assumed in business combinations and the fair value of non-cash common stock issuances.
Cash and cash equivalents	Cash and cash equivalents   The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company maintains cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. (See Note 14)
Accounts receivable and allowance for doubtful accounts	Accounts receivable and allowance for doubtful accounts   On June 1, 2023, the Company adopted ASC 326, "Financial Instruments - Credit Losses". In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting from the possible inability of customers to make required payments (current expected losses). The amount of the allowance is determined principally on the basis of past collection experience and known financial factors regarding specific customers.   Accounts receivables comprise of receivables from customers and receivables from merchant processors. The Company has a policy of providing an allowance for doubtful accounts based on its best estimate of the amount of probable credit losses in its existing accounts receivable. The Company periodically reviews its accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may indicate that the realization of an account may be in doubt. Account balances deemed to be uncollectible are charged to bad debt expense and included in the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.
Prepaid expenses and other current assets	Prepaid expenses and other current assets   Prepaid expenses and other current assets consist primarily of cash prepayments to vendors for inventory and prepayments for trade shows and marketing events which will be utilized within a year, prepayments on credit cards and the right to recover assets (for the cost of goods sold) associated with the right of returns for products sold.
Inventory	Inventory   The Company values inventory, consisting of finished goods and raw materials, at the lower of cost and net realizable value. Cost is determined using an average cost method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its net realizable value. The Company evaluates its current level of inventory considering historical sales and other factors and, based on this evaluation, classifies inventory markdowns in the statement of operations as a component of cost of goods sold. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions, customer demand or competition differ from expectations. The Company continuously evaluates the levels of inventory held and any inventory held above the expected level of sales in the next twelve months, is classified as non-current inventory.
Property and Equipment	Property and Equipment   Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed, and any resulting gains or losses are included in the statement of operations.
Product warranty	Product warranty  The Company provides a one-year, two-year or three-year limited warranty on its hearing enhancement and hearing protection products. The Company records the costs of repairs and replacements, as they are incurred, to the cost of sales.
Revenue recognition	Revenue recognition   The Company follows Accounting Standards Codification (“ASC”) 606, Revenue From Contracts With Customers. This revenue recognition standard (new guidance) has a five-step process: a) Determine whether a contract exists; b) Identify the performance obligations; c) Determine the transaction price; d) Allocate the transaction price; and e) Recognize revenue when (or as) performance obligations are satisfied.   The Company sells a variety of hair and skin care products and electronic hearing and enhancement products. The Company recognizes revenue for the agreed upon sales price when a purchase order is received from the customer and subsequently the product is shipped to the customer, which satisfies the performance obligation. Consideration paid to the customer to promote and sell the Company’s products is typically recorded as a reduction in revenues.   The five steps for revenue recognition are as follows:   Identify the contract with a customer. The Company generally considers completion of a sales order (which requires customer acceptance of the Company’s click-through terms and conditions for website sales and authorization of payment through credit card or another form of payment for sales made over the phone) or purchase orders from non-consumer customers as a customer contract provided that collection is considered probable. For payments that are not made upfront by credit card, the Company assesses customer creditworthiness based on credit checks, payment history, and/or other circumstances. For payments involving third party financier payors, the Company validates customer eligibility and reimbursement amounts prior to shipping the product.   Identify the performance obligations in the contract. Product performance obligations include shipment of products and related accessories and service performance obligations include extended warranty coverage.   However, as the historical redemption rate under our warranty policy has been low, the option is not accounted for as a separate performance obligation. The Company does not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.   Determine the transaction price and allocation to performance obligations. The transaction price in the Company’s customer contracts consists of both fixed and variable consideration. Fixed consideration includes amounts to be contractually billed to the customer while variable consideration includes the 30-days and 60-days right of return that applies to the hearing protection and enhancement segment and hair care and skin care segment, respectively. To estimate product returns, the Company analyzes historical return levels, current economic trends, and changes in customer demand. Based on this information, the Company reserves a percentage of product sale revenue and accounts for the estimated impact as a reduction in the transaction price.   Allocate the transaction price to the performance obligations in the contract. For contracts that contain multiple performance obligations, the Company allocates the transaction price to the performance obligations on a relative standalone selling price basis.   Recognize revenue when or as the Company satisfies a performance obligation. Revenue for products is recognized at a point in time, which is generally upon shipment. Revenue for services (extended warranty) is recognized over time on a ratable basis over the warranty period.   As of May 31, 2024 and May 31, 2023, contract liabilities amounted to $1,385,841 and $1,433,048, respectively. Contract liabilities associated with product invoiced but not received by customers at the balance sheet date was $0 and $0, respectively; contract liabilities associated with unfulfilled performance obligations for warranty services offered for a period of one to three years was $1,251,710 and $1,320,401, respectively, and contract liabilities associated with unfulfilled performance obligations for customers’ right of return was $130,201 and $112,647, respectively. Our contract liabilities amounts are expected to be recognized over a period of one year to three years. Approximately $771,180 is expected to be recognized in year 1, $420,630 is expected to be recognized in year 2, and $59,900 is expected to be recognized in year 3. Contract liabilities associated with gift cards purchased by customers amounted to $3,930 as of May 31, 2024. Revenue recognized, during the fiscal year ended May 31, 2023, that was included in the contract liability balance at the beginning of period (acquisition of AXIL) was $391,204
Cost of Sales	Cost of Sales   The primary components of cost of sales include the cost of the product and shipping fees.
Shipping and Handling Costs	Shipping and Handling Costs   The Company accounts for shipping and handling fees in accordance with ASC 606. While amounts charged to customers for shipping products are included in revenues, the related costs of shipping products to customers are classified in marketing and selling expenses as incurred. Shipping costs included in marketing and selling expense were $1,163,954 and $1,001,261 for the fiscal years ended May 31, 2024 and 2023, respectively.
Marketing, selling and advertising	Marketing, selling and advertising   Sales, marketing and advertising costs are expensed as incurred.
Customer Deposits	Customer Deposits   Customer deposits consisted of prepayments from customers to the Company. The Company will recognize the prepayments as revenue upon delivery of products in compliance with its revenue recognition policy.
Fair value measurements and fair value of financial instruments	Fair value measurements and fair value of financial instruments   The Company adopted ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”), for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company’s financial position or operating results, but did expand certain disclosures. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.   Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:    Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities.     Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.     Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.   The Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s (“FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.   The estimated fair value of certain financial instruments, including prepaid expenses, deposits, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.
Business Combinations	Business Combinations   For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets acquired and liabilities assumed of the acquired business, at their fair values.   Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from business combinations and are expensed as incurred. If the business combination provides for contingent consideration, the Company records the contingent consideration at fair value at the acquisition date. Changes in fair value of contingent consideration resulting from events after the acquisition date, such as earn-outs, are recognized as follows: (1) if the contingent consideration is classified as equity, the contingent consideration is not re-measured and its subsequent settlement is accounted for within equity, or (2) if the contingent consideration is classified as a liability, the changes in fair value and accretion costs are recognized in earnings. The increases or decreases in the fair value of contingent consideration can result from changes in anticipated revenue levels and changes in assumed discount periods and rates.
Goodwill	Goodwill   Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur, or circumstances indicate the fair value of a reporting unit is below its carrying value.   The Company performs its annual goodwill impairment assessment on May 31st of each year or as impairment indicators dictate.   When evaluating the potential impairment of goodwill, management first assesses a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company’s reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to the quantitative impairment testing methodology primarily using the income approach (discounted cash flow method).   Under the quantitative method we compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If the carrying value of a reporting unit exceeds its fair value, then the amount of impairment to be recognized is recognized as the amount by which the carrying amount exceeds the fair value.   When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results.
Income Taxes	Income Taxes   The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes” (“ASC 740-10”), which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.   The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.   Tax positions that meet the more likely than not recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.   The Company has adopted ASC 740-10-25, “Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the IRS and state taxing authorities, generally for three years after they are filed.
Impairment of long-lived assets	Impairment of long-lived assets     The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. The Company did not record any impairment loss during the fiscal years ended May 31, 2024 and 2023.
Stock-based compensation	Stock-based compensation   Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718, “Compensation — Stock Compensation” (“ASC 718”), which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.   For non-employee stock option based awards, the Company follows ASU 2018-7, which substantially aligns share based compensation for employees and non-employees.
Net income (loss) per share of common stock	Net income (loss) per share of common stock   Basic net income (loss) per share is computed by dividing the net income or loss by the weighted average number of common shares during the period. Diluted net loss per share is computed using the weighted average number of common shares and potentially dilutive securities outstanding during the period. The following table presents a reconciliation of basic and diluted net income per common share:   Schedule of net loss per share                     For the Year Ended     May 31,   May 31,     2024   2023           Net income   $ 2,003,134     $ 1,824,575   Gain on redemption of preferred shares     1,329,588       -   Income available to common shareholders   $ 3,332,722     $ 1,824,575                     Weighted average basic shares     5,868,570       5,644,771   Dilutive securities:                 Convertible preferred stock     10,030,861       11,952,055   Stock options     268,750       272,438   Weighted average dilutive shares     16,168,181       17,869,264                     Earnings per share:                 Basic   $ 0.57     $ 0.32   Diluted   $ 0.21     $ 0.10
Lease Accounting	Lease Accounting   In February 2016, the FASB issued ASU No. 2016-02, Leases (ASU 2016-02), which requires lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements classified as operating leases under the prior guidance (ASC Topic 840). Under the new guidance, codified as ASC Topic 842, the lease liability must be measured initially based on the present value of future lease payments, subject to certain conditions. The right-of-use asset must be measured initially based on the amount of the liability, plus certain initial direct costs. The new guidance further requires that leases be classified at inception as either (a) operating leases or (b) finance leases. For operating leases, periodic expense generally is flat (straight-line) throughout the life of the lease. For finance leases, periodic expense declines over the life of the lease. The new standard, as amended, provides an option for entities to use the cumulative-effect transition method. As permitted, the Company adopted ASC Topic 842 effective June 1, 2019.   The Company renewed its lease for its corporate headquarters commencing December 1, 2022, under lease agreements classified as an operating lease. Please see Note 11 – “Commitments and Contingencies” under “Leases” below for more information about the Company’s leases.
Segment Reporting	Segment Reporting   The Company follows ASC Topic 280, Segment Reporting. The Company’s management reviews the Company’s consolidated financial results when making decisions about allocating resources and assessing the performance of the Company as a whole and has determined that the Company’s reportable segments are: (a) the sale of hearing protection and hearing enhancement products, and (b) the sale of hair care and skin care products. See Note 15 – “Business Segment And Geographic Area Information for more information about the Company’s reportable segments.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements   In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain convertible instruments. Among other things, under ASU 2020-06, the embedded conversion features no longer must be separated from the host contract for convertible instruments with conversion features not required to be accounted for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also eliminates the use of the treasury stock method when calculating the impact of convertible instruments on diluted Earnings per Share. The Company adopted the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the accompanying consolidated financial statements.   In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This guidance requires additional annual and interim disclosures for reportable segments. This new standard does not affect the recognition, measurement or financial statement presentation. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company adopted the ASU effective June 1, 2024. The adoption of the guidance did not have a material impact on the accompanying consolidated financial statements.   Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

v3.24.2.u1

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	May 31, 2024
Accounting Policies [Abstract]
Schedule of net loss per share	Schedule of net loss per share                     For the Year Ended     May 31,   May 31,     2024   2023           Net income   $ 2,003,134     $ 1,824,575   Gain on redemption of preferred shares     1,329,588       -   Income available to common shareholders   $ 3,332,722     $ 1,824,575                     Weighted average basic shares     5,868,570       5,644,771   Dilutive securities:                 Convertible preferred stock     10,030,861       11,952,055   Stock options     268,750       272,438   Weighted average dilutive shares     16,168,181       17,869,264                     Earnings per share:                 Basic   $ 0.57     $ 0.32   Diluted   $ 0.21     $ 0.10

v3.24.2.u1

Accounts Receivable, net (Tables)	12 Months Ended
	May 31, 2024
Credit Loss [Abstract]
Schedule of accounts receivable	Schedule of accounts receivable                     May 31, 2024   May 31, 2023 Customers receivable   $ 524,730     $ 345,264   Merchant processor receivable     78,417       167,232   Less: Allowance for credit losses     (93,312 )     (95,480 ) Accounts receivables, net   $ 509,835     $ 417,016

v3.24.2.u1

Inventory, net (Tables)	12 Months Ended
	May 31, 2024
Inventory Disclosure [Abstract]
Schedule of Inventory	Schedule of Inventory                     May 31, 2024   May 31, 2023 Finished Goods   $ 3,190,344     $ 1,198,218   Raw Materials     203,679       113,646   Inventory, net   $ 3,394,023     $ 1,311,864

v3.24.2.u1

Property and Equipment (Tables)	12 Months Ended
	May 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Schedule of property and equipment                         Estimated Life   May 31, 2024   May 31, 2023 Promotional display racks   2 years   $ 30,709     $ -   Furniture and Fixtures   5 years     5,759       14,598   Computer Equipment   3 years     22,130       33,146   Plant Equipment   5-10 years     264,168       165,778   Office equipment   5-10 years     8,838       -   Automobile   5 years     24,347       15,000   Less: Accumulated Depreciation         (95,003 )     (71,059 ) Total Property, plant and equipment, net       $ 260,948     $ 157,463

v3.24.2.u1

Intangible Assets (Tables)	12 Months Ended
	May 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of intangible assets	Schedule of intangible assets                         Estimated Life   May 31, 2024   May 31, 2023 Licensing rights   3 years   $ 34,024     $ 11,945   Customer Relationships   3 years     70,000       70,000   Trade Names   10 years     275,000       275,000   Website   5 years     100,000       100,000   Less:Accumulated Amortization         (169,920 )     (74,271 ) Intangible assets, net       $ 309,104     $ 382,674

v3.24.2.u1

Other Current Liabilities (Tables)	12 Months Ended
	May 31, 2024
Payables and Accruals [Abstract]
Schedule of other current liabilities	Schedule of other current liabilities                     May 31, 2024   May 31, 2023 Credit Cards   $ 5,734     $ 833   Royalty Payment Accrual     3,376       8,792   Affiliate Accrual     -       27,673   Sales Tax Payable     231,283       258,023   Accrued Interest     -       10,343   Accrued expenses     92,543       -   Total other current liabilities   $ 332,936     $ 305,664

v3.24.2.u1

Notes Payable (Tables)	12 Months Ended
	May 31, 2024
Debt Disclosure [Abstract]
Schedule of notes payable	Schedule of notes payable                     May 31, 2024   May 31, 2023 Insurance Financing   $ -     $ 21,335   Financing charges     -       1,253   Economic Injury Disaster Loan Program (EIDL)     146,594       150,000   Total     146,594       172,588   Less: Current portion     (146,594 )     (172,588 ) Non-current portion   $ -     $ -
Schedule of notes payments due in the next five years	Schedule of notes payments due in the next five years             Total 2025   $ 146,594   Total   $ 146,594

v3.24.2.u1

Stockholders’ Equity (Tables)	12 Months Ended
	May 31, 2024
Equity [Abstract]
Schedule of stock option assumptions	Schedule of stock option assumptions                     2024   2023 Risk free interest rate     -     4.07 % Expected life     -       6 years   Expected volatility     -     457 % Expected dividend     -       -
Schedule of summarizes relating to the Company’s stock	Schedule of summarizes relating to the Company’s stock                             Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Term Outstanding as of June 1, 2022     265,000     $ 1.80       9.92   Granted     15,000     $ 4.00       9.68   Exercised     -       -       0   Forfeited     (11,250 )   $ 4.00       9.68   Outstanding as of May 31, 2023     268,750     $ 1.83       7.81   Granted     -       -       -   Exercised/Forfeited     -       -       -   Less: Unvested at May 31, 2024     (33,125 )   $ 1.80       7.89   Vested at May 31, 2024     235,625     $ 1.84       7.90

v3.24.2.u1

Commitments and Contingencies (Tables)	12 Months Ended
	May 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of supplemental balance sheet information	Schedule of supplemental balance sheet information                 Assets   May 31, 2024   May 31, 2023 Right of use assets   $ 131,970     $ 131,970   Accumulated reduction     (95,218 )     (30,125 ) Operating lease assets, net   $ 36,752     $ 101,845                     Liabilities                 Lease liability   $ 131,970     $ 131,970   Accumulated reduction     (95,218 )     (29,394 ) Total lease liability, net     36,752       102,576   Current portion     (36,752 )     (65,824 ) Non-current portion   $ -     $ 36,752
Schedule of maturities of operating lease liabilities	Schedule of maturities of operating lease liabilities         Operating Lease     2025   $  38,049   Total   $ 38,049   Less: Imputed interest   $ (1,297 )  Present value of lease liabilities   $ 36,752

v3.24.2.u1

Business Combination (Tables)	12 Months Ended
	May 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Schedule of estimated fair value of the assets acquired	Schedule of estimated fair value of the assets acquired         Cash   $ 1,066,414   Accounts receivable     227,786   Inventory     1,342,461   Prepaid expenses     62,452   Other assets     108,030   Accounts payable     (285,665 ) Contract liabilities     (1,043,332 ) Other current liabilities     (79,826 ) Net tangible assets acquired   $ 1,398,320             Identifiable intangible assets         Licensing rights   $ 11,945   Customer relationships     70,000   Tradenames     275,000   Website     100,000   Total Identifiable intangible assets   $ 456,945             Consideration paid   $ 4,007,480   Total net assets acquired     1,855,265   Goodwill purchased   $ 2,152,215

v3.24.2.u1

Concentrations (Tables)	12 Months Ended
	May 31, 2024
Risks and Uncertainties [Abstract]
Schedule of sales by product line	Schedule of sales by product line                     For the Fiscal Years ended Hair Care Products   May 31, 2024   May 31, 2023 Shampoos and Conditioners     72 %     77 % Ancillary Products     28 %     23 % Total     100 %     100 %
Schedule of sales by product comprised	Schedule of sales by product comprised                     For The Years Ended May 31, Ear Protection and Enhancement Products   2024   2023 Ghost Stryke     48 %     86.7 % Trackr Earmuffs     13 %     9.1 % Bluetooth Earbuds     38 %     3.9 % Accessories and others     1 %     0.3 % Total     100 %     100 %

v3.24.2.u1

Business Segment and Geographic Area Information (Tables)	12 Months Ended
	May 31, 2024
Segment Reporting [Abstract]
Schedule of segment information	Schedule of segment information                     Year ended May 31,     2024   2023 Net Sales                 Hair care and skin care   $ 1,382,877     $ 1,588,958   Hearing enhancement and protection     26,115,662       21,932,069   Total net sales   $ 27,498,539     $ 23,521,027                     Operating earnings (loss)                 Segment gross profit:                 Hair care and skin care   $ 875,230     $ 1,076,834   Hearing enhancement and protection     19,318,707       16,633,977   Total segment gross profit     20,193,937       17,710,811   Selling and Marketing     13,449,054       11,675,206   General and Administrative     5,241,503       4,051,394   Consolidated operating income (loss)   $ 1,503,380     $ 1,984,211                     Total Assets:                 Hair care and skin care   $ 3,172,079     $ 3,785,732   Hearing enhancement and protection     7,802,282       6,383,582   Consolidated total assets   $ 10,974,361     $ 10,169,314                     Payments for property and equipment                 Hair care and skin care   $ -     $ -   Hearing enhancement and protection     138,445       65,650   Consolidated total payments for property and equipment   $ 138,445     $ 65,650                     Depreciation and amortization                 Hair care and skin care   $ 5,553     $ 5,675   Hearing enhancement and protection     125,057       89,504   Consolidated total depreciation and amortization   $ 130,610     $ 95,179

v3.24.2.u1

Income Taxes (Tables)	12 Months Ended
	May 31, 2024
Income Tax Disclosure [Abstract]
Schedule of income taxes expense (benefit)	Schedule of income taxes expense (benefit)           For The Fiscal Years Ended May 31,     2024   2023           Current                 Federal   $ 92,406     $ 84,619   State     81,870       146,294                   Deferred                 Federal and state     (394,481 )     -       $ (220,205 )   $ 230,913
Schedule of federal income tax	Schedule of federal income tax                     For The Fiscal Years Ended May 31,     2024   2023 Tax expense (benefit) computed at statutory rate of 21%   $ 374,415     $ 431,653   State tax expense (benefit) blended rate     81,870       297,928   Permanent differences     87,614       (49,773 ) Deferred tax true up     (366,891 )     3,929   Net operating loss benefit     (397,213 )     (452,824 ) Tax expense (benefit)   $ (220,205 )   $ 230,913
Schedule of deferred tax assets and liabilities	Schedule of deferred tax assets and liabilities             For The Fiscal Years Ended May 31,     2024   2023           Deferred tax assets                 Net operating loss carryforward   $ 231,587     $ -   Total gross deferred tax assets     231,587       -   Less: Deferred tax asset valuation allowance     -       -                     Deferred tax liabilities     -       -   Total net deferred tax assets (liabilities)   $  231,587     $ -

v3.24.2.u1

Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
Accounting Policies [Abstract]
Net income	$ 2,003,134	$ 1,824,575
Gain on redemption of preferred shares	1,329,588
Income available to common shareholders	$ 3,332,722	$ 1,824,575
Weighted average basic shares	5,868,570	5,644,771
Dilutive securities:
Convertible preferred stock	10,030,861	11,952,055
Stock options	268,750	272,438
Weighted average dilutive shares	16,168,181	17,869,264
Earnings per share:
Basic	$ 0.57	$ 0.32
Diluted	$ 0.21	$ 0.10

v3.24.2.u1

Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
Restructuring Cost and Reserve [Line Items]
Stockholders' Equity, Reverse Stock Split	1-for-20
Contract liabilities	$ 1,385,841	$ 1,433,048
Contract Liabilities Description	Contract liabilities associated with product invoiced but not received by customers at the balance sheet date was $0 and $0, respectively; contract liabilities associated with unfulfilled performance obligations for warranty services offered for a period of one to three years was $1,251,710 and $1,320,401, respectively, and contract liabilities associated with unfulfilled performance obligations for customers’ right of return was $130,201 and $112,647, respectively. Our contract liabilities amounts are expected to be recognized over a period of one year to three years. Approximately $771,180 is expected to be recognized in year 1, $420,630 is expected to be recognized in year 2, and $59,900 is expected to be recognized in year 3. Contract liabilities associated with gift cards purchased by customers amounted to $3,930 as of May 31, 2024.
Selling and marketing expense	$ 13,449,054	11,675,206
Impairment loss	0	0
Customer [Member]
Restructuring Cost and Reserve [Line Items]
Selling and marketing expense	$ 1,163,954	1,001,261
Axil [Member]
Restructuring Cost and Reserve [Line Items]
Revenue recognition		$ 391,204

v3.24.2.u1

Accounts Receivable, net (Details) - USD ($)	May 31, 2024	May 31, 2023
Credit Loss [Abstract]
Customers receivable	$ 524,730	$ 345,264
Merchant processor receivable	78,417	167,232
Less: Allowance for credit losses	(93,312)	(95,480)
Accounts receivables, net	$ 509,835	$ 417,016

v3.24.2.u1

Accounts Receivable, net (Details Narrative) - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
Credit Loss [Abstract]
Bad debt expense	$ 25,471	$ 76,969

v3.24.2.u1

Inventory, net (Details) - USD ($)	May 31, 2024	May 31, 2023
Inventory Disclosure [Abstract]
Finished Goods	$ 3,190,344	$ 1,198,218
Raw Materials	203,679	113,646
Inventory, net	$ 3,394,023	$ 1,311,864

v3.24.2.u1

Inventory, net (Details Narrative) - USD ($)	May 31, 2024	May 31, 2023
Inventory Disclosure [Abstract]
Inventory held at third party location	$ 58,242	$ 0
Inventory in-transit	15,738	135,482
Inventory valuation reserves	$ 46,895
Inventory, non-current		$ 0

v3.24.2.u1

Property and Equipment (Details) - USD ($)	May 31, 2024	May 31, 2023
Property, Plant and Equipment [Line Items]
Less:Accumulated Depreciation	$ (95,003)	$ (71,059)
Property and equipment, net	$ 260,948	157,463
Promotional Risplay Racks [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	2 years
Plant Equipment	$ 30,709
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Plant Equipment	$ 5,759	14,598
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Plant Equipment	$ 22,130	33,146
Property, Plant and Equipment [Member]
Property, Plant and Equipment [Line Items]
Plant Equipment	$ 264,168	165,778
Property, Plant and Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Property, Plant and Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	10 years
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Plant Equipment	$ 8,838
Office Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Office Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	10 years
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Plant Equipment	$ 24,347	$ 15,000

v3.24.2.u1

Property and Equipment (Details Narrative) - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
Property, Plant and Equipment [Abstract]
Depreciation	$ 34,961	$ 20,908

v3.24.2.u1

Intangible Assets (Details) - USD ($)	May 31, 2024	May 31, 2023
Finite-Lived Intangible Assets [Line Items]
Less: Accumulated Amortization	$ (169,920)	$ (74,271)
Finite-lived Intangible Assets, Net	$ 309,104	382,674
Licensing Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Life	3 years
Finite-lived Intangible Assets, Gross	$ 34,024	11,945
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Life	3 years
Finite-lived Intangible Assets, Gross	$ 70,000	70,000
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Life	10 years
Finite-lived Intangible Assets, Gross	$ 275,000	275,000
Website [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Life	5 years
Finite-lived Intangible Assets, Gross	$ 100,000	$ 100,000

v3.24.2.u1

Intangible Assets (Details Narrative) - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023	Jun. 16, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 2,152,215	$ 2,152,215	$ 2,152,215
Amortization expense	$ 95,649	$ 74,271

v3.24.2.u1

Other Current Liabilities (Details) - USD ($)	May 31, 2024	May 31, 2023
Payables and Accruals [Abstract]
Credit Cards	$ 5,734	$ 833
Royalty Payment Accrual	3,376	8,792
Affiliate Accrual		27,673
Sales Tax Payable	231,283	258,023
Accrued Interest		10,343
Accrued expenses	92,543
Total other current liabilities	$ 332,936	$ 305,664

v3.24.2.u1

Equipment Payable (Details Narrative) - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
Equipment Payable
Equipment Payable	$ 0	$ 2,200
Interest expense	$ 500	$ 500

v3.24.2.u1

Notes Payable (Details) - USD ($)	May 31, 2024	May 31, 2023
Guarantor Obligations [Line Items]
Total	$ 146,594	$ 172,588
Less: Current portion	(146,594)	(172,588)
Non-current portion
Insurance Financing [Member]
Guarantor Obligations [Line Items]
Total		21,335
Financing Charges [Member]
Guarantor Obligations [Line Items]
Total		1,253
Economic Injury Disaster Loan Program [Member]
Guarantor Obligations [Line Items]
Total	$ 146,594	$ 150,000

v3.24.2.u1

Notes Payable (Details 1)	May 31, 2024 USD ($)
Debt Disclosure [Abstract]
2025	$ 146,594
Total	$ 146,594

v3.24.2.u1

Notes Payable (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	May 18, 2020	May 31, 2024	May 31, 2022	May 31, 2023	May 31, 2020
Debt Instrument [Line Items]
Accrued interest				$ 10,343
Insurance Financing [Member]
Debt Instrument [Line Items]
Insurance financing		53,337
Finance charges		3,164
Economic Injury Disaster Loan Program [Member]
Debt Instrument [Line Items]
Face Amount					$ 150,000
Interest rate	3.75%
Additional borrowings			$ 10,000
Loan forgiveness			$ 10,000
Accrued interest		$ 5,776		$ 10,342

v3.24.2.u1

Stockholders' Equity (Details)	12 Months Ended
	May 31, 2024	May 31, 2023
Equity [Abstract]
Risk free interest rate	4.07%	(0.00%)
Expected life	6 years
Expected volatility	457.00%	(0.00%)
Expected dividend

v3.24.2.u1

Stockholders' Equity (Details 1) - $ / shares	12 Months Ended
	May 31, 2024	May 31, 2023
Equity [Abstract]
Number of option outstanding, beginning		265,000
Weighted average exercise price, beginning		$ 1.80
Weighted average remaining term, beginning		9 years 11 months 1 day
Number of option, granted		15,000
Weighted average exercise price, granted		$ 4.00
Weighted average remaining term, granted		9 years 8 months 4 days
Number of option, exercised
Weighted average exercise price, exercised
Number of option, forfeited		(11,250)
Weighted average exercise price, forfeited		$ 4.00
Weighted average remaining term, forfeited		9 years 8 months 4 days
Number of option outstanding, ending	268,750
Weighted average exercise price, ending	$ 1.83
Weighted average remaining term, ending	7 years 9 months 21 days
Number of option unvested	(33,125)
Unvested weighted average exercise price	$ 1.80
Unvested weighted average remaining term	7 years 10 months 20 days
Vested number of option	235,625
Vested weighted average exercise price	$ 1.84
Vested weighted average remaining term	7 years 10 months 24 days

v3.24.2.u1

Stockholders’ Equity (Details Narrative) - USD ($)		1 Months Ended			2 Months Ended	12 Months Ended
	Mar. 05, 2024	Feb. 14, 2024	Apr. 30, 2023	Jan. 29, 2023	Aug. 14, 2024	May 31, 2024	May 31, 2023	Nov. 01, 2022	May 31, 2022	May 10, 2022
Class of Stock [Line Items]
Common stock, shares authorized						450,000,000	450,000,000
Common stock, par or stated value per share						$ 0.0001	$ 0.0001
Preferred stock, shares authorized						300,000,000	300,000,000
Preferred stock, par or stated value per share						$ 0.0001	$ 0.0001
Reverse stock split						1-for-20
Shares issued value during the period							$ 447,850
Preferred stock, shares issued						42,251,750	250,000,000
Preferred stock, shares outstanding						42,251,750	250,000,000
Common stock, shares issued						5,908,939	5,863,939
Common stock, shares outstanding						5,908,939	5,863,939
Number of restricted stock awards issued						45,000
Exercise price						$ 1.83			$ 1.80
Shares vested						235,625
Stock-based compensation expense						$ 267,183	$ 207,342
Three Board Members [Member]
Class of Stock [Line Items]
Number of restricted stock awards issued		5,000
Fair value of restricted stock		$ 195,000
Director [Member]
Class of Stock [Line Items]
Number of restricted stock awards vested		15,000
Equity Option [Member]
Class of Stock [Line Items]
Shares vested						231,875
Stock-based compensation expense						$ 204,429	207,342
Restricted Stock Awards [Member]
Class of Stock [Line Items]
Stock-based compensation expense						$ 62,754	$ 0
Officers [Member]
Class of Stock [Line Items]
Number of option issued										265,000
Exercise price										$ 1.80
Value of option issued										$ 477,000
Former Executive Officer [Member]
Class of Stock [Line Items]
Number of option issued								15,000
Exercise price								$ 4.00
Value of option issued								$ 60,000
Shares vested				3,750
Shares forfeited			11,250
Fair value of shares vested				$ 15,000
Several Private Placement Agreements [Member]
Class of Stock [Line Items]
Number of common stock sold						97,359
Share price						$ 4.60
Value of common stock sold						$ 447,850
Assets Purchase Agreement [Member]
Class of Stock [Line Items]
Shares issued during the period							3,659,195
Shares issued value during the period							$ 907,481
Non Voting Series A Preferred Stock [Member]
Class of Stock [Line Items]
Shares issued during the period						250,000,000
Shares issued value during the period						$ 3,100,000
Preferred Stock [Member]
Class of Stock [Line Items]
Number of share purchased	207,748,250
Cash consideration	$ 1,246,490
Remaining outstanding					42,251,750

v3.24.2.u1

Commitments and Contingencies (Details) - USD ($)	May 31, 2024	May 31, 2023
Assets
Right of use assets	$ 131,970	$ 131,970
Accumulated reduction	(95,218)	(30,125)
Operating lease assets, net	36,752	101,845
Liabilities
Lease liability	131,970	131,970
Accumulated reduction	(95,218)	(29,394)
Total lease liability, net	36,752	102,576
Current portion	36,752	65,824
Non-current portion		$ 36,752

v3.24.2.u1

Commitments and Contingencies (Details 1) - USD ($)	May 31, 2024	May 31, 2023
Commitments and Contingencies Disclosure [Abstract]
2025	$ 38,049
Total	38,049
Less: Imputed interest	(1,297)
Present value of lease liabilities	$ 36,752	$ 102,576

v3.24.2.u1

Commitments and Contingencies (Details Narrative) - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Lessee, Operating Lease, Description	Company signed an extension of the lease for 3 years. The rent was $7,567 per month for the first year and increased by a certain amount each year. In November 2022, the Company entered into an extension of the lease for a two-year term beginning December 1, 2022. The rent is $6,098 per month for the first year and will increase by a certain amount the following year.
Monthly base rent	$ 6,098
Initial lease liability	235,748
Initial right of use asset	131,970
Lease expense	74,635	$ 84,435
Lease liability	36,752	102,576
Right of use asset	$ 36,752	101,845
Discount rate	12.00%
Claim amount	$ 125,000
Gain on settlement		$ 79,182

v3.24.2.u1

Related Party Transactions (Details Narrative) - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
Related Party Transaction [Line Items]
Compensation paid for services	$ 146,546	$ 126,097
Weston T. Harris [Member]
Related Party Transaction [Line Items]
Consulting fee	$ 231,470	218,696
Mr. Harris [Member]
Related Party Transaction [Line Items]
Shares repurchased	142,021,750
Aggregate purchase price	$ 852,130
Intrepid [Member]
Related Party Transaction [Line Items]
Payable to related party	$ 11,798	$ 158,072

v3.24.2.u1

Business Combination (Details) - USD ($)	May 31, 2024	May 31, 2023	Jun. 16, 2022
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Cash			$ 1,066,414
Accounts receivable			227,786
Inventory			1,342,461
Prepaid expenses			62,452
Other assets			108,030
Accounts payable			(285,665)
Contract liabilities			(1,043,332)
Other current liabilities			(79,826)
Net tangible assets acquired			1,398,320
Identifiable intangible assets
Licensing rights			11,945
Customer relationships			70,000
Tradenames			275,000
Website			100,000
Total Identifiable intangible assets			456,945
Consideration paid			4,007,480
Total net assets acquired			1,855,265
Goodwill purchased	$ 2,152,215	$ 2,152,215	$ 2,152,215

v3.24.2.u1

Business Combination (Details Narrative)	1 Months Ended
	Jun. 16, 2022 USD ($) $ / shares shares
Business Acquisition [Line Items]
Shares consideration	253,659,195
Acquisition Costs, Period Cost | $	$ 4,007,480
Acquisition price per share | $ / shares	$ 0.0248
Common Stock [Member]
Business Acquisition [Line Items]
Shares consideration	3,659,195
Preferred Stock [Member]
Business Acquisition [Line Items]
Shares consideration	250,000,000
Axil [Member]
Business Acquisition [Line Items]
Equity Method Investment, Ownership Percentage	4.68%
Jeff Toghraie [Member]
Business Acquisition [Line Items]
Equity Method Investment, Ownership Percentage	22.33%

v3.24.2.u1

Concentrations (Details) - Revenue Benchmark [Member] - Product Concentration Risk [Member]	12 Months Ended
	May 31, 2024	May 31, 2023
Shampoos and Conditioners [Member]
Concentration Risk [Line Items]
Total	72.00%	77.00%
Ancillary Products [Member]
Concentration Risk [Line Items]
Total	28.00%	23.00%
Product [Member]
Concentration Risk [Line Items]
Total	100.00%	100.00%

v3.24.2.u1

Concentrations (Details 1) - Revenue Benchmark [Member] - Product Concentration Risk [Member]	12 Months Ended
	May 31, 2024	May 31, 2023
Ghost Stryke [Member]
Concentration Risk [Line Items]
Total	48.00%	86.70%
Trackr Headmuff [Member]
Concentration Risk [Line Items]
Total	13.00%	9.10%
Other Bluetooth And Ear Buds [Member]
Concentration Risk [Line Items]
Total	38.00%	3.90%
Accessories Other [Member]
Concentration Risk [Line Items]
Total	1.00%	0.30%
Product [Member]
Concentration Risk [Line Items]
Total	100.00%	100.00%

v3.24.2.u1

Concentrations (Details Narrative) - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
Concentration Risk [Line Items]
Cash, FDIC insured amount	$ 250,000
Cash, uninsured amount	$ 3,003,876	$ 4,582,682
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	47.00%	94.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	27.00%	61.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Two [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	10.00%	12.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Three [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	10.00%	21.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Axil [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	91.20%	97.30%
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | Outside The United States [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	29.00%	25.00%
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | CANADA
Concentration Risk [Line Items]
Concentration risk, percentage	28.00%	20.00%
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | ITALY
Concentration Risk [Line Items]
Concentration risk, percentage	1.00%	5.00%
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | Axil [Member] | Outside The United States [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	4.00%	4.50%
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | Axil [Member] | CANADA
Concentration Risk [Line Items]
Concentration risk, percentage	3.50%	3.70%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Hair Shampoo [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	22.00%	15.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Hair Conditioner [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	17.00%	10.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Bundled Kits [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	23.00%	7.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Ghost Stryke [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	48.00%	86.70%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Trackr Headmuff [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	13.00%	9.10%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Vendors One [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		82.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Vendors Two [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		10.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Axil [Member] | Ear Buds [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	38.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Axil [Member] | Ghost Stryke [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	48.00%	87.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Axil [Member] | Trackr Headmuff [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	13.00%	9.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Two Vendors [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	87.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		8.00%
Purchases [Member] | Product Concentration Risk [Member]
Concentration Risk [Line Items]
Purchased inventories and products	$ 346,796	$ 297,833
Purchases [Member] | Product Concentration Risk [Member] | Vendors [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	97.00%
Purchases [Member] | Product Concentration Risk [Member] | Vendors One [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	77.00%	61.00%
Purchases [Member] | Product Concentration Risk [Member] | Vendors Two [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	20.00%	12.00%
Purchases [Member] | Product Concentration Risk [Member] | Vendor [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		95.00%
Purchases [Member] | Product Concentration Risk [Member] | Vendors Three [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		22.00%

v3.24.2.u1

Business Segment and Geographic Area Information (Details) - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
Segment Reporting Information [Line Items]
Total net sales	$ 27,498,539	$ 23,521,027
Total segment gross profit	20,193,937	17,710,811
Selling and Marketing	13,449,054	11,675,206
General and Administrative	5,241,503	4,051,394
Consolidated operating income (loss)	1,503,380	1,984,211
Consolidated total assets	10,974,361	10,169,314
Consolidated total payments for property and equipment	138,445	65,650
Consolidated total depreciation and amortization	130,610	95,179
Hair Care And Skin Care [Member]
Segment Reporting Information [Line Items]
Total net sales	1,382,877	1,588,958
Total segment gross profit	875,230	1,076,834
Consolidated total assets	3,172,079	3,785,732
Consolidated total payments for property and equipment
Consolidated total depreciation and amortization	5,553	5,675
Hearing Enhancement And Protection [Member]
Segment Reporting Information [Line Items]
Total net sales	26,115,662	21,932,069
Total segment gross profit	19,318,707	16,633,977
Consolidated total assets	7,802,282	6,383,582
Consolidated total payments for property and equipment	138,445	65,650
Consolidated total depreciation and amortization	$ 125,057	$ 89,504

v3.24.2.u1

Business Segment and Geographic Area Information (Details Narrative)	12 Months Ended
	May 31, 2024	May 31, 2023
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | Customers [Member]
Revenue, Major Customer [Line Items]
Concentration Risk, Percentage	95.00%	94.00%

v3.24.2.u1

Income Taxes (Details) - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
Current
Federal	$ 92,406	$ 84,619
State	81,870	146,294
Deferred
Federal and state	(394,481)
Income tax expense (benefit)	$ (220,205)	$ 230,913

v3.24.2.u1

Income Taxes (Details 1) - USD ($)	12 Months Ended
	May 31, 2024	May 31, 2023
Income Tax Disclosure [Abstract]
Tax expense (benefit) computed at statutory rate of 21%	$ 374,415	$ 431,653
State tax expense (benefit) blended rate	81,870	297,928
Permanent differences	87,614	(49,773)
Deferred tax true up	(366,891)	3,929
Net operating loss benefit	(397,213)	(452,824)
Tax expense (benefit)	$ (220,205)	$ 230,913

v3.24.2.u1

Income Taxes (Details 2) - USD ($)	May 31, 2024	May 31, 2023
Deferred tax assets
Net operating loss carryforward	$ 231,587
Total gross deferred tax assets	231,587
Less: Deferred tax asset valuation allowance
Deferred tax liabilities
Total net deferred tax assets (liabilities)	$ 231,587

v3.24.2.u1

Income Taxes (Details Narrative)	12 Months Ended
	May 31, 2024 USD ($)
Operating Loss Carryforwards	$ 1,900,000
UNITED STATES
Federal rate	21.00%
CANADA
state tax rate	8.84%
Utah State
state tax rate	4.65%

v3.24.2.u1

Subsequent Events (Details Narrative) - shares		2 Months Ended
	Aug. 06, 2024	Aug. 14, 2024
Common Stock [Member]
Number of shares issued	500,000
Preferred Stock [Member]
Number of shares converted		10,000,000

---